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Abstract:
Cell-penetrating peptides (CPPs) have the potential to deliver a host o f 
macromolecular therapeutics into cells including peptides, proteins, and nucleotides. 
The mechanism by which they are internalised has been hotly-disputed but is 
important if improvements are to be made in their delivering capacities. Endocytosis is 
thought to be o f significant importance but identifying the exact uptake mechanism 
has been difficult due predominantly to a lack o f specific tools. Multiple pathways 
have been reported to contribute to uptake, including macropinocytosis and those 
regulated by clathrin and cavaeolin-1.
The aim o f this thesis was to utilise siRNA-depletion to develop cell models with 
defects in specific endocytic proteins and pathways that could then be utilised to study 
the uptake o f drug deliveiy vectors such as CPPs. Targeted pathways were those 
regulated by clathrin heavy chain, dynamin-2, caveolin-1, flotillin-1 and P21-activated 
kinase (PAK-1). Significant variation between cell lines emerged in the expression o f 
these proteins and the ease with which they could be depleted. Single siRNA 
sequences were, however, discovered that effectively depleted these proteins and 
using a variety o f endocytic probes the effects of depletion could be determined. 
Eventually, model cell lines were generated that were measurably defective in at least 
one o f the five different endocytic pathways and these were tested to determine routes 
utilised by two well characterised CPPs, HIV-Tat and octaarginine. Only cells 
depleted o f  pak-1 protein and thus macropinocytosis were defective in CPP uptake. 
Further analysis revealed defective actin organisation in these cells that could have 
caused the effects and support data presented here and elsewhere on actin disruption 
with cytochalasin D. With comparative studies using pharmacological inhibitors o f 
endocytic pathways these methods provide new tools to study drug delivery systems 
as shown here for CPPs and also for polyplexes through a collaboration with the 
University o f  Ghent, Belgium.
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Chapter 1: General Introduction
1.1. The drug delivery challenge
Recently, we have observed a remarkable increase in the interest surrounding 
the potential o f using large therapeutic molecules, such as proteins, peptides 
and nucleic acid as therapeutics. This stems in part from an increased 
understanding of the molecular causes of diseases such as cancer and inherited 
genetic diseases. However, progress in this field is restricted by a lack o f 
efficient drug delivery systems for these new therapeutics. Problems include 
poor stability in vivo, insufficient cellular uptake and the difficulty in reaching 
a specific molecular target. This is in addition to a requirement for high doses 
in order to reach the effective potency but at the same time avoiding the risks 
o f side effects. Therefore, there is a real requirement for new and more 
efficient drug delivery systems. To solve this problem there are some issues 
that need to be considered in order to establish potential new delivery systems, 
including (i) delivery or uptake efficiency in different tissues; (ii) rapid 
endosomal escape; (iii) ability to reach a specific target; (iv) efficiency at low 
doses; (v) lack of toxicity; and (vi) affordability for mass production (Sahay et 
al. 2010).
A number of different strategies have been attempted to improve drug delivery 
efficiency (de Fougerolles et al. 2007; Jarver and Langel 2004; Kong and 
Mooney 2007; Torchilin 2005b), including non-viral approaches using for 
example liposomes, polycationic polymers, nanoparticles, and peptide-based 
strategies (Jarver and Langel 2004; Morris et al. 2000; Torchilin 2005b). 
Cell-penetrating peptides (CPPs) is a term used to describe short peptides that 
are typically < 30 residues in length. Today CPPs are still considered to be one 
o f the most promising strategies to overcome the limitations of delivering
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various bioactive molecules such as plasmid DNA, oligonucleotide, siRNA, 
peptide-nucleic acid (PNA), peptides and proteins into cells. As described 
below CPPs come in many different forms but the fact that they are called 
CPPs is due to the fact that they have some kind of mechanism for overcoming 
at least one biological barrier and most importantly a number have also 
demonstrated a further capacity to act as delivery vectors for cargo that may be 
several orders of magnitude larger that the peptides themselves (Derossi et al. 
1994; Meade and Dowdy 2007; Morris et al. 2008; Pooga et al. 1998). 
Importantly this also includes cargo with therapeutic potential such as those 
described above (Johnson et al. 2011).
1.2. Membrane active, to cell penetrating peptides
Cellular membranes such as the plasma membrane and endosomal membranes 
serve as the major barriers to drug delivery for many therapeutic agents thus 
limiting their prospects o f ever reaching the clinic. The search is therefore 
always on for agents that can interact with membranes and aid in the delivery 
o f a bioactive molecule to the interior o f the cell. This may be directly across 
the plasma membrane but more likely the strategy would depend on uptake of 
the vector and carrier into the cell interior by one o f several endocytic 
pathways that cells have (Jones 2008). Peptide sequences that have affinities 
for biological membranes have been described for decades and in the main 
focus was given to antimicrobial peptides or those that were toxic to 
mammalian cells such as mastoporan (Bemheimer and Rudy 1986). There was 
also interest in pH sensitive peptides such as GALA, a 30 residue synthetic 
peptide that partitioned into membranes (Parente et al. 1990). However, at the
3
very end of the last century, peptide sequences were discovered that were 
membrane active without necessarily being membrane damaging and thus 
cytotoxic. The first one to be highlighted was transcription-transactivating 
(Tat) protein of HIV-l(Frankel and Pabo 1988) followed closely by Drosophila 
Antennapedia (Derossi et al. 1994). Initially they were called protein 
transduction domains as they formed the domains of larger proteins, such as 
the 100 residue HIV-Tat protein, but this terminology has now largely been 
replaced with cell penetrating peptides or CPPs. Since then hundreds of 
different sequences have been described that fall into this classification and 
some older peptides such as mastoparan have since fallen into this category. It 
is often asked whether CPP is a good terminology for these entities over 
membrane active or translocating peptides.
CPPs are generally composed of small (<30 amino acid) peptides and several 
classes have been described that compose a variety of sequences and 
electrostatic charges (Fischer et al. 2005; Foerg and Merkle 2008). In addition 
to their ability to penetrate the plasma membrane, they have the ability to 
deliver a wide variety of otherwise membrane impermeable macromolecules 
including fluorophores, peptide nucleic acids, proteins, oligonucleotides, and 
plasmids (Aoki et al. 2010; Jarver and Langel 2006; Johnson et al. 2011; 
Morris et al. 2008).
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1.3. CPPs Classification
Several attempts have been made to classify CPPs depending on, for example, 
the basis o f their primary sequences, or whether they are natural peptides, 
synthetic or chimeras. Recently, Andre Ziegle introduced another classification 
system for CPPs, which stands on studies carried out on model membranes. 
This classification grouped CPPs into sub-classes according to their physical 
properties in the presence of membranes of different compositions (Ziegler 
2008). The system highlighted in Figure 1.1 is based on a number of factors 
(Fischer et al. 2005) but highlights the most common variants. This formed the 
basis for organisation o f the sequences shown in Table 1.1 that classifies them 
into three main groups:
1.3.1. Antimicrobial peptides
They were first isolated from blood leukocytes and lymphatic tissue 100 years 
ago. They have antimicrobial activity against Gram positive and Gram negative 
bacteria (Skames and Watson 1957). Examples include: buforin, magainin and 
LL-37 (Sandgren et al. 2004; Takeshima et al. 2003).
1.3.2. Protein derived CPPs
They are usually known as protein transduction domains PTDs, and are 
composed of minimal effective sequence of the parent protein, which is 
responsible for the translocation activity. For example, Penetratin, pVEC, and 
Tat are derived from the third helix of the Drosophila antennapedia 
transcription factor, the murine vascular endothelial cadherin and HIV-1 Tat
5
protein, respectively (Derossi et al. 1994; Elmquist et al. 2001; Vives et al. 
1997).
1.3.3. Designed CPPs 
They can be subdivided to:
• Amphiphilic : MAP (Oehlke et al. 1998).
• Chimeric: Transportan and MPG (Morris et al. 1997; Pooga et al. 1998).
• Homing peptides: Lyp-1 and F3 (Laakkonen and Vuorinen 2010).
• Synthetic: Pep-1 and oligoarginines (Argn where n is usually 7-20
residues) (Futaki et al. 2001; Morris et al. 2001).
At physiological pH, most CPPs have net positive charge and most often have 
only negative charge at the C terminus when that terminus is amidated. That 
negative charge does not prevent the penetration of CPPs, an example given by 
VT5 peptide that carries five positive charges and four negative charges and 
internalised efficiently (Oehlke et al. 1997). It should be noted that a number of 
the sequences described in Table 1.1 have been synthesised in the D form as 
this will significantly reduce proteolysis (Gammon et al. 20Q3).
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Origin Sequence Reference
Antimicrobial peptides (MAPs)
Buforin Stomach of the 
Asian toad Bufo 
bufo
gargarizans
TRSSRAGLQFPVGRVHRLLRK (Takeshima et al. 
2003)
Magainin skin of the 
African clawed 
frog Xenopus 
laevis
GIGKFLHSAKKFGKAFVGEIMNS (Takeshima et al. 
2003)
LL-37 Induced from
Bacterial
infections
epithelial
surfaces
interaction
LLGDFFRKSKEKIGKEFKRIVQRIK
DFLRNLVPRTES-C-amide
(Sandgren et al. 
2004)
SynB
Peptides
protegrin 1, an
antimicrobial
peptide
RGGRLSYSRRRFSTSTGR,
RRLSYSRRRF
(Drin et al. 2003)
Protein derived CPPs
Tat HIV TAT GRKKRRQRRRPPQ (Gump et al. 
2010; Vives et al. 
1997)
Penetratin
(pAntp)
Drosophila
Antennapedia
Homeodomain
RQIKIWFQNRRMKWKK (Derossi et al. 
1994)
pVEC Vascular
endothelial
Cadherin
LLIILRRRIRKQAHAHSK-amide (Elmquist et al. 
2001)
Designed CPPs
MAP Model
amphipathic
peptide
KLALKLALKALKAALKLA-amide (Oehlke et al. 
1998)
Transportan Galanin(l-12)-
Lys-
Mastoparan, 
desigened as 
GalR ligand.
GWTLNSAGYLLGKINLKALAALA
KKIL-amide
(Pooga et al. 
1998)
MPG Cationic NLS + 
Hydrophobic 
tail
GALFLGWLGAAGSTMGAPKKKR
KV-cysteamide
(Morris et al. 
1997)
Pep-1 Cationic NLS + 
hydrophobic 
tail
KETWWETWWTEWSQPKKKRKV-
cysteamide
(Morris et al. 
2001)
Polyarginines Synthetic (R)n (Futaki et al. 
2001; Rothbard 
et al. 2000)
Table 1.1. A three classification system for the more common CPPs.
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Penetratin and Penetratirv- 
derived peptides
- Penetratin
RQIKIWFQNRRMKWKK
- retro-inverso 
kkwkmrmqfwvrvqr
- W/R Penetratin 
RRWRRWWWRRWWRRWRR
Buforin
GIGKFLHSAKKFGKAFVGEIMNS
Magainin
TRSSRAGLQFPVGRVHRLLRK
Nuclear localization sequences 
VQRKRQKLMP 
PKKKRKV 
ERKKRRRE
Amphiphatic model peptide
KLALKLALKALKAALKLA Antimicrobial
peptides
Cationic
CPPsAmphipathic 
peptides
Proline-rich 
CPPs
Prdine-nch
dendrimers
ChimericCPPs from 
various sources CPPsHydrophobic 
CPPs
PreS2-TLM
PLSSIFSRIGDG
Loligomers
Signal
sequences
TAT and TAT-derived peptides 
TAT YGRKKRRQRRR
N-terminal repetitive domain 
of maize gamm-zein
(VRLPPP)n
(VHLPPP)n
(VKLPPP)n
Poly-arginine 
iptides_
SynBI
RGGRLSYSRRRFSTSTGRA
Chariot (Non-covalent delivery of 
peptides and proteins 
KETWWETWWTEWSQPKKKRKV
MPG (Non-covalent delivery of nudeic adds) 
GALFLGFLGAAGSTMGAWSQPKKKRKVC
Calcitonin-derived peptide: 
LGTYTQDFNKFHTFPQTAIGVGAP
Transportan 
GWTLNSAGYLLGKINLKALAALAKKIL1
Fusion sequence of HIV- gp41
GALFLGFLGAAGSTMGA
Membrane Permeable Sequences 
- Kaposi FGF signal sequence 
AAVALLPAVL LALLAP 
• human integrin beta3 
signal sequence 
VTVLALGALAGVGVG
1.4. CPPs and the deliveiy of therapeutic molecules
Although the mechanisms of uptake of CPPs alone or with cargo is largely 
undetermined they have been shown to successfully deliver a wide range of 
interesting pharmacological molecules into different cell-lines (Foerg and 
Merkle 2008; Gupta et al. 2005; Johnson et al. 2011; Temsamani and Vidal 
2004). The following sections show the main applications of CPPs in the drug 
delivery field emphasising the nature of the cargo.
1.4.1. Peptide delivery
Rather than using full-length proteins to modify cellular physiology in a 
disease state, it is preferable to use a specific peptide sequence that can have 
protein-specific biological activity. One o f the main reasons for this is that 
peptides are easier to manufacture and to deliver. Many studies have been done 
on different CPP conjugated peptides but relatively few studies have been 
described where their mechanism o f uptake has been scrutinized at the same 
time as measuring their bioactivities. The fact that CPPs can enter most cell 
types offers some advantages and disadvantages but for cancer it is often 
required that some form of specific cell targeting is needed and this has also 
been shown for CPPs. For example, conjugating DV3, the ligand for 
chemokine receptor 4 (CXCR4) that is over-expressed in more than 20 types of 
cancer, to a CPP enhanced the delivery o f CPPs specifically to cancer cells 
(Snyder et al. 2005). Recently, two interesting studies were performed using a 
sequence derived from the C-terminus of p53-derived linked to the N-terminus 
of penetratin (p53p-Ant) (Li et al. 2005b; Senatus et al. 2006). They first 
showed that p53p-Ant induced cell death selectively only in pre-malignant or
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malignant cells, and avoided normal cells or p53 null cells (Li et al. 2005b). 
The second study showed that the same chimeric peptide promoted apoptosis 
in human and rat glioma cells both in vitro and in vivo (Senatus et al. 2006). 
Now hundereds of manuscripts are published describing the use of CPPs for 
the delivery of bioactive peptides, and these show great potential for treating 
cancer, ischemia and heart disease, inflammation, diabetes and many other 
diseases.
It is however important to note that the sequence itself may have effects on the 
ability of CPPs to enter cells. Work from our lab on the proapoptotic peptide 
(KLAKLAK)2 (PAD) showed that attaching this to R8 led to the manufacture 
of a highly necrotic peptide but that cells incubated with a combination of R8 
and PAD were unaffected (Watkins et al. 2009a). Here charge is a major 
factor as the PAD sequence is also highly positive, and also helical. But this 
highlights that peptide cargo and CPP together could produce non-specific 
effects (Watkins et al. 2009a).
1.4.2. Protein Delivery
Entire proteins do however offer exciting alternatives to peptides as therapeutic 
molecules but here the problem of delivery is higher as they are larger and 
there is a need to maintain their three-dimensional structure (Tan et al. 2009). 
Furthermore, another obstacle for using proteins as therapeutics (to function 
inside cells) is their stability, which depends on weak non-covalent interactions 
between their secondary, tertiary and quaternary structures. Thus, these 
molecules have short in vivo half-lives and poor bioavailability. Accordingly,
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they require vectors that efficiently deliver them into cells both in vitro and in 
vivo (Morris et al. 2001; Tan et al. 2009; Wadia and Dowdy 2005).
Different types of delivery vectors based, for example, on lipids and polymer 
have been used for protein delivery, including liposomes, microparticles and 
nanoparticles, but unfortunately most o f them show relatively poor efficiency 
(Tan et al. 2009).
On the other hand, CPPs have been shown to be able to promote the delivery of 
several different types of proteins and importantly this maintained biological 
activity. In fact it was the demonstration that a CPP (HIV TAT) coupled to p- 
galactosidase could deliver the enzyme into several mouse tissues following IV 
injection that sparked initial interest in this field and significantly raised the 
profile o f CPPs as potential delivery vectors (Fawell et al. 1994; Schwarze et 
al. 1999). Other studies have used p- galactosidase as a delivery model and 
other proteins that have been shown to be successfully delivered by CPPs are 
eGFP (Caron et al. 2001), Bcl-xL (Cao et al. 2002; Embury et al. 2001), human 
catalase (Jin et al. 2001), and human glutamate dehydrogenase (Yoon et al. 
2002). Most of CPPs are coupled to proteins via either covalent bonds, avidin- 
biotin affinity or via fusion constructs (Deshayes et al. 2008; Gros et al. 2006; 
Jones 2010; Patel et al. 2007). These studies demonstrate that CPPs can be 
considered as effective tools to mediate protein-based therapeutics for curing 
many diseases, such as cancer, inflammatory diseases, diabetes and brain 
injury.
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/. 4.3. Delivery o f  low molecular weight drugs
A main obstacle for successful cancer treatment is clinical resistance 
highlighted by the ability of cancer cells to develop resistance initially to one 
or two types of drugs but to then evolve to be multidrug resistance (Szakacs et 
al. 2006). Thus, many studies have been done to enhance the uptake of 
anticancer agents and to overcome clinical resistance. An example of low 
molecular weight drug or small molecule that has been commonly studied in 
drug delivery applications is the anthracycline doxorubicin, which is 
commonly used as anticancer agent; but also as a model drug for multidrug 
resistance. Studies have been published whereby doxorubicin has, via one form 
or other, been associated with CPPs in an attempt to overcome resistance 
mechanisms. Two studies have assessed the uptake of a doxorubicin-SynB 
conjugate into the brain of mice and rats following in vivo cerebral perfusion 
(Rousselle et al. 2000; Rousselle et al. 2001). The SynB peptide (Table 1.1) 
was conjugated to doxorubicin and an in situ brain perfusion technique was 
applied. This method is a simple and sensitive method in which the BBB is 
exposed for a short time (15 to 90 s) to a drug under infusion conditions where 
the fluid composition and the rate of infusion are controlled. The studies 
highlighted that SynB vectors enhanced brain uptake of doxorubicin without 
affecting blood brain barrier integrity and the same results were obtained when 
doxorubicin was administered intravenously (Rousselle et al. 2000). Cardiac 
levels of doxorubicin-SynB conjugate were very low, and this is important as 
cardiac complications are one of the main side effects of doxorubicin 
treatment. D- penetratin has also been conjugated to this drug (DOX-D- 
penetratin) using in vivo brain perfusion, which has been mentioned previously
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(Rousselle et al. 2000). The results show that even at low concentration of 
DOX-D-penetratin shows a fivefold to sevenfold improvement in delivery, 
compared with free doxorubicin (Bolton et al. 2000).
Antibiotics have also been linked to CPPs in an attempt to deliver them into the 
brain and these include benzyl-penicillin (Rousselle et al. 2002). These types of 
antibiotics required for CNS infection are characterized by poor brain 
permeability, which reduce their therapeutic efficacy. Benzyl-penicillin was 
conjugated to SynBl vector through glycolamidic ester linker and its uptake 
into brain was evaluated via in situ brain perfusion. Uptake increased eightfold, 
compared with free B-Pc (Rousselle et al. 2002).
1.4.4. DNA delivery
There is also a wealth of literature on the use of CPPs for delivering DNA and 
other nucleotide based compounds. One major advantage of cationic CPPs is 
that they have high affinity for negatively charged phosphates on nucleotides 
and this allows the formation of complexes similar to those of cationic polymer 
or lipids with nucleotides. For example a series of synthesized complexes 
containing 1-8 Tat moieties and plasmid DNA, in different cell lines have been 
evaluated (Tung et al. 2002). The study reveals that high transfection ability 
was only found with complexes, containing eight molecules of Tat peptide per 
DNA molecule. Liposomes, are widely used to deliver genes for gene therapy 
but their poor cellular penetration decreases the bioactivity of their cargo. 
Researchers have examined the potential for improving cellular penetration, 
and nucleotide delivery of liposomes when they are further conjugated with 
different CPPs. For example, penetratin and Tat peptides when conjugated to
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liposomes enhanced cellular delivery and transfection capacity (Console et al. 
2003; Torchilin et al. 2001; Tseng et al. 2002). The Torchilin group have also 
shown how a polyethylene glycol masked liposome can be constructed that 
hides the CPP Tat until low pH, that is typically seen in the tumour 
environment, cleaves the mask to reveal the CPP that then mediates uptake of 
the liposome into cells and presumably aids in endosomal escape (Torchilin 
2005a)
1.4.5. Delivery o f  oligonucleotides (ONs)
The discovery of short sequences o f mRNA, typically 21-27 residues in length 
could potentially silence the expression of any protein in the genome was a 
new opportunity for drug delivery research. These are however membrane 
impermeable and like plasmid DNA they require a delivery vector (Meade and 
Dowdy 2007). These have largely overtaken the use of antisense systems that 
at one time were also of considerable interest and other examples of ONs are 
locked nucleic acids (LNAs) and phosphorodiamidate morpholino oligomers 
(PMOs), decoy-ONs and plasmids, and their analogues such as peptide nucleic 
acids (PNAs) (Saleh et al. 2010). Again there are several examples of the use 
of CPPs for delivering these short nucleotide sequences to modify cell 
physiology (Eguchi and Dowdy 2010; Palm-Apergi et al. 2011; Saleh et al. 
2010)
14
o
siRNAPeptide Plasmid
CPP s-s'X /X /^
& A l i « A n < d  f l M
(D ^ v x z r a m m z x ^ v  
Peptode-protem interaction siRNA-modiated mRNA degradation
Protem-proten. 
Protetn-ON interaction Antisense
Protein expression
Protein-proiem, 
Protein-ON interaction
Protein
Figure 1.2. (Jarver and Langel 2004). Various possible applications for cell 
penetrating peptides.
(a) Peptide-protein interaction in the cytoplasm, (b) Peptide-protein and 
peptide-ON interaction in the nucleus, (c) Protein-protein interaction in the 
cytoplasm, (d) Protein-protein and protein-ON interaction in the nucleus, (e) 
Antisense ON-mRNA hybridization, (f) siRNA-mediated mRNA degradation, 
(g) Transfected plasmid and protein expression.
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1.5. Cellular Uptake of CPPs
Despite the wide use of CPPs for delivery purposes, the exact mechanisms 
underlying their cellular uptake remain unclear and are still debatable. It is 
often claimed that CPP internalisation is highly efficient and non-toxic to the 
cells, without causing membrane destabilization and loss of cellular integrity. 
But there is also plenty of evidences to suggest that even at low micro-molar 
concentrations (5-50) that even the most commonly studied are not without 
effects on cells. There are reports of leakage out of cellular material at 20-50 
pM and also leakage in of normally membrane impermeable probes such as 
propidium iodide (El-Andaloussi et al. 2007; Tunnemann et al. 2008)
It is important to note here, as shown in Table 1.1, the high degree of 
heterogeneity in amino acid sequences between one class of peptides called 
CPP and this complicates matters when a single pathway or mechanism is 
searched for to answer questions regarding uptake. It is now appreciated that a 
single mechanism is unlikely to emerge but there remains a need to study their 
uptake further in order to understand how this can be improved for drug 
delivery purposes.
Initially, CPP internalisation was reported to occur even at low temperatures, 
excluding endocytotic pathways as the main mechanism responsible for the 
uptake of these peptides. This suggested the existence of an energy- 
independent internalisation mechanisms, not requiring the involvement of 
membrane receptors or any active process (Derossi et al. 1996). In fixed cells 
using microscopy, peptides such as HIV-Tat and R9 were shown to enter cells 
efficiently and then move to the nucleus. Later two independent studies 
showed that both CPP protein delivery to the nucleus and CPP-fluorophore
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delivery to the same organelle was a product of fixation artefact (Lundberg et 
al. 2003; Vives et al. 2003). This required a complete reassessment of the 
mechanisms involved in CPP internalisation.
The data, which has been obtained from these reassessment studies, were 
performed in live cells, and overall they highlight that in addition to the 
previously described endocytosis-independent mechanisms, uptake of CPPs 
could involve several endocytic pathways, such as caveolae-mediated 
endocytosis (Ferrari et al. 1998; Fittipaldi et al. 2003), macropinocytosis 
(Kaplan et al. 2005; Wadia et al. 2004) and clathrin-mediated endocytosis 
(Richard et al. 2005). Additionally, variations were observed between the 
internalisation of unconjugated (small fluorophore) and conjugated CPPs, 
suggesting different internalisation mechanisms for the same peptide, 
depending on the presence or absence of cargo and the size of the cargo. 
Moreover, it has been shown that cell surface heparan sulphate proteoglycans 
(HSPG) play an important role in the CPPs uptake process (Belting 2003) 
especially with cationic peptides that are likely to have high affinity for 
negatively charged sugars that reside on these molecules. Figure 1.3 illustrates 
different proposed mechanisms to explain the internalisation of free or cargo- 
conjugated CPPs.
CPP attached to fluorophores and cargo have been shown to be enriched in 
endocytic organelles thus clearly demonstrating the roles for some kind of 
internalisation pathway but as mentioned a cell has many different kinds of 
endocytic pathways. Endocytosis is discussed in the following section, which 
deals with this process itself breaking it down into several pathways and 
describing proteins that regulate specific events and routes and some that
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regulate multiple pathways. Characterising the roles of these proteins and 
pathways in the uptake of CPPs was a major focus of the thesis.
1.6. Endocytosis
The plasma membrane acts as a highly effective barrier between the inside and 
outside o f cells and this is necessary to maintain and control the intracellular 
microenvironment. Only few compounds can pass this barrier and this depends 
mostly on their molecular size, net charge and polarity. Essential amino acids 
and ions such as sodium and potassium cross the plasma membrane via 
specific proteins pumps and ion channels, while large molecules enter via 
endocytosis. During this process, the plasma membrane is invaginated and 
converted into a vesicle, for example a clathrin coated vesicle, which then 
detaches from the plasma membrane and migrates into the cell. This then fuses 
with some sort of sorting endosome that regulates further delivery to many 
different organelles or back to the cell surface (Conner and Schmid 2003; 
Doherty and McMahon 2009; Johannes and Lamaze 2002). Endocytosis plays 
key roles in allowing entry of nutrients for the cell and in regulating many 
intracellular signaling cascades. As mentioned, several types of endocytic 
pathways have now been described and a number of reviews have been written 
to describe these and but it is highly unlikely that the list is complete. (Doherty 
and McMahon 2009). The most characterised pathways and mechanisms are 
described below and shown in Figure 1.3.
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1.6.1. Endocytic pathways
1.6.1.1 .Clathrin-mediated endocytosis (CMEJ
CME is by far the most studied endocytic pathway and takes place in several 
mammalian cell lines, and plays an important role in the uptake of a number of 
receptor ligands such as transferrin (Tf), and low-density lipoprotein (LDL). 
CME is also crucial for essential for tissues and organ development as it is 
required for intracellular communication and to control transduction of signals 
by mediating or down-regulating activated signaling receptors (Brodsky et al. 
2001; Conner and Schmid 2003; Di Fiore and De Camilli 2001; Johannes and b 
Lamaze 2002; Schmid 1997). Furthermore, CME also plays an important role 
in regulating membrane pumps that control the uptake of small molecules, ions 
(Conner and Schmid 2003) and in controlling the strength of synaptic 
transmission, as well as in efficient recycling o f synaptic vesicle membrane 
proteins after neurotransmission (Beattie et al. 2000; De Camilli and Takei 
1996; Royle and Lagnado 2010).
Three different types of coat proteins have been described in cells and these 
organise themselves usually on the cytosolic portion of transmembrane 
proteins to initiate the budding process whether this be on the plasma 
membrane for endocytosis or on other locations such as the trans-Golgi 
network or endoplasmic reticulum for secretion. These three types are known 
as coat protein-1 (COP-I), coat protein-II (COP-II), and clathrin. Their 
organisation on membranes is involved with cargo selection and usually the 
coat consists of several different proteins. COP-I coats are responsible for 
transfer of material from the Golgi apparatus and the endoplasmic reticulum 
(ER), whereas, COP-II coats are associated with vesicles that transferred from
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ER to Golgi apparatus (Alberts 2002; Johannes and b Lamaze 2002). However 
COPII has also been implicated in mediating traffic from early to late 
endosomes (Aniento et al. 1996).
Clathrin is the major protein component of clathrin coated vesicles (CCV). 
Clathrin associates as a triskelia consisting of three clathrin light chains (CLC, 
25 kD), and three much larger proteins called clathrin heavy chains (CHC, 190 
KDa) (Alberts 2002; Marsh and McMahon 1999). The clathrin triskelions form 
hexagons and pentagons to organise the classical basketlike frameworks that 
by electron microscopy can be seen as coated pits on the cytosolic surface of 
the plasma membrane (Figure 1.4).
Other members of the clathrin coat proteins family are the adaptor proteins 
(APs); multi-subunit complexes, which are necessary to attach the clathrin coat 
to the membrane. Furthermore, they are required to pack or cluster specific 
membrane proteins (i.e. cargo receptors) and proteins that interact with them 
into each newly made CCV (Alberts 2002). Clathrin is known to function not 
only on the plasma membrane but also on sorting endosomes for recycling and 
the trans-Golgi network for secretion of proteins from this organelle (Harasaki 
et al. 2005). Specificity for these membrane trafficking systems comes in part 
from the fact that four different types of adaptor complexes have now been 
identified and are termed API, AP2, AP3, and AP4. Each is required for a 
specific set of cargo receptors but importantly only AP2 is associated in CCV 
formation at the plasma membrane (Conner and Schmid 2003; Motley et al.
2003). AP2 is composed of four sub-units called a-adaptins and p2-adaptins, 
p2, and ct2 sub-units Figure 1.5.
21
Another important regulator of endocytosis via clathrin is the GTPase 
Dyriamin. This acts as a scissor to separate the CCV from the plasma 
membrane. It assembles as a ring around each CCV neck and it is considered 
as regulatory GTPase in CME (Alberts 2002; Conner and Schmid 2003). 
Activation of dynamin occurs when it goes through GTP-hydrolysis-driven 
conformational change (Song and Schmid 2003). Many studies show that over­
expression of dominant-negative GTPase domain mutants of dynamin can 
inhibit receptor-mediated endocytosis (Damke et al. 1994; Damke et al. 2001). 
There are two major isoforms of this protein termed Dynamin I and Dynamin
II. Dynamin I is neuron specific but Dynamin II is ubiquitously expressed and 
also occurs as several different splice variants and each may have a different 
role to play in endocytosis (Cao et al. 2007). CME is a dynamic network of 
protein-protein and protein-lipid interactions and several other proteins such as 
Epsin, API80, amphiphysin are involved in regulating this process then in 
stripping the coat off the CCV through to fusion of this vesicle with the sorting 
endosome.
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Figure 1.5 The organisation of the AP2 adaptor protein complex (Conner 
and Schmid 2003).
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1.6.1.2.Caveolae-dependent endocytosis
Lipid rafts are major sites for non-clathrin coated invaginations and in many 
cell types these are the sites of membrane invaginations called caveolae. They 
are flask-shaped pits that cover the plasma membrane of many cell types, and 
are 55-80 nm in diameter (Conner and Schmid 2003; Parton and Richards
2003). Only a low amount of fluid phase uptake is thought to occur through 
cavaeloae and the internalisation rate is also low due to their small size and 
their high cholesterol content (Conner and Schmid 2003; Mayor et al. 1998). 
The most notable protein in cavaeolae is caveolin o f which there are three 
types, Caveolin 1, 2 and 3. Caveolin 1 and 2 are expressed in many different 
tissues but caveolin 3 is specific for muscle. Cells lacking caveolins do not 
have caveolae but it is still unclear exactly how caveolin organizes caveolae or 
whether caveolin are actually involved in the invagination of caveolae into 
caveosomes. It is however well known that the cytosolic portion of caveolin 
acts as a signaling scaffold that regulates a number of different cellular 
processes such as G-protein subunits, receptor and non-receptor tyrosine 
kinases, endothelial nitric oxide synthase (eNOS), and small GTPases (Couet 
et al. 2001; Frank et al. 2003). Caveolin-1 is a 21 KDa integral membrane 
protein that strongly binds to cholesterol (Anderson 1998; Furuchi and 
Anderson 1998; Parton and Richards 2003), and caveolin dependent uptake 
also has a requirement for active dynamin and the actin cytoskeleton (Nichols 
2002; Thomsen et al. 2002). Different types of cargo such as; lipids, proteins 
and lipid-anchored proteins are internalised by caveolae (Doherty and 
McMahon 2009; Mayor and Pagano 2007). Caveolin mediated endocytosis 
results in the formation of caveosomes, which are then able to fuse with early
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endosomes. Only a few proteins are thought to be involved in the invagination 
process but one example is PTRF-Cavin (Hill et al. 2008). To study and to 
investigate the involvement o f caveolin dependent endocytosis in the uptake o f  
different cargo researchers have used cholesterol sequesters/binders methyl-fl- 
cyclodextrin (M0CD), filipin and nystatin; thus the effects are not directly on 
caveolin but on the entire plasma membrane. Overexpression o f dominant- 
negative caveolin mutants, and genetic knockout o f caveolin genes, have also 
been used to inhibit caveolin dependent uptake (Drab et al. 2001; Razani et aL 
2002). Despite the fact that much is known about caveolins, relatively little 
knowledge is available on the regulation o f endocytosis by this pathway. It is 
also important to note that cells o f the haematopoietic system do not express 
caveolin (Fra et al. 1994, 1995) and these can be a good models to study the 
absolute requirement o f caveolae in uptake o f any particular cargo.
Several attempts have been made to identify a protein or cargo that is 
specifically internalised by caveolae and not through other pathways. An 
initial candidate was cholera toxin B that enters cells via the GM1 ganglioside 
receptor. This probe is available commercially as a fluorescent conjugate but 
more recent studies have shown that the protein can also enter cells through 
CME (Hansen et al. 2005). The group o f Pagano demonstrated that the 
glycosphingolipid (GSL) LacCer (lactosylceramide) enters cells through 
caveolae and several studies have used this probe as a marker for caveolae 
endocytosis. This was shown by Pagano’s group via a detailed study o f GSL 
analog internalisation in multiple cell types, such as HeLa, CHO-K1, Calu-1, 
and Calu-6, and they have compared those results to parallel studies using 
fluorescent Cholera toxin B. Their data has provided strong evidence that
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fluorescent GSL analogs of widely varying structure are internalised primarily 
by a Cav-1 dependent process (Singh et al. 2003). a new role for caveolae has 
been proposed by Sinha B et al, where caveolin acts as a physiological 
membrane reservoir that quickly accommodates sudden and acute mechanical 
stresses such as osmotic swelling, shear stress, or mechanical stretching (Sinha 
et al. 2011).
1.6.1.3.Clathrin and Caveolin independent endocytosis (Flotillin-dependent 
endocytosis
It has been shown that different types of cargo and receptor molecules are 
internalised into cells by vesicular carriers that are formed without the 
requirement for clathrin and caveolin. Recently, a new pathway was described 
that is regulated by flotillin-1 and 2, also known as Reggie-2 and 1, 
respectively. These have been reported to be expressed as integral membrane 
proteins in cholesterol rich membrane microdomains. Although they have 
similar topology to caveolin-1 and generate structures that look like caveolae, 
it has been shown that flotillin-1 is not colocalized with caveolin (Frick et al. 
2007; Glebov et al. 2006; Solis et al. 2007; Stuermer et al. 2001). Flotillin and 
caveolin share same characteristics as both of them bind to Src-family kinases 
and any mutation in specific tyrosine residues cause an alteration in their 
subcellular distribution (Neumann-Giesen et al. 2007). Lately, flotillin 
dependent uptake was described as a new clathrin and caveolin independent 
pathway (Glebov et al. 2006). Beside flotillin itself, there are no well- 
characterised probes available for labelling this pathway inside cells. It has 
however been shown that depleting flotillin-1, reduces the uptake rate of an
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antibody recognising CD59 (protectin) (Glebov et al. 2006). This was 
demonstrated through siRNA depletion of flotillin-1 that reduced the uptake of 
anti-CD59 antibody but it should be noted that inhibition was only 25-30 % 
suggesting it may also enter via a different mechanism. CD59 is a 
glycophosphatidyinositol (GPI) linked protein that protects cells form self 
damage by the complement system but may have other functions (Kimberley et 
al. 2007). For demonstrating the role o f flotillin-1 in CD59 uptake a 
commercial FITC-anti-CD59 was used, but this is no longer available. The 
group of Professor Paul Morgan at the University of Wales Hospital in Cardiff 
has studied CD59 in detail and has published on different antibodies 
recognizing distinct regions of the molecule (Bodian et al. 1997). To use an 
antibody for live uptake studies, it is important that it recognizes the 
extracellular domain of the protein and one such example is A35 that was used 
for this thesis- see section 2.3.5.2. Interestingly uptake of the cationic polymer 
and vector polyethylenimine was also shown to be inhibited in siRNA-flotillin 
silenced cells (Payne et al. 2007) and as CPPs studied here are also cationic it 
is interesting to discover if they also enter through this pathway. One of the 
problems of using siRNA to deplete endocytic proteins and pathways is that 
there may be effects on other pathways and depleting flotillin-1 was shown to 
significantly decrease caveolin-1 expression but the effect was not observed 
after down-regulation of flotillin-2 (Vassilieva et al. 2009). This effect was 
reversed after cell exposure to lysosomal inhibitor, but not proteosomal 
inhibitor.
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1.6.1 A Macropinocvtosis
Macropinocytosis is a form of endocytosis that is associated with cell surface 
ruffling in which a large amount of extracellular fluid and other components 
are internalised (Doherty and McMahon 2009; Jones 2007a). The so formed 
macropinocytic vesicles or macropinosomes are heterogeneous in size and can 
be up to 10 pm in diameter. There are different forms of ruffles, such as 
planner folds, cup-shaped, and circular extensions of cytoplasm and the extent 
of ruffling is different from one cell type to another, therefore the rate of 
macropinocytosis may varying between cell types. It is still debatable whether 
all cell types can mediate this pathway and also whether this can be a 
constitutive process or one that will only proceed in an activated cell. Ruffles 
occur due to actin polymerization near the plasma membrane, which cause an 
extension of the cell surface (Swanson and Watts 1995). The ruffling process 
can therefore be inhibited by cytochalasin D, which disrupts the actin 
cytoskeleton (Grassme et al. 1996). In addition, it has been shown that actin- 
based mechanochemical enzymes such as myosin II, which are required for 
ruffling, can be inhibited using a drug called blebbistatin (Mercer and Helenius 
2008). It is a small molecule inhibitor discovered in a screen for inhibitors of 
nonmuscle myosin IIA and its effects are reversible upon washout of the drug 
(Limouze et al. 2004). Moreover, it has been shown that macropinocytosis is 
inhibited by amiloride, which is a guanidinium-containing pyrazine derivative 
and inhibitor of the Na+/H+ exchanger; more recently it has also been shown to 
also affect intracellular and endosomal pH (Koivusalo et al. 2010). This 
amiloride effect has been used as an identification tag for macropinocytosis, 
however the exact mechanism of inhibiting macropinocytosis by this drug is
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still unclear (Meier et al. 2002; Veithen et al. 1996). Studies from our 
laboratory have however shown that the drug and the more commonly used 
amiloride analogue 5-(N-Ethyl-N-isopropyl) (EIPA) also has large effects on 
the distribution o f endocytic organelles.
Once inside the cell the ruffle is invaginated as a macropinosome and studies 
have shown that these can then be delivered to lysosomes in some cells types 
or be recycled in others (Jones 2007). They have also been shown to contain 
classical early endosomal markers such as EEA1 and Rab5 (Schnatwinkel et al.
2004).
Although, there is no specific endocytic marker for macropinocytosis, growth 
factor induced ruffling results in a rapid increase in fluid phase endocytosis o f 
endocytic probes/markers such as dextrans and horseradish peroxidase and it is 
the uptake o f these that is measured to show that macropinocytosis is 
occurring. For example it has been shown that treatment o f skin epithelia A431 
cells with epidermal growth factor (EGF) results in extensive membrane 
ruffling and this is associated with an extremely rapid increase in dextran 
uptake (Haigler et al. 1979; Liberali et al. 2008). It has been reported that many 
pathogens utilize this mode o f endocytosis to invade eukaryotic cells and these 
include ebola virus, HIV, vaccinia viris and adenovirus (Marechal et al. 2001; 
Meier and Greber 2004; Mercer and Helenius 2008; Saeed et al. 2010).
It is now established that P21-activated kinase (PAK-1) plays an important role 
in macropinocytosis. This protein is characterized by its capacity to bind 
activated Rho, GTPases, Cdc42, and Racl (Parrini et al. 2005) and its function 
is to coordinate extracellular signals with the reorganization o f the actin 
cytoskeleton and focal adhesions (Hofmann et al. 2004). It was shown that
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endogenous PAK-1, in Swiss 3T3 fibroblasts, localized to pinocytic vesicles 
(Dharmawardhane et al. 1997) and they also revealed that PAK-1 can induce 
the formation o f circular dorsal ruffles, which can be associated with the 
macropinocytic uptake process. In another study from the same group, the 
inhibition o f endogenous PAK activity using a PAK-specific autoinhibitory 
domain inhibits growth factor-induced macropinocytosis, proving that PAK 
activity is required for normal macropinocytosis (Dharmawardhane et al. 
2000). The roles o f PAK-1 and PAK-2 in breast carcinoma cell invasion was 
studied by targeting these proteins with siRNA sequences (Coniglio et al. 
2008). The depletion o f PAK-1, compared with PAK-2 had a stronger 
inhibitory effect on lamellipodial protrusion, and highlighted the importance o f 
this protein in regulating the actin cytoskeleton during cell motility and 
invasion
1 -6.1.5.Qther endocytic pathways and proteins
The best characterized endocytic pathways have been described but this list is 
incomplete as others have also been discovered. But they are still new and 
there is no real agreement on the types o f proteins that act as regulators or the 
types o f probes that should be used to mark them. Examples include pathways 
regulated by ARF-6 and GRAF-1. ARF-6 is a member o f the ADP ribosylation 
factor family o f GTP-binding proteins and has been shown to be required for a 
number o f different endocytic processes (D'Souza-Schorey and Chavrier 2006; 
Schweitzer et al. 2010). GRAF-1 (GTPase regulator associated with focal 
adhesion kinase-1) has been shown to be involved in the internalisation GPI 
(glycosylphosphatidylinositol)-anchored proteins, bacterial toxins and large
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amounts of extracellular fluid and is thought to mediate the formation of 
Clathrin-Independent Carriers (CLICs) and GPI- Enriched Endocytic 
Compartments (GEECs) (Fig 1.3) (Doherty and Lundmark 2009).
1.6.2. Tools to study different endocytic pathways
Cell biologists studying endocytic proteins, lipids and pathways and drug 
delivery researchers interested in intracellular transport need tools to be able to 
selectively target different endocytic pathways. A number of approaches have 
been investigated but the three main methods are : (i) Using pharmacological 
inhibitors (ii) Depleting a key regulatory endocytic protein using a siRNA 
sequence and (iii) transfecting cells with a mutated or truncated from of an 
endocytic protein. The following section will cover the first two methods and 
will highlight the advantages and disadvantages of each.
1.6.2.1 .Chemical Inhibitors
It is essential to have simple, reliable, and affordable methods that can be used 
to investigate different endocytic pathways. By far the most common, 
especially in drug delivery studies, employ the use of pharmacological or 
chemical inhibitors. There are several advantages of these inhibitors over the 
more sophisticated molecular biological tools. First, they equally affect all cells 
in a population, and these effects can be easily quantified. Second, the 
incubation period of cells with these drugs are usually short, and thus exclude 
the development of delayed side effects or compensation machinery. Third, 
pharmacological inhibitors still considered as the tools of choice for in vitro 
studies. In addition, they are relatively cheap to purchase and experiments
31
using these is technologically less demanding then other methods. On the 
whole, however, they suffer enourmously from lack o f specificity (Ivanov 
2008; Vercauteren et al. 2010). Table 1.2 shows the most common endocytic 
pharmacological inhibitors, their mechanism o f action and the pathways that 
they effect. An in depth analysis o f their lack o f specificity is not given here 
but for example MfiCD is commonly used as a drug affecting lipid rafts and 
uptake through cavaeolae but in some cell types it inhibits CME (Rodal et a l 
1999). Cytochalasin D is also used to inhibit macropinocytosis and 
phagocytosis but chlopromazine has been shown to be be a strong inhibitor o f 
CME in many cell types (Fujimoto et al. 2000). It is also important to consider 
their toxicity, even at short time points, and this was noted recently for 
chlorpromazine through work with our collaborators in Ghent (Vercauteren et 
al. 2010).
1.6.2.2.siRNA depletion o f endocvtic proteins to modify endocytic pathways 
Today there is documentation in thousands o f manuscripts studies describing 
RNA interference for silencing the expression o f specific proteins in eukaryotic 
cells. It is an experimental process in which a small synthetic RNA fragment 
binds to its complementary sequences o f mRNA target and consequently 
blocks the expression o f this mRNA and thus the expression o f one protein is 
depleted or silenced altogether. These RNA fragments are so called siRNAs 
Figure 1.6 and siRNA mediated gene silencing provides a reliable way to 
characterize a gene knockdown phenotype in vitro. The method is however not 
without its own problems such as the need for transfection and the possibility 
o f affecting other protein targets beyond the one selected for study.
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The application of RNAi technology is widely used now in different research 
areas; for instance, it has been shown that RNAi tools was used to inhibit the 
replication of HIV-1 in established cell lines as well as in primary peripheral 
blood lymphocytes (Jacque et al. 2002). For neurodegenerative diseases, 
siRNA was used to suppress the toxic gain-of-function gene mutation for 
amyotrophic lateral sclerosis (Ding et al. 2003) and Huntington’s disease 
(Harper et al. 2005). In addition, the RNAi-mediated gene-silencing machinery 
is also used to study cancer (Billy et al. 2001), and different studies have 
studied knockdown phenotypes o f oncogenes using siRNA (Wilda et al. 2002). 
There is also very active research into the use of siRNA as therapeutic entities 
(Walton et al. 2010).
Furthermore, siRNA depletion has also been utilized to evaluate and 
investigate different endocytic pathways and Table 1.3 highlights some of 
these studies. This allows for one single protein to be depleted and then one 
can study the effects of this depletion on one or more endocytic pathways. 
siRNA has the capacity to be highly specific but there are also reports of the 
siRNA target depleting more than one protein, and the possibility that by 
depleting one protein you are affecting a relationship between one protein and 
another and so the loss of activity o f one protein could increase or decrease the 
activity of another. Some proteins are also critical for survival and thus 
depletion leads to lack of viability; this was shown for long term (72 hrs) 
depletion of clathrin heavy chain (Motley et al. 2003). The method also 
depends on having the available reagents to transfect the cells with the siRNAs 
and also measure the loss of depletion using PCR or immunolabelling; not all 
cells are equally easy to transfect. For endocytosis studies it is also critical that
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the loss of a protein can be functionally assayed with an endocytic probe such 
as measuring the reduced uptake of transferrin in CHC depleted cells (Table 
1.3). For some of the more recent and less well characterised endocytic 
proteins and pathways this is not so easy.
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Inhibitor Mode of action Affected endocytic pathways
References
Chlorpromazine
Prevents assembly of 
clathrin-coated pits at 
the plasma membrane
Clathrin-Mediated
Encocytosis
(Marina- 
Garcia et al. 
2009)
Dynasore Dynamin GTPase inhibitor
Dynam in-dependent 
endocytosis
(Kirchhausen 
et al. 2008)
MaCD
'
Disrupts rafts by its 
ability to extract 
cholesterol from the 
membrane
Caveolin dependent 
and lipid raft 
endocytosis
(Duchardt et 
al. 2007)
Filipin
Disrupt raft and 
caveolae function by 
precipitating 
cholesterol in the plane 
of the host cell plasma 
membrane.
Caveolin dependent 
and lipid raft 
endocytosis
(Ruter et al. 
2010)
Nystatin
Disrupt raft and 
caveolae function by 
precipitating 
cholesterol in the plane 
of the host cell plasma 
membrane
Caveolin dependent 
and lipid raft 
endocytosis
(Rothe et al. 
2010)
CytoD
Blocks act in 
polymerisation by 
occupying fast growing 
end of filament
Macrop inocytps is
(Kalin et al. 
2010)
EIPA Na+/H+ ion exchange inhibitor M acrop inocytos is
(Mercer and 
Helenius 
2008)
Bleb bistatin
.... ..
Myosin II inhibitor, 
prevents membrane 
blebbing
Macropinocytosis
(Mercer and 
Helenius 
2008)
Wortmannin PI-3 kinase inhibitor M acrop inocytos is (Elmquist et al. 2006)
Table 1.2. Chemical inhibitors for different endocytic pathways.
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Endocytic
proteins
siRNA
Endocytic
Probe(s)
Reference
CHC Single sequence Transferrin
(Huang et al. 2004) 
(Motley et al. 
2003)
DNM2
Pooled mixture of 
siRNA duplexes
Transferrin
dextran
(Cao et al. 2007)
Flot-1 Single sequence CD59 antibody
(Glebov et al. 
2006)
Cav-1
Pooled mixture of 
siRNA duplexes
BODIPY-
LacCer
(Trushina et al. 
2006)
PAK-1 Single sequence 70-kD Dextran
(Mercer and 
Helenius 2008)
Table 1.3. Different endocytic proteins that have been depleted using 
siRNA targeting.
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Figure 1.6. The mechanism of RNA interference
1.6.3. Endocytosis and CPP entry
There is good evidence to support the fact that fractions of most CPPs enter 
cells via endocytosis, but there is little agreement on the type of pathway(s) 
that is used by each variant and whether there is any commonality between 
them. It was believed for a long period in the history of CPPs research that 
uptake was independent of endocytosis and energy. The problems of fixation 
has already been described and since this period endocytosis gained popularity 
as a mechanism of uptake. Lebleu and co-workers originally presented a 
revised cellular uptake mechanism for CPPs, which was deemed to be 
dependent on CME (Richard et al. 2003) but there has been little agreement 
since then . It is important here to distinguish here between studies 
investigating CPP uptake when attached to small cargo such as fluorescent 
probes over other studies looking at entry when CPPs are attached to larger 
cargo such as proteins. It is likely that the mechanism will be different. Also 
important is that the term CPP relates to hundereds of different sequences and 
sequence is also a vital factor. In the main, in this section, focus will be given 
to CPP attached to small cargo and cationic sequences such as HIV-TAT and 
oligoarginines.
Most of the studies have based their interpretation on the visualization of CPPs 
inside cells using fluorescently labelled CPPs and either microscopy or flow 
cytometry. More recently, radiolabelled peptides and mass spectrometry have 
been used together as an alternative mechanism that also allows for analysis of 
peptide degradation (Aubry et al. 2010)
Overall, several endocytic routes of entry have been suggested, but there 
continues to be reports of the capacity of the cationic forms to directly cross
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membranes without the need for endocytosis (Fretz et al. 2007; Jiao et al. 2009; 
Rothbard et al. 2004; Thoren et al. 2003; Watkins et al. 2009b)
Although it remains difficult to establish a general proposal for a CPP uptake 
mechanism, there is an agreement that the first interaction between the cationic 
CPPs and the cell surface occur via electrostatic interactions with 
proteoglycans. Proteoglycans play an essential role in the regulation of cell 
surface microdomains, and it has been reported that there is a direct 
relationships between cytoskeletal organization and activation of small 
GTPases (Conner and Schmid 2003). Heparan sulfate proteoglycans and 
syndecans are the major elements of the extracellular matrix, and their 
aggregation stimulates cytoskeletal remodelling upon activation of protein 
kinase C and Rho/Rac GTPases (Beauvais and Rapraeger 2004).
The initial CPPs and cell surface interaction occur through electrostatic binding 
with cell surface proteoglycans called glycosaminoglycans (GAGs), followed 
by a remodelling of the actin network and then an activation of the small 
GTPase Rho A or Racl (Duchardt et al. 2007). It is suggested that actin 
remodeling, affecting membrane fluidity influences R8, penetratin and Tat 
uptake via macropinocytosis or clathrin-dependent endocytosis (Nakase et al. 
2009; Nakase et al. 2007; Richard et al. 2005) or for MPG via membrane 
perturbation (Gerbal-Chaloin et al. 2007). CPPs interaction with extracellular 
matrix is suggested to stimulate the uptake through an energy-dependent 
endocytotic process and this has been shown for Tat (Console et al. 2003; 
Murriel and Dowdy 2006), polyarginine and penetratin (Nakase et al. 2004; 
Nakase et al. 2007). Macropinocytosis has been reported as the main route of 
internalisation of cationic CPPs (Kaplan et al. 2005), however other
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endocytotic pathways such as clathrin-and caveolin-dependent endocytosis has 
also freen reported (Richard et al. 2005; Ziegler et al. 2005).
The uptake mechanisms of cationic CPPs and other variants have been studied 
in detail and some consensus is emerging regarding the possibility of both 
endocytosis and direct translocation being involved. For translocation there is 
only the plasma membrane to overcome and then the peptide and its cargo -low 
molecular weight- will emerge in the cytosol. However if the cargo is large 
then it probably needs endocytosis for uptake and then there is the problem of 
breaking across the membrane(s) of the endo lysosomal system. Very little is 
known regarding this step though some elegant studies have been attempted 
using fluorescent proteins (Lee et al. 2008). Only small fraction of CPPs is 
probably able to escape from endosomes and it is likely that a major fraction is 
sent to lysosomes and degraded (Al-Taei et al. 2006) . It has been shown that 
internalised CPPs may be degraded upon delivery to late endosomes and 
lysosomes or inside the cytoplasm and it has been demonstrated that a large 
fraction of internalised TAT and penetratin peptides is degraded after a 2 hrs of 
incubation (Fischer et al. 2004). There is also the possibility that much 
degradation occurs outside the cells, i.e. during the incubation, especially when 
full serum containing medium is used (Aubry et al. 2010; Palm-Apergi et al. 
2011).
1.7. Arginine-rich cell penetrating peptides
Arginine-rich cell-penetrating peptides have been the most extensively studied 
among all cell-penetrating peptides (El-Sayed et al. 2009; Wender et al. 2008). 
The most well characterized examples are peptide from HIV transactivator
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protein Tat, penetratin, a 16 amino acid domain from the antennapedia protein 
of Drosophila (Derossi et al. 1994), and oligoarginines (El-Sayed et al. 2009; 
Wadia and Dowdy 2005). Arginine rich CPPs have been successfully 
employed to deliver various macromolecular cargos, including proteins, 
oligonucleotides, plasmid DNA, and liposomes into mammalian cells (Dietz 
and Bahr 2004). Despite the fact that arginine rich CPPs can be successfully to 
deliver various macromolecules, their mechanism of uptake remains 
undetermined.
1.7.1. Challenges fo r  studying cellular uptake o f  cationic CPPs 
It is clear that methodological issues has hindered progress in our 
understanding of the mechanisms of uptake of cationic CPPs. As mentioned, 
the most common experimental techniques, used to study arginine rich CPPs, 
are fluorescence microscopy and flow cytometry. Unfortunately, they are 
subject to the artifacts that relate to the highly cationic nature of these entities. 
Initially their cationic nature attract them to negative surfaces such as the 
plasma membrane of cells and cell culture plastic (Chico et al. 2003). The 
normal simple washes with buffer such as PBS is not efficient to remove the 
fraction bound to the plasma membrane (Richard et al. 2003). Common 
methods that have been introduced many studies for efficient removal of 
surface-bound CPP are (i) protease digestion (Richard et al. 2005; Wadia et al.
2004), washing with negatively charged compounds such as heparin and a 
combination of both (Kaplan et al. 2005). Another major problem facing the 
researcher when studying the uptake of cationic CPPs using microscopy is that 
the cells cannot be fixed. Therefore, live-cell imaging is preferred and when 
the extracellular concentration of peptides R8 and HIV-TAT, is low (l-2pM)
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then the peptide is predominantly observed in cytoplasmic vesicles. But 
increasing the concentration above 5pM highlights that the cytosol itself is also 
labeled suggesting strongly that the peptides are leaking through the plasma 
membrane (Fretz et al. 2007; Watkins et al. 2009b). The concentration of 
peptide that allow this to occur will be much lower if experiments are 
performed in the presence of serum free medium compared to full medium 
(Kosuge et al. 2008). Thus when studying these peptides one has to consider at 
least two entry mechanism. There may also be a third as studies have suggested 
that zones on the plasma membrane allow for initial entry of the peptide into 
the cytoplasm at a distinct site and that the peptide then spreads across the 
cytoplasm (Duchardt et al. 2007).
1.7.2. Internalisation o f arginine rich CPPs via endocytic pathways 
For endocytosis the data is confusing but at low concentrations (<5pM) both 
live-cell microscopy and flow cytometry show efficient inhibition of cellular 
uptake of different cationic CPPs at 4 °C or using ATP depletion with 
various metabolic inhibitors (Ferrari et al. 1998; Fretz et al. 2004; Letoha et al. 
2003; Watkins et al. 2009b). For fluorophores and other cargoes, endocytic 
pathways suggested to be involved are CME (Drin et al. 2003; Richard et al. 
2005; Saalik et al. 2004), caveolin-dependent endocytosis (Ferrari et al. 1998; 
Fittipaldi et al. 2003; Saalik et al. 2004) and macropinocytosis (Kaplan et al. 
2005; Potocky et al. 2003; Wadia et al. 2004). The uptake of TAT has been 
shown to occur via clathrin dependent endocytosis in cell lines such as HeLa, 
CHO and HepG2 (Potocky et al. 2003; Richard et al. 2005). Many studies 
employed chemical inhibitors to study CPPs uptake. Clathrin-dependent
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endocytosis inhibitors such as chlorpromazine, competently inhibited the 
uptake of TAT in HeLa and CHO cell lines. Moreover, nystatin, an inhibitor of 
raft dependent endocytosis, has a weak inhibition effect on the internalisation 
of TAT in the same cell lines (Richard et al. 2005). On the other hand, caveolin 
dependent uptake and macropinocytosis were suggested to be involved in the 
uptake of TAT in Namalwa cells using MBCD and CytD (Kaplan et al. 2005). 
Similarly, macropinocytosis has been suggested to be involved the uptake of 
R8 in HeLa cells and of TAT-Cre protein in T cells (Nakase et al. 2004; Wadia 
et al. 2004). The later study used cells expressing dynamin K44A mutant as an 
addition to inhibitors. Moreover, there was no evidence of colocalization with 
transferrin or caveolin-1, indicating that a clathrin- and caveolin-dependent 
pathway may have limited contribution in the uptake of TAT-Cre in cells of 
these types. Involvement of the caveolin-dependent pathway is also proposed 
by the inhibition of GST-TAT-GFP uptake by MpCD treatment of HeLa cells 
(Fittipaldi et al. 2003), which is also inhibits the uptake of TAT-avidin and 
penetratin-avidin (Saalik et al. 2004). More recently the involvement of 
caveolin- 1 and flotillin-1 in the uptake of a transportans-avidin complex was 
studied highlighting that transportan/avidin complex uptake is mediated via 
caveolin dependent rather than flotillin. Interestingly these experiments were 
performed by depleting flotillin-1 and caveolin-1 with siRNA (Saalik et al. 
2009). Furthermore, arginine rich CPPs were reported to cause up-regulation 
of specific endocytic pathways. For example R8 stimulates F-actin 
polymerization in HeLa cells (Nakase et al. 2004), and TAT induces the uptake 
of 70-kDa neutral dextran, suggesting it is activating macropinocytosis (Wadia 
et al. 2004). More recently the capacity to increase the fluid phase uptake of
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dextran was also proposed for penetratin, and its analogs PenArg and PenLys 
(Amand et al. 2008).
These studies highlight the fact that a number of entry pathways have been 
proposed to be involved in the uptake of unconjugated or cargo-conjugated 
arginine rich CPPs and other CPPs. So many factors could influence this but 
until suitable methods are in place to measure uptake and specifically inhibit 
distinct pathways then confusion is likely to continue.
1.8. Model cell lines for CPP study
Many different cell lines have been utilized to study CPPs and CPPs-cargo 
uptake, including non-mammalian cells such as yeasts and bacteria (Holm et al. 
2005; Nekhotiaeva et al. 2004) as well as mammalian cultured cell lines, 
embryonic stem cells and primary cells (Manceur et al. 2007; Mueller et al. 
2008; Simon et al. 2009b). In this thesis two adherent cell lines were employed 
to study the uptake of CPPs and the following section will describe their 
different features and characteristics.
1.8.1. HeLa Cells
HeLa cells are a human epithelial cervical cancer (cervical cancer), and was the 
first human permanent cell line established in culture. In 1951, surgeon 
Lawrence Wharton Jr. removed the tissue from the patient Henrietta Lacks, a 
31-year-old African American woman and thus the cell line called HeLa was 
originated, representing the first two letters from her name and surname. The 
tissue was passed along to Dr. George Gey, head of tissue culture research at 
Johns Hopkins, where they grew very quickly. The cells were from the 
carcinoma of the cervix and these cells have been widely used for many
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research purposes throughout the world (Masters 2002). We have also used this 
cell lines for our studies with cationic CPPs (Al-Taei et al. 2006; Watkins et al. 
2009a; Watkins et al. 2009b) and have also experience of careful analysis of 
the endocytic pathways of these cells (Simpson et al. 2004).
1.8.2. A431 Cells
A431 cells are a model epidermoid carcinoma cell line used in many 
biochemical researches. A431 cells were established from epidermoid 
carcinoma in the vulva of a 85 year old female patient. Since these cells 
express very high level of epidermal growth factor receptors (EGFR), they are 
usually used to study cell signaling pathways related to activation of this 
growth factor (Todaro et al. 1980). As EGF addition to cells stimulates 
macropinocytosis there have also been widely used to study this process (Araki 
et al. 2007; Liberali et al. 2008; West et al. 1989). This cell line was used in 
chapter 6 to study the uptake of CPPs via macropinocytosis.
1.9. Aims of the Thesis
Cell-penetrating peptides (CPPs) have the potential to deliver a host of 
therapeutic macromolecules into cells including peptides, proteins, and nucleic 
acids. Endocytosis is thought to be of significant importance for allowing 
cellular access under defined conditions. However, identifying the uptake 
mechanisms of different CPPs has remained problematic due in large part to a 
lack of suitable tools to perform accurate and specific analysis. Multiple 
pathways have been reported to contribute to CPP uptake, such as clathrin 
dependent uptake, cavaeolin and clathrin-independent routes and via
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macropinocytosis. This work aims to enhance the use of cell penetrating 
peptides as drug delivery vectors by developing new tools to investigate 
cellular entry specifically through endocytosis. Almost exclusively the uptake 
of these molecules and other drug delivery vectors has been performed using 
chemical inhibitors of endocytosis but as described there are major problems 
with these and interpreting the data that is generated following their use. The 
main aim of this thesis was therefore to develop methods for siRNA targeted 
depletion o f a number of different endocytic proteins. Once this was achieved 
an intention was to look at the cellular effects of this depletion on the uptake of 
specific probes thus generating cellular models of endocytosis. Finally it was 
hoped that thee models would allow for careful scrutiny of the uptake of 
fluorescent conjugates of CPPs HIV-TAT and R8 and that they could then be 
used for similar studies with other drug delivery vectors.
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Chapter 2: Materials and Methods
2.1. Materials
2.1.1. General Chemicals
Triton X-100 [XI00], Tricine (N-Tris [hydroxymethyl] methylglycine) and 
bovine serum albumin (BSA) [A2153] were purchased from Sigma-Aldrich 
(Gillingham, UK). Ethanol [E/0650/D17], Methanol (MeOH) [M/4056/17], 
Sodium Chloride (NaCl) [S/3120/53] and Potassium Chloride (KC1) [BPE360- 
500], Phosphate buffered saline tablets (PBS) [2810306], acetic acid [64-19-7] 
were purchased from Fischer Scientific laboratories (Leicestershire, UK).
2.1.2. Tissue Culture
Foetal Bovine Serum (FBS) [10270706] and D-MEM containing Glutamax 
[21885] were obtained from Invitrogen (Paisley, UK). Penicillin/Streptomycin 
[15070], Trypsin-EDTA (ethylenediamine tetraacetic acid) [25300], Trypan 
Blue [T8154] and dimethyl sulphoxide (DMSO) [D2650] were purchased from 
Sigma-Aldrich (Gillingham, UK). The cervical cancer HeLa cells [93021013] 
were from ECACC (Wiltshire, UK). A431 cells were a kind gift from Dr Jon 
Lane Bristol University.
2.1.3. Conjugation o f Alexa488 C5 maleimide to peptides
Alexa Fluor® 488 C5 maleimide salt [A 10254] was purchased from Invitrogen 
(Paisley, UK). R8 & Tat peptides were from American Peptide Company 
(California, USA).
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2.1.4. High pressure liquid chromatography (HPLC)
Trifluoroacetic acid (TFA) [T/3258/PB05] and Acetonitrile (ACN) 
[A/0626/17] were purchased from Fisher Scientific Laboratories 
(Leicestershire, UK). Luna C l8 100A 5 pm, 250 x 10 mm, semi preparative 
column [OOG-4252-NO] and a Luna C l8 100A 5 pm, 150 x 4.6 mm, 
analytical column [OOF-4252-EO] were purchased from phenomenex 
(Macclesfield, UK).
2.1.5. Flow cytometry
Fluorescence assisted cell sorting (FACS) flow sheath fluid [342003], FACS 
rinse [340346] and FACS clean [340345] were purchased from Becton 
Dickinson (Oxford, UK). Heparin [H3149] was purchased from Sigma-Aldrich 
(Gillingham, UK).
2.1.6. Fluorescence Microscopy
Hoechst [861405] was purchased from Sigma (Dorset, UK). Microscope lens 
immersion oil [11513859] was from Leica Microsystems (Cambridge, UK). 
Imaging media (IM-RPMI 1640 without phenol red) [11835] was purchased 
from Invitrogen (Paisley, UK).
2.1.7. Reagents
Alexa Fluor488 transferrin (Alexa488-TF) [T13342], Alexa Fluor488 Dextran 
(Alexa488-Dextran) (10 KDa) [D22910], tetramethylrhodamine-Dextran 
(TMR-Dextran) (70 KDa) [D1819], and BODIPY® (4,4-difluoro-4-bora-3a,4 
adiaza-s-indacene)-LacCer (lactosylceramide) (BODIPY-LacCer) [B34402]
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were purchased from Invitrogen (Paisley, U.K). FITC-Dextran (40 KDa) 
[FD40S] and epidermal growth factor (EGF) [E9644] from Sigma-Aldrich 
(Dorset, UK) and FITC-Anti-CD59 antibodies (clones A35 and YTH53.1) 
were kindly provided by Dr Rossen Donev, School of Medicine, Cardiff 
University.
2.1.8. Pharmacological inhibitors
Dynasore [D7693], chlorpromazine (CPZ) [C8138], cytochalasin D (CytD) 
[C8273], Blebbistatin (Blebb) [B0560] and 5-ethylisopropyl amiloride (EIPA) 
[A3085] were obtained from Sigma-Aldrich (Dorset, UK).
2.1.9. Cell Transfection
Oligofectamine [12252-011] and Opit-MEM [51985] were purchased from 
Invitrogen (Paisley, UK). All siRNA sequences were purchased as desalted and 
at scale of 0.05pmol from Eurofins MWG Operon (Ebesburg, Germany) 
except for those sent by the University o f Ghent. Details on each siRNA 
sequence is given in the appropriate chapter.
2.1.10. Cell lysis
Complete mini protease inhibitor cocktail tablets [11836153001] were from 
Roche Diagnostics (Mannheim, Germany).
2.1.11. Protein determination
Bicinchoninic acid (BCA) [B9643], copper sulphate [C2284] and bovine serum 
albumin (BSA) [B4287] were from Sigma-Aldrich (Gillingham, UK).
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2A .12. Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS- 
PAGE) and Immunoblotting 
Bis-acrylamide (40%) [A7168], Tween® 20 [P7949], ammonium persulphate 
(APS) [A3678], Dithiothreitol (DTT) [D9163] and Ponceau S [P7767] were 
purchased from Sigma-Aldrich (Gillingham, UK). N, N, N, N- 
tetramethylethylenediamine (TEMED) [161-0800], Coomassie Brilliant blue 
G-250 [161-0406] and sodium dodecyl sulphate (SDS) [160-0301] were from 
BioRad laboratories (Hertfordshire, UK), [tris(hydroxymethyl) aminomethane] 
(Tris-base) [BPE152-1], [tris(hydroxymethyl) hydrochloric acid] (Tris-HCl) 
[BPE153-1], glycerol [G/0600/08] and acetic acid [A/0400/PB17] were 
purchased from Fisher Scientific laboratories (Leicestershire, UK). Full range 
rainbow molecular weight marker [RPN800E] and Enhanced 
Chemiluminescence (ECL) hyperfilm [28906836] were from GE Healthcare 
Life Sciences (Buckinghamshire, UK). Marvel dried milk powder was from 
Tesco. Nitrocellulose paper [BRP-100-540T] was purchased from Schleicher 
& Schuell (Dassel, Germany). Super Signal Wesr Dura ECL Immunoblotting 
analysis system [37071] was from Pierce (Northumberland, UK).
2.1.13. Antibodies
HRP goat-anti-mouse [32430] and HRP goat-anti-rabbit [32460] were 
purchased from PIERCE (Northumberland, UK). Anti-oc-tubulin [T6199], anti- 
ARF6 [A5230], and anti-GRAF-1 [SAB2500488] were from Sigma (Dorset, 
UK). Anti-clathrin heavy chain [610499], anti-dynamin-2 [610263] and anti- 
flotillin-1 were from BD Transduction (Oxoford, UK). Anti-Caveolin-1 [3238]
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was from Cell signalling (Hertfordshire, UK) and anti-PAK-1 [sc-882] was 
from Santa Cruz (Heidelberg, Germany). Anti-EGFR [MS-378] was from 
Thermo scientific (Cheshire, UK), and Anti-GFP [MMS-118P] was purchased 
from Covance (New Jersey, USA). Species and dilution information on these is 
provided in Table 2.5.
2.1.14. Cell viability assays
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) 
[M5655 was from Sigma-Aldrich (Gillingham, UK).
2.2. Equipment
2.2.1. General Laboratory Equipment
Varifuge 3.0 RS centrifuge was obtained from Heraeus Instruments 
(Germany). Eppendorf centrifuge 5417R was from Eppendorf (Hamburg, 
Germany). Weighing scale Precisa 180A was purchased from Sartorius 
(Hanover, Germany). Sunrise multiwell plate absorbance reader was from 
Tecan (Austria).
2.2.2. Cell Culture
A Neaubauer haemocytometer was purchased from Weber Scientific (Sussex, 
UK). Tissue culture flasks (25 cm2 and 75 cm2) with vented lids, cryogenic 
vials, sterile 5, 10 and 25 ml pipettes and 39 ml universal tubes were purchased 
from corning, Fisher Scientific Laboratories (Leicestershire, UK). BD 
Plastipak syringes were from Becton Dickinson (Madrid, Spain). Ministart® 
0.2 pM filters were from sartorious (Hanover, Germany).
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2.2.3. Fluorescence Microscopy
2.2.3.1 .Confocal Microscopy
Confocal microscopy was performed on a Leica TCS SP5 AOBS confocal 
inverted microscope equipped with an Ultraviolet 350 nm (UV), 405 nm, 
Argon 488 and HeNe 543 and 633 lasers and 20x, 40x, and 63x oil objectives 
(Cambridge, U K ). In some cases live cell imaging dishes were placed on a 
temperature s tage  equilibrated to 37°C. Images were acquired using the Leica 
LCS Lite softw are and finally processed using Photoshop.
2.2.3.2.W ide-field Microscopy
Wide-field fluorescent images were obtained on a Leica DMIRB inverted 
fluorescence microscope equipped with a 63x oil-immersion objective and 
Qlmaging R etiga 1300 camera. The acquired images were processed with 
Improvision O penlab 5.0.2 software. 35mm imaging dishes [P35G-1.5-10-C] 
were from M atTek (Ashland, USA).
2.2.4. Flow Cytometry
®A FACSCalibur flow cytometer was purchased from Becton Dickinson 
(Oxford, UK).
2.2.5. Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS- 
PAGE)
Mini PROTEAN II gel electrophoresis tank with its accessories and the 
Powerpac 300 were purchased from BioRad Laboratories (Hertfordshire, UK).
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2.3. Methods
2.3.1. Tissue Culture
2.3.1.1.General
All tissue culture procedures were carried out in a class II laminar flow hood 
following decontamination of all sterilised consumables with 70% v/v Ethanol 
solution. All cells were maintained at 37° C with 5% CO2 in a humidified 
incubator.
2.3.1.2.Maintenance
HeLa and A431 cells were grown in DMEM-GlutaMAX-I media containing 
10% FBS and 100 U/ml penicillin and lOOpg/ml streptomycin (Complete 
Media (CM)). Cell passaging was done routinely three times per week and the 
whole procedure was done in a laminar flow cabinet. First, the media was 
aspirated from the flask (75cm3) then the cells were washed once with PBS. 
The PBS was removed and 1ml of 0.05% Trypsin-EDTA was added and the 
cells were incubated in humidified incubator for 4min or until they were 
detached. 9ml of CM were added and the whole suspension was transferred to 
universal tube for centrifuging fro 5 min at 1000 x g. The supernatant was 
aspirated and the cell pallet was re-suspended in 10ml of CM. After counting 
the cells the required volume of cells suspension was taken and added to media 
in a 75cm2flaskThe flask was maintained under tissue culture conditions and 
passage number 5-40 were used for all experiments.
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2.3.1.3.Cell storing (freezing")
2.3.1.3.1. HeLa cells
Cell stocks were maintained in liquid nitrogen. Freezing media consisted of 
90% FCS (v/v), which was filtered and warmed at 37° C, and 10% DMSO 
(v/v). Cells were counted and centrifuged at 1000 x g for 1 min, and then the 
supernatant was aspirated. The cells were resuspended in freezing media with 
seeding density 2 x 106 cells/ml. 1ml aliquots of cell suspension were 
transferred to cryogenic vials and placed in -20° C freezer for lhr. later, the 
vials were placed at -80° C overnight before being placed in liquid nitrogen.
2.3.1.3.2. A431 cells
Cell stocks were maintained in liquid nitrogen. Freezing media consisted of 
95% FCS (v/v), which was filtered and warmed at 37° C, and 5% DMSO (v/v). 
Cells were counted and centrifuged at 1000 x g for 1 min, and then the 
supernatant was aspirated. The cells were resuspended in freezing media with 
seeding density 2 x 106 cells/ml. 1ml aliquots of cell suspension were 
transferred to cryogenic vials and placed in -20° C freezer for lhr. later, the 
vials were placed at -80° C overnight before being placed in liquid nitrogen.
2.3.1.4.Cell recovery from frozen stock
The frozen vials were thawed in a water bath at 37° C for 5 min and cells were 
transferred to a 30 ml sterile universal sterilin. 5 ml of CM was then added, 
before centrifugation for 5 min at 1000 x g. The supernatant was aspirated and 
the cell pallet was re-suspended in 5ml of CM, and transferred to a sterile 25 
cm2 flask. The cells were then incubated until confluent (~2 days HeLa, and ~3
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days A431) with the culture media being changed every 2 days. Once a 
confluent mono Iyer had formed they were seeded into 75 cm2 flasks as 
described in 2 .3.1.2.
2.3.2. Conjugation o f Alexa488 C5 maleimide salt to peptides
2.3.2. l.HPLC
The peptides used in this study (Table 2.2) were synthesised with an extending 
GC at the C-terminus to allow conjugation to Alexa Fluor® 488 C5 maleimide 
salt. Labelling was performed with an excess of the peptide, at peptide:label 
molar ratio of 1:1.2. Peptides and Alexa488 were dissolved in MeOH at a 
concentration of 1 mg/ml, mixed together in a sterile 1.5 ml eppendorf and the 
reaction was allowed to proceed in the absence of light at room temperature. 
The reaction was monitored by HPLC every hour by taking 10 pi of reaction 
mixture and loading it on to an analytical C l8 column. The reaction then was 
left for 4 hrs, and then the product was purified using a C l8 5p 100 A semi­
preparative column and the gradient shown in table 2.1. Fractions were 
collected, freeze dried, checked for purity on the semi-preparative column, and 
then analysed by mass spectrometry.
2.3.2.2.Mass Spectrometry
1 pi of a cyano matrix was loaded onto each well to be used then left to dry 
completely at room temperature. 1 pi of peptide sample (immediately 
following HPLC or following freeze drying and ressupension) was placed on 
the dried cyano matrix before analyzing by MALDI-TOF MS (Matrix-assisted 
laser desorption/ionisation-time o f flight mass spectrometry) with a vacuum set
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at 2 e_6. This was performed under supervision of either Dr Catherine Watkins 
or Rob Smart in the School of Chemistry.
2.3.2.3.Calculation of Alexa488-Peptide concentration
An aliquot of the sample was used to determine the concentration based on the 
molar extinction coefficient of Alexa488- 71,000. The solution was then finally 
freeze dried and resuspended to a stock concentration of ImM in distilled 
water. These were aliquoted and stored at -80°C. The final masses of R8- 
Alexa488 was determined by Dr Catherine Watkins and are shown in Table 
2 .2 .
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Peptide-Alexa488 Gradient Peptide- Alexa488 Retention time (min)
R8
TO; 5% B 
T5; 20% B 
T25; 40% B 
T30; 95% B
11.5
Tat
TO; 5% B 
T5; 20% B 
T25; 40% B 
T30; 95% B
10.2
Table 2.1. HPLC ACN gradient used in the purification of Alexa488-R8 
&-Tat
Peptide Origin Sequence Massunlabelled
Mass
Alexa488
labelled
(Precised)
Mass
Alexa488
labelled
(calculated)
R8
American
Peptide
company
RRRRRRRRGC 1427.7 2126.4 2125.3
Tat
American
Peptide
company
GRKKRRQRRRPPQ
GC 1880.0 2578.9 2577.6
Table 2.2. Peptides used in this thesis
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Figure 2.1. HPLC purity check for Alexa488-R8 and -T at and Mass 
Spectrometry for Alexa488-Tat.
MALDI is know to cause some fragmentation including the breakage of the 
Alexa488-Cys linkage (I Nakase correspondence) resulting in these peaks that 
also correspond to different charged species (1289.46)
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2.3.3. Cells Transfection
Transfection was curried out on HeLa and A431 cells in either 12 well or 6 
well plates essentially as described the information provided with 
Oligofectamine. The cell confluency on the transfection day was 50-60% and 
different siRNA oligonucleotides were used based on the information given in 
Table 2.3. This describes the volumes required based on the relative surface 
area in proportion to the amount of oligonucleotide and oligofectamine that 
should be used.
The procedure was modified according to the above table depending on the 
plate type and the required oligonucleotide concentration. The following 
procedure was used for a final siRNA concentration of 50nM siRNA in a 6- 
well plate:
lpL of a 50pM stock oligonucleotide was diluted with 179pL of Opti-MEM I 
and mixed gently. In a separate tube 4pL of Oligofectaime was added to 16pl 
of Opti-MEM I and left at room temperature for 5-10 min. The two solutions 
were combined (total volume = 100 pL) and mixed gently, then incubated at 
room temperature for 15-20 min. From the 6 well plates, the growth medium 
(DMEM) was removed from the cells and they were washed once with Opti- 
MEM medium. 800pL of Opti-MEM medium was then added to each well 
prior to adding the Oligonucleotide/oligofectamine complex. The mixture on 
the cells was gently agitated and incubated with the cells under tissue culture 
conditions for 4 hours. Finally, 500pL of Opti-MEM containing 3X the normal 
concentration of serum was added without removing the transfection mixture 
and the cells were incubated for 48 hrs. The cells were then processed for 
further experiments as described later.
6 0
Oligo
final
Cone.
Culture
Vessel
Relative
Surf.
Area
vs.96-
well
Oligo (pi of 50 
pM stock) & 
dilution vol. (pi)
Oligofectami 
ne (pi) & 
final dilution 
vol. (pi)
Plating
medium
vol.
Total
vol.
per
well
Added 
vol. 
medium 
with 3X 
serum
50nM 6-well 25 lpl in 179pl 2-4 pi to 20pl 800 pi 1 ml 500 pi
50nM 12-well 10 0.5pl in 89.5pl l-3pl to lOpl 400 pi 500 pi 250 pi
50nM 96-well 1 0.1 in 16pl
0.4-0.8pl to 
3pl 80 pi 100 pi 50 pi
T able 2.3. Volumes o f reagen ts used fo r p rep a rin g  the  transfection 
m ix tures based on the  surface a re a  o f  th e  wells.
As many wells were treated for each experiments the volumes here were 
further scaled up as required. Oligo = Oligofectamine.
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2.3.4. Fluorescence Microscopy
2.3.4.1 .Transferrin internalisation in siRNA-transfected HeLa Cells 
Cells growing on cover slips in 12-well plates were transfected with siRNA 
targeting CHC for 48hrs. On the day of experiment the growing media was 
removed and the cells were washed twice with serum free media (DMEM) 
containing 0.2% w/v BSA, pH7.3-7.4 (SFM/BSA) then incubated at 37° C in 
the incubator for 30 min in 2ml SFM/BSA. The cells were washed twice with 
PBS then 500 pi of lOOnM Alexa-488 Tf (1/625 dilution in SFM/BSA) was 
added. The cells were incubated for 0, 4, 8, 16, or 32 min at 37° C. The media 
was then removed and the cells were incubated for 5 min in complete media. 
The plate was then placed on ice and the cells were washed three times for 1 
min with ice cold PBS. The cells were fixed in 3% PFA (0.5ml) for 20 min at 
room temperature. After fixation, the cells were washed three times with PBS 
and incubated for 5 min in PBS/0.2% Triton-X followed by washing 2x with 
PBS. Finally, the cover slips were lifted and washed once in PBS followed by 
distilled water and then mounted on cover slides containing mounting oil.
2.3.4.2.Transferrin internalisation in dvnasore treated HeLa Cells 
Dynasore was stored as a 50mM stock solution in DMSO. Cells were grown 
on cover slips on 12-well plates until they were 80% confluent. The growing 
media was then removed and the cells were washed twice with PBS at room 
temperature and incubated at 37°C and 5% C 02 humidified incubator for 30 
min in SFM/0.2%BSA containing 0 to 80pM Dynasore. Here and for all 
experiments with inhibitors a diluent control was used that is referred to as 0 
pM or control. The medium was then removed and the cells were washed twice
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with PBS at room temperature. 500 pi of lOOnM Alexa-488 Tf in SFM/BSA is
\
this right was then added in the continued presence of dynasore, and then the 
wells were incubated for 15 min at 37° C. The plate was then placed on ice and 
the cells were washed three times for 1 min with ice cold PBS. Prior to fixing 
as described above and processing for fluorescence microscopy.
2.3.4.3.PAK-1 immunolabelling in si-GFP vs. si-PAK-1 transfected A431 cells 
Cells grown on cover slips in a 12-well plates were transfected with siRNA 
targeting PAK-1 or GFP as described in 2.3.3 and incubated for 48 hrs. The 
media was removed and the cells were washed 3x in PBS, then 3% PFA in 
PBS was added to each well left on the cells for 15 min prior to washing 3x 
with PBS. 50mM NH4CI/PBS was then added and left for 10 min, followed by 
3x PBS washing. 0.2% w/v Triton X-100/PBS was then added and left for 10 
min, followed by 3x PBS washing. The cells then were incubated with block 
solution (2% FBS, 2% BSA fraction V in PBS) for 30 min at room 
temperature. Then the blocking solution was removed and PAK-1 antibody in 
blocking buffer (1:50) was added and left for 30min, followed by 3x PBS/0.1% 
Triton washes and lx  PBS wash. Secondary Alexa488 chicken anti-rabbit in 
blocking buffer was then incubated with the cells (1:500) for 30 min. Finally, 
the cells were washed 3x PBS/0.1% Triton wash and lx in PBS wash then 
processed for microscopy as described in 2.3.4.1.
2.3.4.4.Actin distribution in PAK-1 depleted A431 cells
Cells in 12-well plates were grown overnight on glass cover slips . They were 
transfected with siRblA against GFP or PAK-1 and incubated at 37° C and 5%
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C 02 for 48 hrs. Cells were then were washed 2x with PBS, followed by 
fixation with 3% PFA for 20 min at room temperature. Then cells were washed 
3X with PBS and incubated for 5 min in PBS/0.2% Triton-X 100. Then they 
were washed 2X with PBS before incubation for 10 min with 2pg/ml 
rhodamine-phalloidin in PBS. The cells were washes 2X and then processed 
for fluorescence microscopy as described in 2.3.4.1.
2.3.4.5.Measuring the effect of Blebbistatin on actin distribution in EGF 
stimulated A431 cells 
Cells in 12-well plates were grown overnight on glass cover slips. After 24 hrs 
they were washed 2x with PBS then were incubated in serum-free Ringer’s 
buffer (155 mM NaCl, 5mM  KC1, 2mM  CaCl2, Im M  MgCl2, 2mM 
NaH2PC>4, lOmM HEPES, lOmM glucose, and 0.5 mg/ml bovine serum 
albumin, pH 7.4) for lhr prior to incubation with or without 100 pM 
Blebbistatin (Blebb) for 30 min at 37° C. The cells were then incubated in the 
presence or absence 50 nM EGF in absence or presence of Blebb. The cells 
were washed and then processed for labelling actin with rhodamine phalloidin 
as described in 2.3.4.4 and analysis by fluorescence microscopy.
2.3.4.6.Immunofluorescence of PAK-1 distribution after addition of cationic 
lipids, cationic polymers. EGF. and CPPs to A431 Cells 
The complexes were formed first before starting the experiment. For 
Oligofectamine-siRNA complex, it was formed as mentioned in section 2.3.3 
and also the same procedure was applied for lipofectamine/siRNA complex. 
Fugene-6/DNA complex was formed by diluting 3 pi of Fugene-6 [from
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Roche, Mannheim, Germany] with 97 pi of DMEM media, followed by adding 
1 pg of plasmid DNA, and then the solution was mixed and left for 30 min in 
room temperature before loading on to cells. PEI/DNA complex was formed 
by adding 2 pi of jetPEI™ transfection reagent (a linear polyethylenimine 
derivative from Polyplus transfections, Boulevard Sebastien Brant, France) to 1 
pg of DNA plasmid and then the mixture was left for 15 min at room 
temperature before adding to cells. The cells in 12-well plates (1 x 105 ) were 
grown overnight on glass cover slips; for all experiments in 12-well dishes. 
After 24 hrs they were washed 2x with PBS prior to starvation for 1 hr in 
Ringer’s buffer. The cells were then incubated with 50 nM EGF, 
oligofectamine-siRNA, lipofectamine-siRNA, Fugene-DNA or PEI-DNA 
(polyplexes) complexes or with 2pM unlabelled R8 or Tat for 10 min before 
washing with 2x with PBS and fixing with 3% PFA in PBS for 15 min. Then 
the cells were processed as mentioned in section 2.3.4.3 for immunodetection 
of PAK-1.
2.3.4.7.TMR-dextran internalisation in the presence of EGF and CPPs in A431 
cells
A431 cells were seeded into glass-bottomed, 35 mm culture dishes and allowed 
to adhere for 24 h. The cells were then serum starved using Ringer’s buffer for 
1 hr before incubation for lhr with 0.75 mg/ml TMR-dextran, 50 nM EGF, or 
2pM of either unlabeled R8 or Tat. Then cells were washed 2x with ice cold 
PBS and lx  with ice cold acid wash (0.2M acetic acid, 0.2M NaCl, pH 2.0), 
followed by 3x PBS wash, then analyzed in imaging media (RPMI 1640
i
without phenol red) via confocal microscopy on the 37°C temperature stage.
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2.3,4.8.Dextran internalisation in cvtochalasin D pre-treated cells 
A431 cells were seeded into glass-bottomed, 35 mm culture dishes and allowed 
to adhere for 24 h. The cells were washed 2x with PBS before incubating with 
10 pM CytD in SFM/0.2%BSA for 15 min then incubated with SFM 
containing 5 mg/ml FITC-Dextran at 37 °C for 1 hr. The cells were washed 
with ice cold acid wash buffer followed by 3x PBS washes and then analysed 
in imaging media via confocal microscopy on the 37°C temperature stage.
2.3.4.9.Intemalisation of Alexa488-CPPs in HeLa cells 
HeLa cells were seeded into glass-bottomed, 35 mm culture dishes and allowed 
to adhere for 24 h. The cells were washed 2x with PBS before incubating with 
2 pM AIexa488-R8 or Tat in SFM/0.2%BSA for 1 hr. The cells were then 
either directly imaged by confocal microscopy in the presence of the peptides 
o r , washed 3x in PBS and analysed in imaging media via confocal microscopy 
on the 37°C temperature stage.
2.3.5. Flow Cytometry
In all flow cytometry experiments 10,000 gated cells were measured and all the 
data shown are an average of at least three independent experiments.
2.3.5.1.Measuring the effect of acid wash and temperature on Alexa488- 
Transferrin internalisation in HeLa cells 
Cells were plated for 24 hrs on to 12-well plates and incubated at 4°C or 37°C
with lOOnM Alex488-Tf for 0-32 in as described section 2.3.4.1. The cells
/
were then either washed 3x with ice cold PBS and then washed in either PBS
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or acid wash solution for 1 min. The cells were then washed 3x with PBS prior 
to addition of300pl trypsin/EDTA and incubation at room temperature for 2-3 
min. The detached cells were then placed in a 1.5ml eppendorf tube containing 
300pl ice cold PBS and centrifuged at 1500x g for 3 min. The pellet was then 
resuspended in 500pl PBS and the cells were centrifuge-washed again prior to 
resuspending the final pellet in 200pl of ice cold PBS. The cell suspension 
was then analysed by flow cytometry.
2.3.5.2.Internalisation of Alexa-488-Tf. FITC/Alexa488/TMR-Dextran. FITC - 
anti-CD59 antibody, and BODIPY-LacCer 
Cells were plated for 24 hrs on to 12-well plates and transfected as described 
using siRNA sequences targeting CHC, DNM2, Flot-1, Cav-1, PAK-1 or GFP 
(control). After 48 or 72 hrs (only for DNM2), the cells were washed 2x with 
PBS at room temperature and then incubated for 30 min at 37° C in SFM 
containing 0.2% w/v BSA. The cells were then washed 2x with PBS at room 
temperature and incubated for various periods of time with SFM/BSA 
containing either 100 nM Alexa-488 Tf, 2pg/ml anti-CD59 antibody FITC- 
Dextran (40 KDa, 5.0mg/ml), Alexa488-Dextran (lOKDa, 0.2 mg/ml) or TMR- 
Dextran (70KDa, 0.75 mg/ml). The plates were then placed on ice and washed 
2x with ice cold PBS followed by a 1 min incubation in ice cold acid wash. 
The cells then were washed 3x with PBS at room temperature, prior to 
trypsinisation and processing fro flow cytometry as described.
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For BODIPY-LacCer uptake cells were washed 2x with PBS at room 
temperature then incubated with 1 pM BODIPY-LacCer at 10°C for 30 min to 
load the plasma membrane with the lipid analog (Singh et al. 2003). The cells 
were then washed 3x times with SFM at 10°C, followed by incubation at 37° C 
for 15 min to allow endocytosis. Two methods were then used to remove the 
surface label. (1) Trypan Blue Method: the cells were rinsed 2x with ice-cold 
PBS and trypsinised at room temperature, followed by adding 0.33 mM trypan 
blue for 30 min to quench the extracellular fluorescence of BODIPY-LacCer. 
The cell suspension was washed with ice cold PBS, before measuring cell 
associated fluorescence by flow cytometry (2) Back exchange method. 
Following the endocytic step the cells were washed (6x 10 min) in PBS 
containing 5% fatty acid-free BSA at 4° C.
2.3.5.3.Cellular internalisation of Alexa488-CPPs in HeLa and A431 cells 
Cells in 12 well plates cultured and transfected with the various siRNA 
sequences as described in Section 2.3.5.2. After 48 (72 hrs for siRNA-DNM2) 
of transfection, the cells were washed 2x with PBS at room temperature and 
then incubated for 30 min at 37° C in SFM containing 0.2% w/v BSA; this step 
was performed to keep consistency with the methods described above. The 
cells were then washed 2x with PBS at room temperature and incubated for 
various periods of time with SFM/BSA containing 2pM Alexa-488-R8 or 
Alexa-488-TAT for 0-80 min at 37° C. Cells were then placed on ice to stop 
endocytosis and washed 2x with ice cold PBS, lx with PBS at room 
temperature, trypsinised as above and finally washed 2x with 14 pg/ml ice cold
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heparin. The cell suspension was washed 2x with ice cold PBS and the 
internalised peptide was quantified by flow cytometry as previously described. 
In experiments investigating the effect of temperature on uptake of CPPs, the 
same procedure was carried out with non-transfected cells. The experiment was 
carried out 24 hrs after cells seeding and the uptake experiments were 
performed at 4° C and 37° C in parallel.
2.3.5.4.Endocvtosis inhibitor studies
Cells were grown for 24 hrs on 12-well dishes. On the day of the experiment 
they were washed 2x with PBS at room temperature then preincubated with 
lOpM Cytochalasin D (CytD) for 15 min, lOpg/ml chlorpromazine (CPZ), 
80pM dynasore, lOOpM 5-ethylisopropyl amiloride (EIPA) or lOOpM 
blebbestatin for 30 min at 37°C. The media was removed and fresh SFM/BSA 
media containing endocytic probe or Alexa488-CPP peptide as well as 
corresponding inhibitor was added and the cells were incubated for various 
periods of time (0-80 min). The cells were then processed as above for analysis 
of cell-associated fluorescence of either endocytic probe or Alexa488-CPP. For 
all inhibitor studies control cells were incubated with an equivalent volume of 
inhibitor diluent (DMSO or PBS).
2.3.5.5.EGF stimulation of macropinocvtosis in A431 cells
Cells were grown for 24 hrs on 12-well dishes, washed 2x with PBS at room 
temperature and incubated in serum-free Ringer’s buffer for lhr. Then cells 
were incubated with Ringer’s buffer containing 5mg/ml FITC-dextran or 
0.75mg/ml TMR-dextran +/- 50nM EGF. The plates were then placed on ice
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and washed 2x with ice cold PBS followed by a 1 min incubation in ice cold 
acid wash buffer. The cells were then washed 3x in PBS and processed for 
flow cytometry as described. In experiments employing blebbistatin the cells 
were pretreated with the drug 30 min before EGF stimulation and blebbistatin 
was present throughout the experiment. The effect of serum starvation was 
tested and in those experiment the cells are either serum starved, as mentioned 
above, or not, before measuring the effect of EGF stimulation on CPP and 
Dextran uptake.
2.3.5.6.Co-incubating CPPs with different molecular weight dextrans
Cells were grown for 24 hrs on 12-well dishes, washed 2x with PBS at room 
temperature and then incubated for 30 min at 37° C in SFM containing 0.2% 
w/v BSA. The cells were then washed 2x with PBS at room temperature and 
incubated for various periods of time with SFM/BSA containing either 5.0 
mg/ml FITC-Dextran or 0.75 mg/ml TMR-Dextran +/- 2 pM unlabbeled R8 or 
Tat. The plates were then placed on ice to inhibit further uptake and washed 2x 
with ice cold PBS followed by a 1 min incubation in ice cold acid wash buffer. 
The cells then were washed 3x with PBS at room temperature, prior to 
trypsinisation and analysis by flow cytometry.
2.3.6. Bicinchonic Protein Assay (BCA)
This assay is used to measure the protein concentration in the cell lysates. The 
protein assay solution was prepared containing 49 parts BCA and 1 part 
Copper Sulphate. A calibration curve of BSA in lysis buffer (50 mM Tris-HCl, 
150 mM NaCl, pH 8.0, 1% Triton X-100), was prepared by adding 20pl
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volumes of different concentrations to the wells in addition to 20 |nl of the cell 
lysates. 250|li1 of protein assay solution then was added to each well that was 
incubated at 37 0 C for 20min. the absorbance at 550nm was determined and 
the cell lysate concentration was extrapolated from the BSA calibration curve.
2.3.7. Sodium Dodecyl Sulphate-Polyacrylamide Gel (SDS-PAGE) 
Electrophoresis
Cells in 6-well plates were transfected with various siRNA sequences as
described. 48 hours after transfection, the cells were washed three times in ice
/
cold PBS prior adding 300 pi of ice-cold lysis buffer containing protease 
inhibitor cocktail. The plates then were placed on ice and then on a laboratory 
shaker for 5 min. The lysates were then transferred to eppendorf tubes and 
centrifuged at 13,000g for 10 min at 4°C. The supernatant was collected and 
protein concentration determined. Aliquots corresponding to 20-50pg of 
protein was then added to 4x SDS sample buffer (40% Glycerol, 240 mM 
Tris/HCl pH 6.8, 8% SDS, 0.04% bromophenol blue, 5% beta-
mercaptoethanol) containing dithiothreitol at a final concentration of lOmM 
and then either immediately processed for electrophoresis or stored at -20°C.
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Stock
Solution
10%  separating 
gel
TRIS 3M pH 8.8
11%  separating 
gel
TRIS 3M pH 8.8
4% stacking gel 
TRIS 1M pH 
6.8
40% acry/Bis 5.0 ml 5.5 ml 1.0ml2.5ml 2.5ml 1.3mlTris 0 .2ml 0 .2ml 0.1ml10% SDS 
dH20
12..3ml 11.8.ml 7.6ml
Temed 15pl 15pl lOpl
APS 10% \50\x\ 150|ul 75^120ml 20ml 10ml
Table.2.4. Solutions used for preparing running and stacking gels for SDS 
PAGE.
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Depending on the percentage of the gel the solutions in table 2.4 were then 
used to prepare a running gel and stacking gel in the gel holders.
All protein samples were heated at 95° C for 5min, centrifuged at 1000 x g for 
30 s and then loaded on to the gels; lOpl of multi colour molecular weight 
marker was loaded in the first well lane: The gel was run at 110 V until the 
dye-front reached the end of the gel. The gel was then removed from the 
cassette and immersed in PBS then incubated for 5-10 min in ice cold transfer 
buffer (150 mM Glycine, 20 mM Tris-base, MeOH (20% final), and completed 
to 2 L with dH20).
2.3.8. Western Blotting
Two pieces of sponge pads, filter papers, and one piece of nitrocellulose (NC) 
paper were cut to the size of the gel and pre-soaked in the transfer buffer. The 
pre-soaked sponge placed on the cassette, followed by filter paper, then the gel, 
NC paper and the surface was rolled to take out air bubbles. Another filter 
paper was layered on the NC paper followed by sponge pad then the cassette 
was closed carefully. For efficient transfer, an ice unit was placed in the tank to 
cool down the transfer system and a stirrer was placed in the tank to ensure 
uniform temperature during the transfer process. Transfer was for 90 min at 
100 V thereafter the NC paper was removed and washed with dH20 . Ponceau
S solution was added to the NC paper for 1 min to ensure that effective 
transferred had occurred and this also allowed for cutting the paper for 
immuno label ling with different antibodies. The Ponceau S was then removed 
via successive washes with PBS and the paper was then stored in PBS.
2.3.8.1. Detection of Transferred Proteins after Western blotting 
For immunolabelling the NC paper was soaked in a block solution 5% w/v 
milk powder dissolved in TBS (50 mM Tris-base pH 7.5, 150mM NaCl, 0.01% 
Tween made to 1 L with dH20) for 45 min to block non-specific protein 
binding sites. The paper was then washed with PBS and primary antibody 
solution in block solution was added and the container was placed on the 
laboratory shaker for gentle agitation for 1 hr. The dilutions of the antibodies 
used are shown in Table 2.5.
Following the primary antibody incubation, the paper was washed once in 
PBS/0.05% Tween for 5 min prior washing twice in PBS for 5min, then 
incubated for 1 hour in HRP goat anti-mouse/anti-rabbit secondary antibody 
solution [dilution 1:5000 in 5% milk/TBS]. The NC Paper was washed again, 
one in PBS 0.05% Tween for 5 min and twice in PBS for 5 min before 
developing. Initially, 1 ml of each of the ECL reagents were mixed and added 
to the NC paper and left for 1 min. The paper was gently shaken to remove any 
excess reagents, and placed inside the developer cassette, covered by cling 
film, and transferred to a dark room. The cassette was opened and the 
chemiluminescence film paper placed over the cling film. The cassette was 
then closed for the required exposure time and after the film was placed in the 
developer.
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Primary antibody Type
Dilution 
5% Milk/PBS
Ant i-oc-Tubulin Mouse 1:1000
Anti-clathrin heavy chain Mouse 1:500
Anti-DNM2 Mouse 1:250
Anti-Flot-1 Mouse 1:500
Anti-Cav-1 Rabbit 1:1000
Anti-PAK-1 Rabbit 1:200
Anti-GFP Mouse 1:2000
Anti-EGFR Mouse 1:500
Anti-Arf6 Mouse 1:1000
Anti-GRAF-1 Goat 1:500
Table 2.5. Antibodies and dilutions used for I m mu nolabelling NC papers
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2.3.9 MTT Assay to determine cell viability
HeLa cells were seeded into 96 well plates at 8 x 103 cells/well 24 hrs prior to 
the experiment. On the day of the experiment the media was removed and cells 
were transfected as mentioned in section 2.3.3. 48 hrs after the transfection, an 
aliquot (20 pL) of a sterile, filtered solution of MTT in PBS (5mg/ml) was 
added to each well and the plate was then incubated for 5 h at 37 °C, 5 % CO2. 
The media and MTT solution were aspirated and an aliquot (100 pL) of DMSO 
was added to each well to dissolve the resulted purple formazan crystals. After 
the plate had been incubated for 30 min at 37 °C, 5 % CO2 the UV absorbance 
was measured at 550 nm (Sunrise, Tecan). Cell growth as % was determined 
relative to the control cells.
Reduction of yellow MTT to the purple formazan crystals is irreversible and is 
catalysed by enzymes located within the mitochondria and thus measures cell 
viability.
X, ^ t r e a t e d  cells
CellViability{%)=— ^ -----------— -*100
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Chapter 3: Revaluation of the role of Clathrin 
Mediated Endocytosis in cellular uptake of CPPs Tat
andR8
3.1. Introduction
Widespread studies on the internalisation mechanism of cell penetrating 
peptides have been performed with non-amphipathic peptides Tat (48-60) and 
oligoarginines, mostly as fluorescent conjugates. The uptake of pTat as well as 
pTat-PNA conjugates were reported to take place via an energy-dependent 
clathrin-mediated endocytosis (CME) (Richard et al. 2003). An alternative 
mechanism not involving endocytosis was proposed for polyarginine peptides 
that also suggested internalisation of when experiments were performed on ice 
(Kosuge et al. 2008; Maiolo et al. 2005; Zaro and Shen 2005). Three different 
studies show that at low concentrations (2 pM) polyarginine peptides were 
shown to be trapped in endosomal vesicles clearly indicating the involvement 
of an endocytosis process (Duchardt et al. 2007; Fretz et al. 2007; Potocky et 
al. 2003). At concentrations greater than 5pM there is strong evidence to show 
that these peptides can enter cells directly across the plasma membrane and this 
was especially noted in leukaemia cells (Watkins et al. 2009b).
In order to study CME, or any other endocytic pathway, and its involvement in 
CPP uptake, it is necessary to have knowledge of proteins that distinctly 
regulate the pathway such that they can then be modified (mutated) or depleted 
to generate a cellular model that is deficient in only this pathway. CME is by 
far the most well-characterized endocytotic pathway and is known to be 
regulated by many different proteins and lipids. This process initiates via the 
formation of well structured ligand-receptor complexes on the plasma 
membrane using clathrin assembly proteins such as adaptors working in 
conjunction with clathrin heavy and light chain. Consequently, these coated 
pits invaginate and pinch off from the plasma membrane to form intracellular
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clathrin coated vesicles (Khalil et al. 2006). Within two minutes the vesicles 
loses its clathrin coat and the stripped vesicle then fuses with an early or 
sorting endosome. Fluorescent labelled HIV-Tat peptide, has been reported to 
colocalize with transferrin, which is considered as a classical CME marker 
(Potocky et al. 2003; Richard et al. 2003). Another study demonstrated that Tat 
uptake is inhibited by 50 % in chlopromazine treated HeLa cells(Richard et al. 
2005). This drug is a well characterised CME inhibitor, and to support these 
findings incubation in potassium-free buffer, another inhibitor of CME, 
resulted in a 40% decrease in peptide uptake. Other studies, however, with 
fluorescently labeled polyarginine revealed very little colocalization with 
transferrin (Jones et al. 2005; Nakase et al. 2004) suggesting only a minor role 
for CME and the involvement of other pathways. Thus the actual involvement 
of CME remains to be fully determined.
In this chapter the role of CME was investigated using two approaches: The 
use of classical pharmacological inhibitors and the use of siRNA depletion of 
the CME regulator clathrin heavy chain (CHC). Transferrin is known to be a 
well-characterised probe for this pathway thus published methods and Alexa 
probes were available. The goal here was to develop the siRNA methods in the 
laboratory using this identifiable probe and then test the models for uptake of 
CPP Tat and R8 that formed our CPf models. The uptake of the fluid phase 
marker dextran was assessed using the same approach.
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3.2. Methods
HeLa cells were used as a model cell-line to study CME pathway in this 
chapter. Different concentrations of Alexa-488 Tf were tested, 2 nM, 20 nM, 
and 100 nM and the requirement of energy/temperature on Tf uptake was 
analysed by carrying out the incubation at both 4 and 37° C as described in 
section 2.3.5.1. In addition, the effect of acid washing to remove the plasma 
membrane binding was also examined.
HeLa cells were transfected using different siRNA sequences as described in 
chapter 2.3.3. Alexa-488 Tf uptake was investigated in siRNA-Lamin A/C 
(+ve control) and CHC depleted cells. To optimize the transfection procedure, 
different siRNA concentrations and different incubation periods were tested. 
Cell associated fluorescence was measured by flow cytometry and by confocal 
microscopy as described in sections 2.3.4 and 2.3.5.
To study the role of CME in dextran internalisation, two different dextran 
conjugates, Alexa488-Dextran (10 kDa) and FITC-Dextran (40 kDa), were 
used. To characterize the involvement of CME pathway in Alexa-488 R8 and 
Tat uptake, 2 pM of CPPs was added to either CHC depleted HeLa cells or 
after pre-incubation with chlorpromazine (CME inhibitor) for different 
incubation period 0-80 prior to analysis by flow cytometry. For these peptide 
experiments an additional wash in Heparin was included to further remove 
surface bound peptide.
Finally, SDS-PAGE electrophoresis and Western blotting techniques were used 
to measure CHC depletion as described in sections 2.3.7 and 2.3.8
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siRNA Sequences Ref.
Lam in A/C CUGGACUUCCAGAAGAACAdTdT (Schmid et al. 2007)
GFP GGCUACGUCCAGGAGCGCAdTdT Designed by MWG
CHC UAAUCCAAUUCGAAGACCAAUdTdT (Motley et al. 2003)
Table 3.1. siRNA sequences used as control or for targeting CHC.
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3.3. Results
3.3.1. Effect o f temperature and acid washing on Alexa488-Tf uptake 
Alexa-488 Tf was used as a classic marker for CME and its cellular uptake was 
evaluated at two different temperatures 37° C and at 4° C (Figure 3.1.A). 
Alexa488-Tf internalisation was completely inhibited at 4° C, which confirms 
that CME is an energy dependant process. Here and in most experiments 
uptake was measured at different time points rather than at a single time point 
as is most often the case.
To investigate whether some of the cell associated fluorescence was probe on 
the plasma membrane further experiments were performed employing an acid 
wash step as described in chapter 2. The flow cytometry results show a 
significant reduction in Alexa488-Tf cell associated florescence in acid washed 
cells compared with non-acid washed (Figure 3.1.B) cells. Therefore, acid 
wash was applied as an essential step to exclude the fraction that was localised 
to the plasma membrane thus giving a more accurate value for the fraction that 
was intracellular.
3.3.2. Effect o f depleting clathrin heavy chain (CHC) expression on 
Alexa488-Tf uptake
Initially, the siRNA concentration was optimized and evaluated to ensure that 
the general procedure was non-toxic to the cells prior to assessing the 
effectiveness of transfection. Many reasearchers use siRNA at concentration 
<100 nM and in this chapter different siRNA concentrations were tested 10 
nm, 50 nM, 100 nM, and 250 nM (Figure 3.2.A). Using a single time point 
assay we observed a similar reduction in transferrin uptake at all siRNA
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concentrations studied and marginally the highest reduction was observed at 50 
nM. For siRNA controls in each experiment, we used either siRNA targeting 
Lamin A/C protein, which is required to form the nuclear lamina and has no 
role in CME or siRNA targeting green fluorescent protein (GFP) that is not 
normally expressed in these cells. Cells transfected with siRNA targeting 
Lamin had much higher Tf levels compared with cells targeted with siRNA 
against CHC (Figure 3.2.B) and fluorescence values in these siRNA Lamin 
cells were the same as non-transfected cells showing that the transfection 
procedure had no effect on transferrin uptake.
SDS-PAGE electrophoresis was then used as stated previously to detect the 
effectiveness of the siRNA method in depleting CHC. Figure 3.3 shows that 
there was effective though not complete depletion of clathrin in these cells 
(Figure 3.3 A) but repeated experiments showed a consistent reduction of over 
85%.
Following the development of these transfection protocols time course studies 
of Tf uptake was performed. Cells, 48 hrs after transfection, we incubated with 
lOOnM Alexa-488-Tf for different incubation periods 0-32 min and processed 
as mentioned previously for flow cytometry studies. From the earliest time 
point there was a reduction in Tf uptake in siRNA CHC cells. This continued 
throughout the experiment though the percentage inhibition gradually 
decreased with increasing incubation time. (Figure 3.4.A).
In order to observe these findings using a different method, cells following 
transfection with siRNA targeting CHC or Lamin were plated on coverslips 
and incubated for different periods of time with Alexa488-Tf. The cells were
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then washed in PBS and acid wash buffer prior to analysis by confocal 
microscopy. Data in (Figure 3.4.B) shows a reduction in cell associated 
fluorescence in siRNA CHC cells at all time points. In agreement with flow 
cytometry studies, there was some uptake of Tf in CHC targeted cells rather 
than a complete inhibition.
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Figure 3.1. Effect of tem perature and acid washing on cellular uptake of 
Alexa488-Tf.
(A) HeLa cells were incubated with 100 nM Alexa488-Tf at 37° C and at 4°C 
for 0-32 min prior to washing and analysis by flow cytometry (n=3). (B) 
Following Tf incubation, HeLa cells were either washed in PBS or acid wash 
buffer prior to trypsinisation and flow cytometry analysis (n=3).
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Figure 3.2. Effect of using siRNA transfections on cell viability and 
Alexa488-Tf uptake.
HeLa cells were transfected using different siRNA (CHC) concentrations for 
48hr then incubated with 100 nM Alexa488-Tf at 37° C for 15 min prior to 
washing and analysis by flow cytometry (n=3). (B) Cells were transfected with 
50nM si-Lamin A/C and si-CHC for 48hr then incubated with 100 nM 
Alexa488-Tf for 15 min prior to processing and analysis by flow cytometry 
(n=2). (C) MTT cell viability assays were performed on untreated cells, cells 
incubated with oligofectamine alone or cells transfected with siRNAs against 
CHC, Lamin. The assays were performed 48 hrs after transfection. The data 
representative of two independent experiments performed in triplicate.
87
3.3.3. Evaluation of dextran internalisation via CME
Dextran is often used as a fluid-phase marker to characterize endocytic and 
transcytotic processes. To study the role o f CME in dextran uptake, CHC was 
depleted using the optimised siRNA method. Two different molecular weight 
and two different probes of conjugated dextran were used, FITC-Dextran 
(40KDa) and Alexa488-Dextran (10 KDa). Cells were incubated with 5mg/ml 
FITC-Dextran (40KDa) and 0.2 mg/ml Alexa488-Dextran (10 KDa) for 
increasing periods of time prior to cell washing (including acid wash) prior to 
trypsinisation and analysis by flow cytometry (Figure 3.5). A consistent 
inhibition in dextran uptake was also observed after 20 min of uptake and for 
both probes but this was not statistically significant. For these experiments an 
internal control was also added to ensure that we were investigating cells with 
depleted CHC expression and thus reduced Tf uptake. These are shown as 
inserts in the figure and highlight effective transfection and an effect on Tf 
uptake. This gave us confidence that the transfection was successful and this 
“Internal siRNA control” was included from here on in in most experiments.
3.3.4. Characterize the requirement of CME in Alexa488-R8 and -Tat uptake 
Previous studies have suggested that CME route may be utilized by CPPs to 
cross plasma membrane. Thus, the uptake of both Alexa488-RL8 and -Tat were 
investigated further using two methods: siRNA depletion and pharmacological 
inhibition. As CPPs have been shown to be internalised by both a temperature 
independent (translocation) and dependent method it was important to show 
that uptake was energy dependent and therefore most probably due to 
endocytosis. At 2pM extracellular peptide concentration in HeLa cells these
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CPPs labels endocytic vesicles and no cytosolic labelling can be seen (Watkins 
et al. 2009b) This concentration also allows a sufficient signal to noise ratio for 
us to be able to monitor uptake by flow cytometry. The requirement for energy 
was therefore determined at this concentration. Hela cells were incubated for 
15 min at either 37°C or 4°C prior to adding Alexa488-R8 or -Tat for various 
periods of time prior to washing trypsinisation and analysis by flow cytometry 
(Figure 3.6). The data shows that for all time points only approximately 15% of 
peptide associates with the cells when incubated at 4°C. Thus under these 
conditions only a very small fraction of the peptide enters cells in an energy 
independent manner.
Intially, AIexa488-R8 and -Tat were incubated in control HeLa cells for 1 hr, 
then washed (Figure 3.7.A) or unwashed (Figure 3.7.B) with PBS and imaging 
media before being processed immediately for life-cell imaging with confocal 
microscopy. The result in Figure 3.7 shows a clear internalisation of both 
Alexa488-R8 and -Tat and very well distributed inside the cells in a vesicular 
manner.
Alexa488-R8 and -Tat were then incubated in with siRNA CHC cells or those 
transfected with control (GFP/Lamin) siRNA. Under these conditions the 
internal siRNA control showed effective inhibition of transferrin uptake but 
there was no effect on internalisation of either CPP (Figure 3.8). 
Chlopromazine (CPZ) was then used as a CME inhibitor to further investigate 
CME in CPPs uptake. Cells were pre-equilibrated with the drug for 30 min and 
then incubated with either CPPs or Alexa488-Tf in the continued presence of 
the drug. High inhibition was shown for transferrin uptake, but again there was 
no evidence of a reduction in CPP uptake between 0 and 80 mins (Figure 3.9).
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Figure 3.3. Analysis of CHC expression and depletion following siRNA- 
CHC targeting.
Following transfection of cells with different siRNAs, lysates were prepared 
and 20 or 25 pg protein were loaded on to 10 % SDS-PAGE gels, transferred 
to nitrocellulose papers, probed with antibodies against CHC, Lamin, GFP or 
a-tubulin that were then detected with HRP conjugated secondary antibodies. 
Control lanes are corresponding to non-transfected cells, while si-Lamin and 
si-GFP lanes are representing positive control. In (A) duplicate loading has 
been performed to assess reproducibility and in (B).
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Figure 3.4. Uptake of Alexa488-Tf in si-Lamin A/C vs. si-CHC transfected 
HeLa cells.
HeLa cells were transfected with si-Lamin A/C (I) or with si-CHC (II) for 
48hr, then incubated for the indicated time points with 100 nM Alexa488-Tf at 
37° C before washing and analysis by either Flow cytometry (A) or confocal 
microscopy (B). Flow cytometry data represents cell associated fluorescence 
for three independent experiments (n=3). Confocal images represent maximum 
projection images. Scale bars = 25pm.
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Figure 3.5. Evaluation of Dextran Internalisation via CME.
HeLa cells were transfected with si-Lamin A/C or si-CHC for 48hr, then
incubated for the indicated time points with either 5mg/ml FITC-dextra (A) or
0.2mg/ml Alexa488-Dextran (B) at 37° C before washing and analysis by Flow
cytometry. The data represents cell associated fluorescence for three
*
independent experiments (n=3). Parallel uptake experiments with transferrin
(siRNA Internal Control) was performed to ensure protein depletion and an 
effect on CME.
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3.4. Discussion
The uptake o f CPPs such as R 8 and HIV Tat has been intensely studied 
and in the most the peptides are covalently coupled to one o f the many 
fluorophores that are now available and analysis is performed using flow 
cytometry and/or fluorescence microscopy. However new methods such 
as mass spectrometry o f radiolabelled peptides are now emerging to 
support the fluorescence approach or raise questions about the suitability 
o f fluorescence-peptides (Jiao et al. 2009). Despite these studies there is 
still controversy in the field and it is important to note that it is likely that 
different CPPs will have their own entry mechanism thus one model is 
unlikely to emerge that fits all peptides. It is generally accepted that 
some variants can enter in an energy dependant and independent 
mechanism but for this thesis the main focus was on studying the 
endocytic uptake rather than direct translocation and here it is seen that 
at 2 jliM  that 8 5 %  of uptake can be inhibited by performing the 
internalisation experiments on ice. In collaboration with the Futaki 
laboratory has focused on D and L forms o f octaarginine and Tat 
peptides but the main focus o f this thesis was the L forms o f these two 
peptides.
Most o f the reports on these two peptides and other fluorescent CPPs 
have described experiments using endocytosis inhibitors that as 
discussed in Chapter 1 have their own problems o f lack o f specificity 
(Ivanov 2008). M utant proteins such as dynamin have also been used to
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characterise uptake (W adia et al. 2004) bu t it is now  know n that dynam in  
II regulates m ore than  one endocy tic  pathw ay  (D oherty  and M cM ahon 
2009).
For this thesis attempts were made to inhibit several endocytic pathways 
through the use of siRNA depletion of endocytic proteins. This was a new 
technique in the laboratory and the earlier part of the work concentrated on 
developing this method. CME is by far the best characterised uptake route and 
therefore the initial work focused on this pathway. CME is regulated by several 
proteins including CHC, clathrin light chain and adaptor proteins and there is 
data available of the use of siRNA to deplete these proteins (Motley et al. 
2003; Poupon et al. 2008; Thiery et al. 2010). From screening siRNAs from a 
number of proteins regulating CME, CHC and adaptor proteins were identified 
the most effective targets (Johannessen et al. 2000). For the project, CHC was 
chosen as the target protein and HeLa cells were used as they have been a 
model used in the laboratory to study CPPs, they are known to be relatively 
easy to transfect and studies have been published on using siRNA to affect 
endocytosis in these cells (Motley et al. 2003).
Fluorescently labelled endocytic probes transferrin and dextrans were 
employed as markers on CME and fluid phase uptake. The use of fluorescein 
isothiocyanite (FITC) as a fluorescence label is attractive due to the fact that 
FITC labels are relatively cheap compared with Alexa variants however it is 
known that the emission of this probe is sensitive to pH thus careful analysis 
needs to be made when interpreting data using this probe to study endocytosis. 
Therefore, two different fluorescence labelled dextrans were chosen to validate 
the results noting that Alexa dyes are not known to be pH sensitive.
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The uptake o f  transferrin was initially studied and it was decided at the start o f 
the project that time course experiments would be used as choosing a single 
time point could mean the loss o f  important information. This however is 
much more labour intensive especially as three independent experiments were 
required to allow statistical analysis o f  the data. The siRNA concentration was 
also briefly investigated and 50nM was finally selected due it giving slightly 
better inhibition o f transferrin uptake. Over 85% o f CHC expression could be 
depleted with CHC siRNA sequence shown in Table 3.1. This sequence was 
then used to look at timed uptake o f  the probe and viability o f  the cells. The 
relative inhibition in transferrin uptake was found to be time dependent being 
very high at early time points 0-15 min and then reducing at longer 
incubations. This is probably due to the fact that clathrin coated pits are also 
known to be required for recycling o f  this probe (van Dam and Stoorvogel 
2002). Therefore, in CHC deficient cells there would also be a fault in 
recycling and that the material entering at a reduced levels compared to control 
cells would also be retained at a higher level.
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Figure 3.6. Effect of temperature on Alexa488-R8 and -Tat uptake.
HeLa cells were incubated with 2 pM Alexa488-R8 (A) and -Tat (B) at 37° C 
and at 4° C for 0-80 min, followed by washing, trypsinisation and analysis by 
flow cytometry (n=3).
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Figure 3.7 Subcellular distribution of Alexa488-R8 and -Tat in HeLa cells
HeLa cells were washed and incubated with 2pM of Alexa488-R8 or -Tat in 
DMEM media for 1 hr, then the cells were either unwashed (A) or washed (B) 
and analysed immedietly by confocal microscopy on the 37° C temperature 
stage. Shown are fluorescence and bright field images.
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Figure 3.8. Uptake of Alexa488-Rt8 and -Tat uptake in CHC depleted 
cells.
HeLa cells were transfected with si-CHC, si-Lamin A/C or si-GFP for 48hr, 
then incubated for the indicated time points with 2 juM Alexa488-R8 (A) or -  
Tat (B) at 370 C for the indicated time points. Cells were washed, trypsinised 
and immediately analysed by flow cytometry. Values above obtained from 
three independent experiments (n=3) *Parallel uptake experiments with 
transferrin (siRNA Internal Control) is performed to ensure protein depletion 
and an effect on CME.
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F igure 3.9 Effect o f using pharm acological C M E  in h ib ito r (CPZ) on CPPs 
up take
Cells were pre-incubated for 30 min in the absence (Control) or presence 
(CPZ) o f  lOpM CPZ at 37°C, prior to washing and incubation with 100 nM 
Alexa488-Tf (A) or with 2 //M Alexa488-RL8 (B) or -T at (C) at 37° C for the 
indicated time points. Cells were washed, trypsinised and analysed by flow 
cytometry. Results represent data from three independent experiments.
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The viability of the cells at following these siRNA treatments was tested using 
MTT assays and the results in Figure 3.2 show that cell viability remained 
>85% 48 hrs following transfection. siRNA targeting LaminA/C has often 
been used as a control for these kinds of experiments (Schmid et al. 2007), but 
microscopy revealed that the nucleus of Lamin A/C depleted cells had unusual 
shapes (Figure 3.10). Although, they had control uptake of Tf it was decided to 
use siRNA against a protein not expressed in these cells thus GFP was chosen 
for all subsequent experiments.
There is a possibility that inhibiting one pathway may affect the efficiency of 
another pathway and the uptake of Dextran was investigated in siRNA CHC 
cells. The studies show that uptake of both FITC and Alexa488 dextran was 
reduced at later time points but this was not statistically significant. This may 
have been a consequence of the slight effect on cell viability of the transfection 
procedure. The data are essentially in agreement with another study that 
investigated dextran uptake in CHC depleted cells (Zhang et al. 2009).
The development of these methods then allowed us to reach the main objective 
here, namely to study the uptake of the two CPPs Alexa488-R8 and -Tat. 
Again, the effect of temperature was initially investigated at different time 
points. Unlike Tf there was some temperature independent uptake of both R8 
and Tat amounting to approximately 15% of the uptake. This is in agreement 
with other studies (Jiao et al. 2009; Nakase et al. 2004). It is however very 
difficult to distinguish between peptide that is actually inside the cells and 
peptide that may still be present on the surface of the plasma membrane or
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Figure 3.10. Effects of lamin depletion on nuclear shape.
HeLa cells were transfected with si-CHC (left) or si-Lamin A/C for 48hr, 
washed with PBS and the fixed in 3%  PFA before incubation with PBS/0.2 
Triton-X 100 for 5min. 10 pM of Hoechst was then added to the cells for 10 
min before washing and mounting on coverslips and analysis by confocal 
microscopy.
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even in the plasma membrane and this is despite washing with heparin and 
trypsinisation. There was no effect on uptake on uptake of either CPPs in CHC 
depleted cells leading to the conclusion that CME endocytosis plays no role in 
endocytosis of these peptides an this is contrary to results obtained using 
inhibitors (Richard et al. 2003).
Other studies also suggest that arginine rich CPPs utilise CME pathway to gain 
entry to the cytoplasm (Potocky et al. 2003) and Tat has been shown to be 
partially colocalized with transferrin (Richard et al. 2003). The uptake of retro- 
inverso form of a Tat peptide, R.I.-CKTat9, was also studied highlighting a 
concentration- and energy-dependent uptake mechanism. In addition, the 
labelled R.I.-CKTat9 colocalized with labeled transferrin in the punctate 
structure, suggesting that the peptide enters HeLa cells by CME. And in 
support of this they also show a significant inhibition in R.I.-CKTat9 in siRNA 
CHC depleted cells and in CME inhibitors (monodansylcadaverine & sucrose) 
pretreated cells (Zhang et al. 2009). However, these results were gained from 
very few cells using microscopy methods and from appearance the viability of 
the cells needs to be questioned. It may be that in the results presented in this 
thesis, 100% depletion CHC was not observed that the remaining fraction was 
sufficient for CPP uptake; but this is very unlikely. To make sure that 
transfection was successful in each experiment, control experimental points 
were employed for each assay, and this proved to be a highly efficient way of 
validating the data. It is very rare that these kinds of control experiments are 
performed.
The data is supported by another study using the BHK21-tTA/anti-clathrin 
heavy chain (CHC) cell line that can be induced to become defective in CME
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(Ter-Avetisyan et al. 2009). They confirmed that the uptake of Tat is not 
mediated by CME.
To validate the data obtained using siRNA method, the CME inhibitor 
chlorpromazine (CPZ) was used in experiments using Tf and CPPs. The data 
shows a significant inhibition in transferrin uptake, whereas it failed to inhibit 
the uptake of both Alexa488-RL8 and -Tat. Information on Dynasore, another 
CME inhibitor, is given in Chapter 4 and the data is supportive of the results 
obtained here. It has been reported that at peptide concentrations <5 pM, CPZ 
has no effect on cellular uptake of R9 and Tat, however, by increasing peptide 
concentration, the inhibitory effect of CPZ increased (Duchardt et al. 2007). 
Additionally studies from independent laboratories show that the higher the 
extracellular concentrations of cationic CPPs, the greater the fraction that is 
diffusely localized in the cytoplasm (Duchardt et al. 2007; Fretz et al. 2007; 
Tunnemann et al. 2008). Thus, the concentration of CPPs is a critical factor 
that may affect the uptake mechanism and possibly the type of endocytic 
pathway utilised. The concentration, used here was 2 pM and as shown 85% of 
the uptake occurs via an energy dependent manner. However, different cell- 
lines may have different threshold concentrations, due to the differences in the 
composition of the plasma membrane -lipids, proteins and their associated 
carbohydrates.
In conclusion, methods were developed for depleting CHC from HeLa cells, 
showing a strong inhibitory effect on Tf uptake. Using these methods 
paralleled with inhibitor studies allowed for us to conclude that there was no 
requirement for CME on uptake of CPPs R8 and Tat. Parallel studies using 
siRNA depletion were running in the University of Ghent as they attempted to
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study the uptake of disulfide-based poly(amido-amine)/DNA polyplexes as 
part of their drug delivery programme. For the project, all the 
immunolabelling of lysates was developed and conducted by myself as part of 
this thesis. This was recently published in Biomaterials (Vercauteren et al. 
2011) and they were able to successfully deplete CHC and show that 
internalisation of p(CBA-ABOL) polyplexes in ARPE-19 cells is independent 
of CME.
Efforts for this thesis were then concentrated on investigating other pathways 
that are less well characterised and more of a challenge to study.
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Chapter 4: Evaluation of the role of Dynamin-2, 
Caveolin-1 and Flotillin-1 in cellular uptake of CPPs
Tat and R8
4.1. Introduction
It has been shown that several molecules and receptors are internalised into 
cells via vesicular carriers, which are not clathrin or caveolin 1 dependent. The 
caveolin-1 dependent pathway will be discussed later in this chapter. The 
products of invagination called clathrin-independent carriers (CLIC), or GPI- 
enriched endocytic compartments (GEEC) are still poorly described. Actin and 
small GTPases like dynamin, RhoA, ARF1, ARF6 and Cdc42 have been 
shown to mediate the formation of CLICs. The most well known examples of 
molecules that enter cells via clathrin- and caveolin independent endocytosis 
are interleukin receptor 2, major histocompatibility complex class I (MHC I) 
and GPI-anchored proteins. The first plasma membrane receptor to be shown 
to utilize CLIC is Interleukin-2 and it also has been shown to be dependent on 
RhoA (Cheng et al. 2006; Lamaze et al. 2001; Sabharanjak et al. 2002). Rho A 
is also required in fluid phase uptake of dextran (Sabharanjak et al. 2002). 
However, the internalisation of the folate receptor, which is a GPI-anchored 
protein occurring through a Cdc42-dependent pathway (Sabharanjak et al. 
2002). Arf6 has been shown to regulate the dynamin independent endocytosis 
of proteins such as class pi integrin, E-cadherin, GPI-APs, I major 
histocompatibility complex molecule (MHC I) (Mayor and Pagano 2007). 
Recently, the McMahon group have reported that a Rho-GAP-domain- 
containing protein GRAF1 to be the first non cargo marker for the 
CLIC/GEEC endocytic membranes (Lundmark et al. 2008). This protein was 
shown to be associated with dynamic tubular and vesicular lipid structures 
together with phosphoinositides PtdIns(4,5)P2, and Cdc42.
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Flotillin-1 (Flot-1) and flotillin-2 (Flot-2), also termed Reggie-2 and 1, 
respectively, are ubiquitously expressed proteins (Solis et al. 2007) and been 
reported to be associated with cholesterol rich membrane microdomains and in 
invaginations that do not contain caveolins (Frick et al. 2007; Stuermer et al. 
2001). Lately, flotillin mediated endocytosis is considered as a new clathrin- 
and caveolin-independent endocytic pathway (Glebov et al. 2006) and more 
recently the same group have suggested it is involved in uropod dynamics of 
neutrophils (Szakacs et al. 2006). Flotillin-1 and 2 have however been studied 
for a number of years and their association with lipid rafts have long been 
established though the flotillin domains on the plasma membrane seem to be 
separate from those enriched in caveolin-1. But in common with caveolin-1 it 
seems that uptake of flotillin-1 structures is a slow and/or infrequent process; 
flotillin has also been implicated in phagocytosis (Dermine et al. 2001). The 
original work in flotillin-1 and endocytosis demonstrated that an antibody 
against CD59 was internalised into HeLa cells in a flotillin-1 dependant 
manner (Glebov et al. 2006). This was shown using siRNA targeting of 
flotillin-1 and investigating the uptake of a fluorescent anti-CD59 antibody. 
CD59 is also known as protectin, and it is a complement regulatory protein, or 
MIRL (membrane inhibitor of reactive lysis) (Venneker et al. 1994). Three 
activities for CD59 h&ve been recognized including downregulation of the 
activation of the C cascade at membrane attack complex formation stage, 
participation in T-cell rosette formation with erythrocytes and it is necessary 
for T-cell activation (Venneker and Asghar 1992; Venneker et al. 1994). CD59 
is present on most tissues and this is compatible with its function of protecting 
cells and tissues from incidentally activated autologous C. Mature CD59 is
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made up of 103 amino acids and 20% of its molar mass is carbohydrate. The 
protein part of the molecule is covalently linked to an oligosaccharide, which is 
glycosydically linked to phosphatidylinositol (PI). Decreased expression of 
CD59 has been shown in two diseases; paroxysmal nocturnal hemoglobinuria, 
and in psoriasis (Venneker and Asghar 1992; Venneker et al. 1994). Like 
many proteins, advances in CD59 biology have been made through the use of 
antibodies recognising this protein and several have been described including 
A35, YTH53.1, BRIC229, MEM34, and HC2 (Bodian et al. 1997). For this 
thesis A35 and YTH53.1 clones were investigated. As CD59 is a GPI linked 
protein most studies on the uptake of this protein have concentrated on this fact 
and the protein was found to be localised to ARF6 compartments before 
merging with cargo internalised via CME (Naslavsky et al. 2004). 
Interestingly CD59 was found in tubular structures after 30 min of uptake and 
mutant API 80 protein involved in CME did not affect uptake of the molecule 
but filipin significantly reduced uptake (Naslavsky et al. 2004).-
Caveolae are 50-80 nm flask-shaped membrane regions also rich in GPI- 
anchored proteins, sphingolipids, cholesterol. The caveolae shape was 
discovered 50 years ago by electron microscopy (Parton and Richards 2003; 
Yamada 1955), whereas its structural components were identified later. The 
main protein in caveolae is caveolin, which is a 21 kDa integral membrane 
protein and is inserted as a hairpin loop into the membrane, and its amino- and 
carboxy-terminal regions are directed toward the cytosol (Dupree et al. 1993). 
Caveolin has three known isoforms, caveolin-1 (Cav-1), caveolin-2 (Cav-2) 
and caveolin-3 (Cav-3). Both Cav-1 and Cav-2 have similar distribution and
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they are highly expressed in adipocytes, endothelial cells, fibroblasts and 
smooth muscle cells. While Cav-3 is highly expressed in cardiac and skeletal 
muscle (Parton and Richards 2003). It has been reported that cellular 
internalisation of caveolae is dependent on active dynamin and the actin 
cytoskeleton (Nichols 2002; Thomsen et al. 2002). Caveolae have been 
implicated in delivering a number of different cargoes and integral plasma 
membrane proteins and lipids (Parton and Richards 2003). It was initially 
thought that cholera toxin B was internalised solely through this pathway and 
this was usually termed ‘the caveolae marker’ but subsequently it was 
discovered that this toxin can enter through other clathrin dependent and 
independent pathways (Pang et al. 2004; Torgersen et al. 2001). The 
endocytosis of fluorescent glycosphingolipid (GSL) analogs in various cell 
types was studied by Pagano’s group, using pharmacological inhibitors and 
colocalization studies with fluorescent lactosylceramide as a GSL probe and 
DsRed caveolin-1 as a marker protein. They found that, all GSLs tested were 
internalised mainly by a clathrin-independent, caveolar-related mechanism, 
regardless of cell type. Their results show that the internalisation of fluorescent 
LacCer was reduced 80-90% in cell types with low Cav-1, but was 
dramatically stimulated by Cav-1 overexpression. However, even in cells with 
low levels of Cav-1, residual LacCer internalisation was clathrin independent. 
In contrast, cholera toxin B subunit was internalised via clathrin-independent 
endocytosis in cells with high Cav-1 expression. There results suggest that 
GSL analogs are selectively internalised via a caveolar-related mechanism in 
most cell types, whereas CtxB may undergo "pathway switching" when Cav-1 
levels are low (Singh et al. 2003).
10 9
In this chapter the role of DNM2, Flot-1, and Cav-1 was investigated using 
chemical inhibitors and siRNA depletion of these three proteins. The goal here 
was to find a specific probe for distinct pathways regulated by these proteins 
and then test the siRNA developed models for uptake of Tat and R8. 
Alexa488-Tf was used as a marker probe for DNM2 dependent endocytic 
pathway as this protein is known to be involved in CME and caveolin 
dependent uptake. But most important here is the recent evidence suggesting 
that DNM2 is involved in fluid phase uptake (Cao et al. 2007). There is every 
possibility that the peptides are entering via fluid phase uptake but this 
pathway does not have a true siRNA target and thus DNM2 was studied. If 
CPPs are entering cells in the fluid phase then it should be possible to inhibit 
their entry in DNM2 depleted cells. Based on literature it was decided to study 
the uptake of anti-CD59 and BODIPY LacCer for Flot-1-dependent and Cav-1 
dependent endocytic pathways respectively.
4.2. Methods
HeLa cells and A431 cells were used to study DNM2 dependent pathways, 
while Flot-1 dependent and Cav-1 dependent pathways were studied using 
HeLa cells only.
Initially, Alexa488-Tf Alexa488-R8, and -Tat uptake was investigated in 
HeLa and A431 cells treated with the DNM2 inhibitor dynasore and cell 
associated fluorescence was measured by flow cytometry as shown in section 
2.3.5.4. Alexa488-Tf uptake was also investigated in dynasore treated cells 
using confocal microscopy as described in section 2.3.4.2. HeLa cells and 
A431 cells were also transfected with different siRNA sequences as described
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in chapter 2 and as shown in Table 4.1. Alexa488-Tf, Alexa488-R8 and -Tat 
uptake was investigated in control (siRNA GFP) and DNM2 depleted cells and 
cell associated fluorescence was measured by flow cytometry as described in 
section 2 .3.5.3
To study the role of Flot-1 in CPP uptake, methods were developed for 
analysing the uptake of anti-CD59 antibody in Flot-1 depleted HeLa cells using 
different siRNA sequences as described in chapter 2 and as shown in Table 4.1. 
Thereafter Alexa488-R8 and -Tat uptake was investigated in Flot-1 depleted 
cells and cell associated fluorescence was measured by flow cytometry as 
described in section 2.3.5.2 and 2.3.5.3.
In order to characterize the requirement of Cav-1 in CPP uptake methods were 
developed for investigating the uptake of BODIPY-LacCer in Cav-1 depleted 
cells. Due to the excessive plasma membrane binding of this marker, even 
following extensive washing, trypan blue quenching and back extraction 
methods was investigated as described in section 2.3.5.2. The uptake of 
Alexa488-R8 and -Tat was finally investigated in Cav-1 depleted HeLa cells 
using a single siRNA sequence as described in chapter 2 and as shown in Table
4.1.
Finally, SDS-PAGE electrophoresis and Western blotting techniques were used 
to measure DNM2, Flot-1, and Cav-1 depletion from cell lysates as described 
in section 2.3.7 and 2.3.8.
This chapter also shows Western blotting data on lysates sent from the 
University of Ghent and preliminary analysis of the effects of transfecting cells 
with siRNAs targeting ARF6 and GRAF-1
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siRNA-Target Sequences Ref.
GFP GGC UAC GUC CAG GAG CGC AdTdT Designed by MWG
DNM2-A 5 ’-GAC AUG AUCGUGC AGUUU ATT-3 ’ (Cao et al. 2007)
DNM2-B
Set of 4 oligo’s:
5 ’ -GGCCCU ACGU AGC AA ACU A-3 ’ 
5’-GAGAUCAGGUGGACACUCU-3’ 
5’-CCGAAUCAAUCGCAUCUUC-3’ 
5 ’-GAGCGAAUCGUC ACC ACUU-3 ’
Designed by Dharmacon
DNM2-C GGA CAU GAU CCU GCA GUU dTdT (Romer et al. 2007)
Flot-1-A AGA UGC ACG GAU UGG AGA AdTdT Designed by MWG
Flot-1-B CACACUGACCCUCAAUGUCdTdT (Glebov et al. 2006)
Cav-1 AGA CGA GCU GAG CGA GAA GdTdT Designed by MWG
Arf6 Set of 4 oligo’s:
CGG CAU UAC UAC ACU GGG AdTdT 
UCA CAU GGU UAA CCU CUA AdTdT 
GAG CUG CAC CGC AUU AUC AdTdT 
GAU GAG GGA CGC CAU AAU CdTdT
Designed by Dharmacon
GRAF1 CCA CUC AUG AUG UAC CAG UUU CAA A Designed by Invitrogen
Table 4.1. siRNA sequences used in this Chapter
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4.3. Results
4.3.1. Characterisation o f the requirement o f  dynamin-2 protein in cellular 
uptake ofAlexa488-RL8 and -Tat
The uptake of both Alexa488-R8 and -TAT were investigated in this chapter 
using the two methods, which have been described in previous chapters 
detailing methods for siRNA depletion and chemical inhibitors (section 2.3.5.3 
and 2.3.5.4). As described in Chapter 2, one of the most important regulators of 
CME is dynamin and it acts as a scissor to separate the CCV from the plasma 
membrane. However it is now known to be involved in uptake through 
caveolae (Yao et al. 2005) and in fluid phase endocytosis (Cao et al. 2007). 
Alexa488-Tf was used as a marker for dynamin dependent endocytosis as 
methods were already in place for quantifying the uptake of this probe (section 
2.3.5.3). Dynasore is a recently discovered dynamin 1 and dynamin 2 inhibitor 
that was shown to be a powerful inhibitor of CME (Macia et al. 2006). It 
inhibits the action of dynamin by interfereing with the GTPase activity of 
dynamin 1 and dynamin2 and rapidly blocking coated vesicle formation (Macia 
et al. 2006). HeLa cells were pre-incubated with 80pM dynasore for 30 min, 
then incubated with 100 nM Alexa488-Tf for the indicated time points. 
Transferrin uptake was significantly inhibited in dynasore treated cells (Figure
4.1.A). Uptake was inhibited by 60-70% from 5-15 min then the inhibition was 
reduced to 40-50% from 20-30 min (Figure 4.1.B), Again this may be due to 
the requirement for this protein, as for CHC, in transferrin recycling. These 
flow cytometry results were also confirmed by confocal microscopy, that was 
performed after incubating untreated cells (Figure 4.2.A) or dynasore treated 
cells for 30 min (Figure 4.2.B). This then allowed analysis of the uptake of
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both CPPs in dynasore treated cells and the data in Figure 4.1C and D 
highlights the fact that the drug had no effect on CPP uptake. Experiments 
were then performed to determine whether there was any requirement for 
DNM2 by depleting this protein from cells.
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Figure 4.1. The effect of Dynasore on CPPs uptake in HeLa cells
Cells were pre-incubated for 30 min in the absence (Control) or presence 
(Dynasore) of 80pM dynasore at 37 °C, prior to washing and incubation with 
100 nM Alexa488-Tf (A-B) , 2 //M Alexa488-RL8 (C) or Alexa488-Tat (D) at 
37 C for the indicated time points. Cells were washed and immediately 
analysed by flow cytometry under standard conditions for CPP uptake. Values 
above obtained from three independent experiments (n=3). (B) Results from A 
expressed as percentage inhibition compared with control siRNA cells.
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Figure 4.2. Uptake of Alexa488-Tf in control and dynasore treated HeLa 
cells.
Cells were pre-incubated for 30 min in the absence (Control) (A) or presence 
(Dynasore) (B) of 80pM dynasore at 37° C, prior to washing and incubation 
with 100 nM Alexa488-Tf before washing, fixation and analysis by confocal 
microscopy. Confocal images represent maximum projection images. Scale 
bars = 25 pm.
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HeLa cells were transfected with a number of different siRNA sequences 
against this protein (si-DNM2-A, si-DNM2-B, and si-DNM2-C in Table 4.1). 
However, all of these siRNAs failed to deplete DNM2 efficiently using the 
standard methods used successfully for depleting CHC; this involves 
incubating the cells for 48 hrs after transfection before performing endocytosis 
assays and immunodetection from SDS gels (Figure 4.3). It was clear that 
some depletion was observed but this was not of a level that would have 
allowed for subsequent functional endocytosis assays in these cells (Figure
4.3.A, B, and D). At this time lystates were also sent from Ghent University to 
study the depletion of this protein from Retinal pigment epithelial cells and 
similar to data shown in Figure 4.3.C, complete depletion was not observed.
It was then decided to attempt to deplete this protein from A431 cells, using the 
standard 48 hr period and extended 72 hr periods, i.e. from start of transfection 
to analysis. A431 were chosen here because studies had already been 
investigated with these cells for studying macropinocytosis (Chapter 5). Both 
si-DNM2-B and si-DNM2-C were investigated here. The results in Figure
4.3.E show that successful depletion of DNM2 was obtained with sequence si- 
DNM2-C after 72 hrs. Following this successful depletion the uptake of 
Alexa488-R8 and -Tat, were investigated in A431 cells depleted of DNM2 or 
treated with dynasore. The data in Figure 4.4.A supports the data in HeLa cells 
showing that dynasore inhibits transferrin uptake but has no effect on uptake of 
CPPs (Figure 4.4.B & C). The same effects were seen in DNM2 depleted cells 
that were deficient in endocytosis of transferrrin (Figure 4.5. A) but had normal 
uptake of both CPPs (Figure 4.5.B & C).
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Figure 4.3. Analysis of DNM2 expression following transfections with 
siRNA targeting DNM2
Cells were transfected with siRNA targeting DYN2 and incubated for 72 hrs 
before preparing cell lysates. The lysates were then separated by 
electrophoresis and transferred to nitrocellulose papers, probed with antibodies 
against DNM2 or a-tubulin that were then detected with HRP conjugated 
secondary antibodies and Enhanced Chemiluminescence (ECL). (A), (B), and 
(D) represent data obtained from HeLa cells using si-DNM2-A, si-DNM2-C, 
and si-DNM-B respectively, while (C) represent ARPE cells (Ghent lysates 
samples) using DNM-C and (E) represent data obtained from A431 cells using 
si-DNM2-C.
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Figure 4.4 The effect of the DNM2 inhibitor Dynasore on CPP uptake in 
A431 Cells
Cells were pre-incubated for 30 min in the absence (Control) or presence 
(Dynasore) of 80pM dynasore at 37 °C, prior to washing and incubation with 
100 nM Alexa488-Tf (A) or with 2 juM Alexa488-R.L8 (B) or -Tat (C) at 37° C 
for the indicated time points. Cells were then processed for analysis by flow 
cytometry under standard conditions for CPP uptake. Values above obtained 
from three independent experiments (n=3).
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4.3.2. Characterisation o f  the requirement fo r  flotillin-1 in cellular uptake o f  
Alexa488-Ri8 and -Tat 
The main obstacle in investigating the flotillin dependent pathway is to find a 
specific and easily available marker for this pathway. As mentioned, flotillin- 
mediated endocytosis is a relatively new discovery and characterised by the 
finding that the uptake of anti-CD59 was reduced in flotillin-1 depleted cells 
(Glebov et al. 2006). However, the exact antibody used in this study was no 
longer available and of note is the fact that no specific chemical inhibitor is yet 
available or indeed characterised for inhibiting this pathway. The School of 
Medicine at the University of Wales Hospital have for a number of years been 
studying the biology of CD59 as part of its role in the complement system 
(Rooney et al. 1991). We were fortunate in having available some pre prepared 
FITC labelled anti-CD59 antibodies that we could investigate initially to 
determine whether we could measure and quantify its uptake in cells. For 
experiments analysing transferrin uptake in cells it is common to include an 
acid wash step to remove the fraction that is still bound to the plasma 
membrane and not inside the cells. Experiments were performed to see if acid 
washing reduced the cell associated fluorescence of cells incubated with this 
antibody. Initially, 2 different anti CD59 epitopes were tested, FITC-CD59- 
A35 and FITC-CD59-YTH-53.1. HeLa cells were incubated with 2.5mg/ml 
FITC-CD59 antibody for 30 min then cells were washed with PBS +/- acid 
washing prior to trypsinisation and flow cytometry analysis. The acid wash 
method was successful in removing the plasma membrane binding of FITC- 
CD59-YTH-53.1by 55% compared to the non acid washed cells (Figure 
4.6.A). FITC-CD59-YTH-53.1 gave extremely high fluorescence values that
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Figure 4.5. Uptake of Alexa488-RL8 and -Tat in DNM2 depleted cells
A431 cells were transfected with si-DNM2, or si-GFP for 72hr, then incubated 
for the indicated time points with 100 nM Alexa488-Tf (A) or with 2 //M 
Alexa488-RL8 (B) or -Tat (C) at 37° C. Cells were then processed for analysis 
by flow cytometry under standard conditions for CPP uptake. Values above 
obtained from three independent experiments (n=3).
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were on the whole non resistant to acid washing (Figure 4.6.A) and it was 
determined at this stage to continue experiments with FITC-CD59-A35.
Once methods were in place for quantifying the uptake of this fluorescent 
antibody siRNA sequences were investigated to determine whether they 
depleted Flot-1 expression and whether this resulted in a reduction in the 
endocytosis of anti-CD59. Initially, two different siRNA sequences against 
Flot-1 were tested, si-Flot-l-A was designed by MWG, while, si-Flot-l-B was 
obtained form the Gelbov et al study (Glebov et al. 2006). Both of them were 
able to reduce Flot-1 expression, however si-Flot-l-A showed higher depletion 
compared with si-Flot-l-B (Figure 4.7). Note that CHC was used as an internal 
control here as the usual tubulin control has a molecular weight similar to that 
of Flot-1. Consequently, only si-Flot-l-A was used for subsequent 
experiments. HeLa cells were then transfected for 48 hrs using si-Flot-l-A, 
prior to adding 2.5 mg/ml of FITC-CD59 antibody for 0-40 min, acid washing, 
trypsinisation and flow cytometry analysis. The results in Figure 4.6.B show a 
significant inhibition of approximately 30% between 20 min- 40 min in the 
uptake of anti-CD59 in siRNA-Flot-1 cells; there was no inhibition at earlier 
time points.
The role of Flot-1 was also investigated in the uptake of both FITC-dextran and 
Alexa488-Tf. Flot-1 was depleted for 48 hrs in HeLa cells that were then 
incubated with 5mg/ml of FITC-dextran (Figure 4.6.C) or lOOnM of Alexa488- 
Tf (Figure 4.6.D) for the indicated times. The cells were then processed for
flow cytometry analysis as previously described. The results show no
/
inhibition of FITC-dextran uptake and though there was a consistent inhibition
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(15-19%) in the uptake of Alexa488-Tf this was statistically insignificant at 
P>0.05. The development of these methods then allowed for analysis of the 
uptake of R8 and Tat and the results in Figure 4.8.A and 4.8.B show that there 
is no requirement for Flotillin dependent endocytosis in the internalisation of 
these two CPPs.
4.3.3. Characterize the requirement o f  caveolin-J protein in Alexa488-R.L8 
and -Tat cellular uptake 
Similar to problems encountered with Flotillin dependent endocytosis one of 
the main issues regarding uptake through caveolin is to find a suitable 
endocytic probe whose uptake is dependent on this pathway. It has been shown 
in literature that lactosylceramide (LacCer) is internalised specifically via a 
caveolae-mediated pathway (Puri et al. 2001; Rejman et al. 2004). Therefore, 
BODIPY®(4,4-difluoro-4-bora-3a,4adiaza-s-indacene)-LacCer 
(lactosylceramide), here termed Bodipy-LacCer was used in this chapter as a 
Cav-1 dependent probe. As described in Chapter 1 Bodipy- LacCer with its 
ceramide backbone will partition into lipid rafts where most of the caveolae are 
located. Lipids such as sphingomyelin that have a ceramine backbone are 
predominantly found in lipid rafts (Silva et al. 2007) and BODIPY-LacCer will 
therefore partition into these structures. Caveolin and cavaeolae are known to 
be enriched in lipid rafts and thus are likely to be internalised with these 
structures. Thus one of the main problems with using this probe is the very 
high fraction that localises to the plasma membrane and is not internalised 
(Singh et al. 2003; Vercauteren et al. 2010). Thus the cell associated 
fluorescence is very high but the fraction of the probe that is inside the cells
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may be a very small part of that. The Pagano’s group have used the so called 
back exchange washing method to remove the plasma membrane fraction. This 
involves extensive washing of cells in several changes of buffer containing 5% 
fatty acid-free BSA. Throughout this procedure lipids on the cell surface are 
extracted from the cell surface and transferred to the BSA acceptor in the 
medium. This back-exchange procedure is usually carried out at low 
temperature to stop any consequent endocytic transport of the lipid analoges 
during the required incubations (Singh et al. 2003).
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Figure 4.6. The effect of depleting Flot-1 on the uptake of FITC-CD59 
antibody, FITC-Dextran, and AIexa488-Tf.
HeLa cells were either transfected (B,C, D) or non-transfected (A) with si-Flot- 
l-A, or si-GFP for 48hr, then incubated for the indicated time points with 2.5 
mg/ml FITC-CD59 antibody (A) & (B), 5mg/ml FITC-Dextran (C), or lOOnM 
Alexa488-Tf (D) at 37° C for the indicated time points. Cells were acid washed 
and followed by PBS wash and then trypsinized before analysed by flow 
cytometry. Values above obtained from three independent experiments (n=3).
125
si-GFP si-Flot A si-Flot B
180 KDa Anti-CHC
Anti-Flot1
48 K D a------
Figure 4.7. Analysis of Flot-1 expression following transfections with 
siRNAs targeting Flot-1
Cells were transfected with siRNA targeting Flot-1-A or Flot-B and incubated 
for 48 hrs before preparing cell lysates. The lysates were separated by 
electrophoresis transferred to nitrocellulose papers, probed with antibodies 
against Flot-1, or a-CHC that were then detected with HRP conjugated 
secondary antibodies and Enhanced Chemiluminescence (ECL).
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Figure 4.8. The effect of depleting Flot-1 on the uptake of Alexa488-R8 
and -Tat.
HeLa cells were transfected with si-Flot-l-A, or si-GFP for 48hr, then 
incubated for the indicated time points with 2pM Alexa488-R8 (A) or -Tat (B) 
at 37° C for the indicated time points. Cells were washed, trypsinized and
processed for flow cytometry under standard conditions for CPP uptake.
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Values above obtained from three independent experiments (n=3).
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(Aoki et al. 2010; Chen et al. 1998; Marks et al. 2005). Although it has been 
shown that the back exchange method is an effective in removing plasma 
membrane binding of BODIPY-LacCer, it was unable to remove extremely 
high BODIPY-LacCer fluorescence from three separate attempts (Figure 
4.9.A). An alternative method was therefore investigated and it was based on a 
live cell study for measuring fatty acid import (Li et al. 2005a). The assay use 
the chromophore, trypan blue, to quench the extracellular fluorescence of the 
fatty acid analoge C1-BODIPY-C12 instead of the back exchange method. 
This method was therefore investigated. HeLa cells were incubated with 1 pM 
BODIPY-LacCer at 10°C for 30 min to load the plasma membrane with the 
lipid analog. The cells were then washed 3 times with SFM at 10°C/followed 
by incubation at 37° C for 15 min to allow a short pulse of endocytosis. To 
remove the plasma membrane binding, the cells were rinsed twice with ice- 
cold PBS and trypsinised at room temperature. This was followed by adding 
0.33 mM trypan blue in PBS for 30 min at room temperature. After, the 
suspension was washed with ice cold PBS, before measuring cell associated 
fluorescence by flow cytometry. The results in Figure 4.9.B show that the 
fluorescence of cells incubated with trypan blue was reduced to 69% of the 
control cells. This developed method was then suitable for further analysis 
once siRNA methods were developed for depleting Cav-1. A number of 
reports have been published whereby Cav-1 has been silenced with siRNA 
(Glebov et al. 2006; Vassilieva et al. 2009). A predesigned sequence from 
MWG was selected for these analysis, based on the fact that the previous 
purchase from this company has shown a successful depletion with pedesigned 
sequences.
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Figure 4.9. The effect of trypan blue Quenching vs. BSA back exchanged 
method on cell associated fluorescence and the effect of depleting Cav-1 on 
the uptake of of BODIPY-LacCer
HeLa cells were incubated with 1 pM BODlPY-LacCer at 10°C for 30 min 
then washed 3X times with SFM at 10°C, followed by incubation at 37° C for 
15 min to promote endocytosis. Cells were then washed, either by BSA back 
exchange method (A) or trypan blue method (B). Then the cells suspension 
was washed with ice cold PBS, before measuring cell associated fluorescence 
by flow cytometry. n=3 from three independent experiments (C). Cells were 
transfected with si-Cav-l-A, or si-GFP for 48hr, and analysed for the uptake of 
BODIPY-LacCer as described for A. Values above obtained from three 
independent experiments (n=3) and are represented in (A.U) values (right).
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Figure 4.10 Analysis of Cav-1 expression following transfection of cell with 
siRNA targeting Cav-1
HeLa cells were transfected with siRNA-GFP, or siRNA-Cav-1 for 48hr prior 
to preparing cell lysates. An amount of lysate equivalent to 25 pg protein was 
separated by electrophoresis and transferred to nitrocellulose papers, probed 
with antibodies against Cav-1, or a-tubulin that were then detected with HRP 
conjugated secondary antibodies and Enhanced Chemiluminescence (ECL).
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(Table 4.1). HeLa cells were transfected using siRNA against Cav-1 for 48 
hrs, and then 25pg of protein from cell lysates were analyzed by SDS-PAGE 
and Western blotting with antibodies against Cav-1, or a-tubulin that were then 
detected with HRP conjugated secondary antibodies and Enhanced 
Chemiluminescence (ECL). The results in Figure 4.10 show clear expression 
of this protein in HeLa cells and efficient inhibition of Cav-1 protein. Thus a 
siRNA cell model was available for investigating the involvement of Cav-1 in 
endocytosis of the lipid raft marker Bodipy-LacCer using the earlier described 
method but also the two CPPs.
Previous to this all the uptake experiments are presented as time dependent 
uptake but the methodological issues surrounding analysis of BODIPY-LacCer 
uptake made this very difficult. Therefore a single time point of 15 min as 
previously described (Li et al. 2005a) and developed for this thesis (Figure 4.9) 
was utilised. HeLa cells were transfected with si-Cav-1 for 48 hrs before 
incubation with BODIPY-LacCer. The results in Figure 4.9.C shows that 
BODIPY-LacCer is inhibited by 60% in Cav-1 depleted cells, and thus 
providing us with a very good siRNA model to study the involvement of this 
protein and pathway in internalisation of CPPs.
Cells were then transfected as above with siRNA targeting Cav-1 and 
incubated for normal time course experiments in the presence of either 
Alexa488-R8 or -Tat. The data in Figure 4.11 show identical uptake of both 
peptides in control siRNA cells and those depleted of Cav-1. This confirms 
that there is no involvement of cavaeolae in uptake of these two CPPs.
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It was previously shown that depleting Flot-1 from intestinal epithelial cells 
lead to a decrease in the expression of Cav-1 (Vassilieva et al. 2009). To test 
the effect of depleting Cav-1 on Flot-1 expression and vice versa, HeLa cells 
were transfected with siRNAs targeting GFP, Cav-1, or Flot-1 and incubated 
fro 48 hrs. Lysates (25 pg)
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Figure 4.11. The effect of depleting Cav-1 on the uptake of of Alexa488-R8 
and -Tat
HeLa cells were transfected with si-Cav-l-A, or si-GFP for 48hr, then 
incubated for the indicated time points with 2 pM Alexa488-R8 (A) or -Tat (B) 
at 37° C. Cells were then washed and processed for flow cytometry under 
standard conditions for CPP uptake. Values above obtained from three 
independent experiments (n=3).
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Figure 4.12. Analysis of Cav-1 and Flot-1 expression following siRNA 
targeting.
HeLa cells were transfected with siRNA-GFP, siRNA-Flot-1 or siRNA-Cav-1 
for 48hr prior to preparing cell lysates. An amount of lysate equivalent to 25g 
protein was separated by electrophoresis and transferred to nitrocellulose 
papers, probed with antibodies against Cav-1, Flot-1, CHC or a-tubulin that 
were then detected with HRP conjugated secondary antibodies and Enhanced 
Chemiluminescence (ECL). CHC and a-tubulin were used as loading controls.
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were separated by electrophoresis, transferred to nitrocellulose papers and 
probed with antibodies against Cav-1, Flot-1, CHC or a-tubulin that were then 
detected with HRP conjugated secondary antibodies. CHC or a-tubulin were 
also detected as loading controls. The results confirm the depletion of Cav-1 
and Flot-1 with targeted siRNA but there was no evidence that loss of one was 
having an effect on level of expression of the other (Figure 4.12).
4.3.4. Preliminary analysis o f transfecting cells with siRNA targeting ARF6 
and GRAF-1
It is still disputed as to whether GRAF1 and ARF6 mediate distinct clathrin 
independent endocytic pathways. For example ARF6 has also been implicated 
in clathrin mediated endocytosis and recycling and also in phagocytosis 
(D'Souza-Schorey et al. 1995; Someya et al. 2010). For distinguishing these as 
distinct endocytic pathways researchers have studies MHC class one proteins 
and carboxypeptidease E (ARF6) or bacterial exotoxins and also fluid phase 
markers (Doherty and McMahon 2009). Though these are interesting findings 
it was not clear as to what endocytic probe to use and time did not allow for 
extensive analysis that was performed for other endocytic pathways. 
siRNA sequences against these two proteins were however acquired (Table 
4.1) and tested to see if they could deplete these proteins. Methods were 
initially developed for detecting the proteins in HeLa cells using Western 
blotting and this then allowed for siRNA targeting experiments and the 
combined results are shown in Figure 4.13. A single band was detected for 
ARF6 at the correct molecular weight of approx. 23KDa and this could not be 
detected in siRNA ARF6 treated cells. Two bands were detected for GRAF1
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Figure 4.13. Analysis of ARF6 and GRAF1 expression in ARPE following 
transfection with siRNA.
ARPE cells were transfected with siRNA-GFP, siRNA-ARF6, or siRNA- 
GRAF1 for 72hr prior to preparing cell lysates (Ghent samples). An amount of 
lysate equivalent to 20 pg protein were separated by electrophoresis, 
transferred to nitrocellulose papers, probed with antibodies against ARF6, 
GRAF1, or a-tubulin that were then detected with HRP conjugated secondary 
antibodies and Enhanced Chemiluminescence (ECL).
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and both were reduced significantly in siRNA GRAF1 treated cells but there 
was -still residual expression. Thus cell models for either full depletion or 
partial depletion were generated and then these were tested for internalisation 
of R8. Data in Figure 4.14 shows that there was no inhibition on the uptake of 
R8 in cell lines transfected with siRNA targeting ARF6, GRAF-1, Cav-1 and 
DNM2 was also targeted in these experiments.
4.3.5. Analysing siRNA targeting in ARPE cells
Performing SDS PAGE and Western Blotitng is not routinely performed at our 
collaborating laboratory at the University of Ghent. In parallel with our studies 
were siRNA depletion assays performed on retinal pigment epithelial cells. For 
this thesis methods were developed for detection of CHC, Flot-1, Cav-1, 
DNM2 and Pak-1 in HeLa and A431 cells (chapter 3, 4, and 5). These methods 
were then used to detect protein expression from siRNA experiments 
performed in Ghent. Typically this would involve the sending over of cell 
lysates for electrophoresis and immunodetection. Figure 4.15 is taken from 
Dries et al (Vercauteren et al. 2011) showing data from analysis performed as 
part of this thesis. The data specifically highlights the problems in a separate 
cell line in depleting DNM2. Interestingly rather than observing that Flot-1 
depletion indirectly reduces Cav-1 expression as previously described 
(Vassilieva et al. 2009), the opposite was determined in that Cav-1 depletion 
led to a significant decrease in Flot-1 expression.
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Figure 4.14. The effect of depleting DNM2, ARF6, Cav-1, and GRAF1 on 
the uptake of of Alexa488-R8.
HeLa cells were transfected with si-GFP, si-DNM2-C, si-ARF6, si-Cav-l-A, or 
si-GRAFl for 48hr, then incubated for the indicated time points with 2pM 
Alexa488-R8 at 37° C for the indicated time points. Cells were washed, 
trypsinized and processed for flow cytometry under standard CPP conditions. 
Values above obtained from two independent experiments (n=2).
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4.4. Discussion
In this chapter endocytic pathways regulated by DNM2, Flot-1 and Cav-1 were 
investigated with a view to silencing the proteins using siRNA and 
investigating the effects of this depletion on uptake of endocytic probes and 
finally CPPs. Dynamin II, was originally identified as a protein regulating 
CME, but it has also been associated in regulating uptake through other 
endocytic pathways including those regulated by Cav-1 and more recently was 
associated in regulating constitutive fluid phase uptake using 70 KDa dextran 
as a marker (Cao et al. 2007). It was the later data that was of most interest to 
us as it gave a possibility of measuring the fraction of CPPs that enter via fluid 
phase endocytosis. Different published single and pooled siRNA sequences 
(Table 4.1) failed to give effective depletion in HeLa cells (>50%) such that its 
role in mediating CPP uptake could not be investigated. Problems of depleting 
this protein using siRNA was also noted in collaborative studies with the 
University of Ghent (Vercauteren et al. 2011). This proved to be a major 
problem and a great deal of time was lost in before the decision was taken to 
move to a different cell line, namely A431 cells. Here for the first time DNM2 
was effectively and consistently depleted to <20%. In these DNM2 depleted 
A431 cells a strong inhibition of transferrin uptake was shown, however fluid 
phase endocytosis of dextran was unaffected, and this completely contradicts 
an earlier study that directed our studies towards this protein (Cao et al. 2007). 
The reason for this is unknown but it should be noted that we observed very 
strong depletion of transferrin uptake in siRNA DNM2 cells thus proving that 
there was an effect on endocytosis. Similarly there was no effect on the uptake 
of either Alexa488-R8 or -Tat in DNM2 depleted cells thus confirming the
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earlier results with CHC depletion, which similarly showed no effect on CPP 
uptake. A431 and HeLa cells were also incubated with Dynasore, a DNM1 and 
DNM2 inhibitor and this drug as expected was a strong inhibitor of CME but 
had no effect on uptake of Dextran or Alexa488-R8 and -Tat in HeLa cells. In 
spite of the strong functional effects of DNM2 depletion on CME, its 
involvement in fluid phase uptake or internalisation of these cationic peptides 
was not confirmed.
An assay was developed for analysing anti- CD59 antibody and in line with a 
previous study (Glebov et al. 2006) it was found that uptake of this probe was 
reduced in cells depleted of Flot-1. It was, however, far from complete 
inhibition but highly consistent and significant (P<0.05) after 10 min uptake. 
The data highlight that a major fraction of this protein also enters cells 
independent of the requirement of Flot-1. It must be noted here that the level of 
inhibition observed in this thesis is entirely consistent with that observed in the 
first study to highlight a role for Flot-1 in mediating a distinct endocytic 
pathway (Glebov et al. 2006). It has been more recently shown that Flot-1 
depleted cells have reduced endocytosis of polyethylenimine/DNA complexes 
and disulfide-based poly(amido amine)/DNA polyplexes (Payne et al. 2007; 
Vercauteren et al. 2011). For the later study it was also shown that Flot-1 
depleted cells were also more difficult to transfect with plasmid DNA. It will 
be interesting to test this further as these polymers may be more suitable probes 
compared with anti-CD59 antibody to analyse the involvement of this pathway. 
From our initial studies it was clear that analysing the uptake of this antibody 
was not a trivial issue but by employing additional acid washing it was possible
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to more accurately measure internalised antibody. There are alternative 
sources of commercial anti-CD59 antibodies and it would be interesting to test 
these. As methods were developed for analysing protein depletion using 
immunodetection and functionally in endocytosis assays it was then possible to 
investigate the effects of Flot-1 depletion on uptake of CPPs Tat and R8. The 
data clearly shows that this pathway is not involved in their uptake.
Caveolin-1 labels flask shaped invaginations on the plasma membrane of cells 
called caveolae that upon splitting from the plasma membrane form 
caveosomes (Nabi and Le 2003). The sphingolipid lactosylceramide has been 
shown to be internalised from the plasma membrane in a clathrin independent 
mechanism involving cavaeolae (Singh et al. 2003; Vassilieva et al. 2009). 
GFP-Tat peptide was shown to be localized to caveaolae suggesting this may 
be an uptake route preferred by this peptide (Ferrari et al. 2003; Fittipaldi et al.
2003). In addition siRNA depletion of Cav-1 from HeLa cells or the use of 
caveolin-1 knockout (Cav-1*7') mouse embryonic fibroblasts cells suggested a 
role for cavaeolae in uptake of transportan-avidin complexes (Saalik et al. 
2009). Blood cells such as the K562 cells that our laboratory have used for 
CPP studies are also Cav-1*7* and these internalise CPPs such as R8 and Tat 
very efficiently (Al-Taei et al. 2006). This suggests that caveolae are not 
absolutely required for CPP uptake but it may be the case that in Cav-1 
positive cells this pathway is utilized. As cavaeolae are enriched in lipid rafts, 
cholesterol sequestering drugs such as MBCD and nystatin are used to disrupt 
these domains prior to performing endocytosis assays. However loss of
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integrity of these domains has multiple effects on cells and can affect a number 
of endocytic pathways (Rodal et al. 1999). In addition is has been shown 
that results with CPPs and, for example, MBCD are very difficult to interpret 
as the effects depend on the CPP concentration (Duchardt et al. 2007). 
Previous studies from our lab also highlight the problems of using this drug for 
CPP uptake studies (Watkins et al. 2009b).
In order to study this pathway it was important to confirm the presence of Cav- 
1 expression and this was clearly confirmed in HeLa cells; this is in agreement 
with other publications (Simon et al. 2009a; Spoden et al. 2008). siRNA 
depletion was very successful here and this then allowed us to develop a 
functional assay for Cav-1 depletion. We made use of the BODIPY LacCer but 
as for CD59 antibodies problems were encountered due to extensive 
partitioning of this lipid into the plasma membrane that was then very difficult 
to remove. This has previously been documented and rigorous washing 
methods including lipid extraction a been employed to reduce this fraction 
(Aoki et al. 2010; Chen et al. 1998; Li et al. 2005a; Marks et al. 2005; 
Vercauteren et al. 2010). Here trypan blue quenching proved to be the most 
effective method for reducing the plasma membrane bound fraction and once 
this method had been optimised, it has moved on to look at the effects of 
depleting Cav-1 on the uptake of this probe. Investigating LacCer uptake assay 
at multiple time points in control siRNA and Cav-1 depleted cells proved to be 
technically difficult and therefore a single time point (15 min) was selected. 
LacCer uptake was however significantly depleted in Cav-1 depleted cells and 
this is the first time that this has been determined experimentally. However
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these cells had control levels of internalised Alexa488-R8 and -Tat and 
together with data from Cav-1 negative leukameic cell lines this suggested 
strongly that cavaeole were not required for uptake, even if expressed.
Recent data has shown that down-regulation of Flot-1 expression, which 
disrupted lipid raft-mediated endocytosis of BODIPY FL C(5)- 
lactosylceramide, also significantly decreased Cav-1 levels in SK-C015 human 
intestinal epithelial cells. They revealed that the decrease in caveolin-1 
expression is specifically related to Flot-1 depletion as they did not observe the 
same results after down-regulating Flot-2. They also show that the decrease in 
Cav-1 levels in Flot-1-depleted cells was not due to suppression of its mRNA 
synthesis and was not mimicked by cholesterol depletion. In addition, they 
show that Flot-1 dependent down-regulation of Cav-1 was reversible after 
exposing cells to a lysosomal/acidification inhibitor such as chloroquine. They 
suggest that Flot-1 regulates Cav-1 level by preventing its lysosomal 
degradation in intestinal epithelial cells. In contrast, the data in this chapter 
revealed that Flot-1-depleted HeLa cells have control level of Cav-1 expression 
and vice versa. In contrast to these two sets of data, the studies in Ghent, 
suggested an alternative relationship between the two proteins as depleting 
Cav-1 also led to a reduction in Flot-1 levels. This may suggest some 
relationship between these proteins and the pathways that they regulate but 
how one regulates the other remains to be fully determined.
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Figure 4.15. siRNA depletion of endocytic proteins in ARPE cells
All siRNA experiments were performed at the University of Ghent 
(Vercauteren et al. 2011) and lysates sent to Cardiff for analysis. For (A), (B), 
(D) and (F) the expression of a-Tubulin served as an internal control for equal 
protein loading, while CHC expression levels were used as a reference in (C) 
and (E). In (E), the (depleted) PAK-1 band at approx. 60 kDa is marked with a 
black arrow.
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The final part of this chapter was involved with initial studies on the role of 
less well characterised proteins GFAF1 and ARF6 in mediating distinct 
endocytic pathways. It was clear that they could be successfully depleted from 
cells and preliminary studies suggest this had no effect on the uptake of at least 
R8. However without probes to functionally assess depletion then it is 
impossible to come to any stronger conclusions about this work.
In conclusions to this Chapter it can be stated that cell models were developed 
to scrutinise roles for DNM2, Flot-1 and Cav-1 in mediating the uptake of 
CPPs R8 and Tat. Despite successful depletion using single siRNA sequences 
and design of functional assays of depletion there was no evidence they play 
roles in uptake of either R8 or Tat.
145
Chapter 5: Evaluation of the role of Macropinocytosis 
in the cellular uptake of CPPs Tat and R8
5.1. Introduction
Macropinocytosis is an actin-dependent and growth factor induced process that 
associated with plasma membrane ruffling lead to intrnalization of fluid and 
macromolecules. It has however also been termed a constitutive process and 
there is much confusion regarding this definition of the process and the most 
characterised response to growth factor activation (Jones 2007b). These, such 
as epidermal growth factor (EGF) and platelet derived growth factor (PDGF) 
(Brunk et al., 1976; Hewlett et a l, 1994) are known to activate signalling 
pathways when they bind to their receptors leading to activation of Rac 
GTPase, which has been shown to regulate actin dynamics and therefore 
macropinocytosis that in its own right is dependant on actin rearrangement 
(Ridley et al., 1992). P21-Activated Kinase (PAK-1) is reported to have a role 
in regulating macropinocytosis and has been shown to induce the formation of 
circular dorsal ruffles similar to those associated with the macropinocytic 
uptake process (Liberali et al. 2008; Mercer and Helenius 2010). It has been 
shown that endogenous PAK-1, identified with PAK-1 antibody, localized to 
pinocytic vesicles containing BSA-rhodamine, a marker for bulk fluid-phase 
uptake, while the distribution of PAK-1 in PDGF stimulated cells was detected 
in membrane ruffles and at the edges of lamellipodia. Moreover, treatment of 
the PDGF-stimulated cells with either cytochalasin D or wortmannin caused 
the complete loss of membrane ruffles, and the absence of the membrane- 
associated PAK-1 observation (Dharmawardhane et al. 1997). Another study 
showed that inhibition of endogenous PAK-1 activity using a PAK-specific 
auto inhibitory domain blocks growth factor-induced macropinocytosis, 
indicating that PAK activity is required for this process. Furthermore, the study
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revealed that PDGF-stimulated macropinocytosis is enhanced by activated 
PAK-1 mutants (Dharmawardhane et al. 2000). These data strongly indicate .a 
regulatory role for PAK-1 in the macropinocytic process, involving PAK-1 
kinase activity and downstream cytoskeletal remodelling.
In recent studies investigating internalisation of mainly cationic CPPs, 
macropinocytosis has emerged as a strong candidate for the mechanism of 
uptake (Kaplan et al. 2005; Nakase et al. 2004; Suzuki et al. 2002; Wadia et al.
2004). Additionally different studies show that the activation of Racl and 
organization of the actin is induced by arginine-rich CPPs and that this is the 
trigger for macropinocytosis or a macropinocytosis-like pathway (Gerbal- 
Chaloin et al. 2007; Nakase et al. 2007). In line with this cationic CPPs have 
been demonstrated to enhance the uptake of fluorescent dextran suggesting 
some of their effects may be similar to the actin rearranging properties of 
growth factors (Gump et al. 2010; Wadia et al. 2004).
It should however be noted that all studies here have used pharmacological 
inhibitors of endocytic pathways as study tools and the most common such as 
CytD, amiloride and amiloride analogues have other effects on cells. There is 
therefore a strong requirement for a protein target regulating macropinocytosis 
to be targeted with the hope that this can reveal the true requirement of this 
process in uptake of CPPs and also other drug delivery vectors (Sahay et al. 
2010).
Due to the fact that CPPs are thought to enter cells by macropinocytosis and 
that PAK-1 regulates this process the studies in this Chapter concentrated on
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initial characterisation of PAK-1 expression and macropinocytosis in different 
cell types. Once this was achieved the role of this pathway and in uptake of R8 
and TAT was investigated in cells depleted of PAK-1.
5.2. Methods
Both HeLa and A431 cells were used to study different aspects of 
macropinocytosis. Cells were transfected with two different PAK-1 siRNA 
sequences as shown in Table 5.1; siRNA targeting GFP was used as control.
To study the role of macropinocytosis in dextran internalisation, different 
dextran conjugates were used: Alexa488-Dextran (10 kDa), FITC-Dextran (40 
kDa), and TMR-Dextran (70 KDa). These were incubated with cells either 
alone or in the presence of CPPs or following stimulation by EGF. The full 
methods are given in section 2.3.5.6
In order to, characterize the involvement of macropinocytosis in Alexa488-R8 
and -Tat uptake, 2 pM of extracellular CPP was added to PAK-1 depleted 
HeLa and A431 cells following pre-incubation with macropinocytosis 
inhibitors such as cytochalasin D (CytD), blebbistatin (Blebb) and 5-(A-ethyl- 
A-isopropyl) amirolide (EIPA). The full methods are given in section 2.3.5.5 
and 2.3.5.4
SDS-PAGE electrophoresis and Western blotting techniques were used to 
detect PAK-1 and EGFR, expression levels. The full methods are given in 
section 2.3.7 and 2.3.8
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siRNA Sequences Ref.
PAK-1-A A ACUU CU CUU G ACGUU G ACdT dT (Mercer and Helenius 2008)
PAK-1-B AU AACGGCCU AG AC AUUC AdT dT Designed by MWG
GFP GGCU ACGU CC AGG AGCGC AdT dT Designed by MWG
CHC U AAU CC AAUUCG AAG ACC AAUdT dT (Motley et al. 2003)
Table 5.1. siRNA sequences used in this Chapter
150
5.3. Results
5.3.1. EGFR and PAK-1 expression in HeLa and A431 Cells 
It was initially important to establish a macropinocytosis model and 
traditionally this has been performed in cells with high levels of EGFR or 
PDGFR so that they can then be stimulated with growth factors. However our 
initial CPP model was HeLa cells and comparisons were made of the 
expression of EGFR in these cells and a well described EGFR high-expressor, 
A431 cells. At the same time the levels of PAK-1 was determined. SDS-PAGE 
electrophoresis and immuno labeling methods were therefore developed 
(sections 1.3.7 & 1.3.8) to detect the expression level of EGFR and PAK-1 
from cell lysates. The data shows that EGFR could not be detected in HeLa 
cells using this method and exposure, but a strong single band at approximately 
180KDa was observed in A431 cells (Figure 5.l.A). PAK-1 was detected in 
both cell lines at the predicted mass of 60 KDa, however three bands were 
detected with the antibody at both lower and higher molecular weight than 
predicted. Similar to expression of EGFR the A431 cells had much higher 
expression of PAK-1 compared with HeLa cells. The two faint bands higher 
than the predicted mass were not always observed as can be seen later.
Two different siRNA sequences were selected for depleting PAK-1 in these 
cells. Cells were transfected with 50nM of these sequences and then PAK-1 
was detected following SDS-PAGE and immunoblotting. Figure 5.1.C shows 
highly effective PAK-1 depletion in A431 cells, while partial depletion was 
observed in HeLa cells (Figure 5.1.B). Note in Figure 5.1.C that only the lower 
band is depleted and the higher band can then act as a positive loading control 
and a-Tubulin staining was used to confirm these results. In HeLa cells CHC
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was used as a loading control but there was evidence that both detected bands 
were reduced in PAK-1 depleted cells.
Repeat experiments showed a consistent reduction of over 90% expression in 
A431 cells (Figure 5.2). Two PAK-1 siRNA sequences were tested here, si- 
PAK-l-A and -B. si-PAK-l-A was obtained from a previous publication 
(Mercer and Helenius 2008) but there was concern that depletion by this 
sequence was not sufficient to then perform functional assays. si-PAK-l-B, 
which was predesigned by MWG was then investigated and found to 
consistently reduce PAK-1 levels to <10% (Figure 5.2)
In order to investigate these findings further repeat transfections were 
performed on cells plated on coverslips. Following 48 hr transfections the cells 
we fixed and then labelled with anti-PAK-1 antibody and Alexa-488 labelled 
secondary antibodies (Section 2.3.4.3). This was the first time that the 
laboratory had used immunofluorescence to investigate the distribution of this 
protein in any cell line and of note was the localisation of the protein to large 
amorphous structures in control cells and there was little evidence of plasma 
membrane labelling but there was significant labelling of the nucleus (Fig. 
5.3). In PAK-1 depleted cells there was a clear reduction cell associated 
fluorescence, indeed it yvas very difficult to observe any staining.
5.3.2. Stimulation o f uptake o f the fluid phase marker dextran in response to 
growth factor stimulation 
In order to study the macropinocytosis process, it is essential to find a specific 
endocytic probe for this pathway. Unfortunately, none as yet exists however it
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A  HeLa/A431
A431 HeLa
180 KDa
60 KDa
48 KDa
m
Anti-EGFR
Anti-PAKl
Anti-aTubulin
B
180 KDa
60 KDa —
HeLa
si-GFP si-PAK1
A431 
si-GFP si-PAKl
Anti-CHC 60 KDa
Anti-PAKl 48 KDa
Anti-PAKl
Anti-aTubulin
Figure 5.1. EGFR expression in A431 cells and PAK-1 depletion via siRNA 
targeting.
(A) Lysates from HeLa or A431 cells were separated by electrophoresis and 
proteins transferred to nitrocellulose papers that were probed with antibodies 
recognizing PAK-1, EGFR or tubulin that were then detected with HRP 
conjugated secondary antibodies and Enhanced Chemiluminescence (ECL). 
HeLa (B) or A431 (C) cells were transfected for 48 hrs with siRNA targeting 
PAK-1 using si-PAK-l-A (B) and si-PAK-l-B (C) and lysates were separated 
by electrophoresis and proteins transferred to nitrocellulose papers that were 
probed with antibodies recognizing PAK-1, EGFR CHC, or a-tubulin that 
were then detected with HRP conjugated secondary antibodies and Enhanced 
Chemiluminescence (ECL). CHC and a-tubulin antibodies were used as 
loading controls.
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siRNA-PAK-1 siRNA-GFP
A
60kDa & 60kDa Anti-PAK-1
a -T u b u lin
si-P A K -si-G F P
B
60kDa 60kDa
A nti-C H C
Anti-PAK-1
siRNA-PAK-1 siRNA-GFP
60kDa 60kD a Anti-PAK-1
a -T u b u lin
Figure 5.2. Analysis of PAK-1 following siRNA targeting in A431 cells.
A431 cells were transfected for 48 hrs with siRNA targeting PAK-1 and 
lysates were separated by electrophoresis and proteins transferred to 
nitrocellulose papers that were probed with antibodies recognizing PAK-1, 
CHC, or a-tubulin that were then detected with HRP conjugated secondary 
antibodies and Enhanced Chemiluminescence (ECL). CHC and a-tubulin 
antibodies were used as loading controls. (A), (B), and (C) are all obtained 
from si-PAK-1-B and they represent 3 independent experiments.
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si-GFP
s i - P A K l
Figure 5.3. PAK-1 immunolabelling in si-GFP vs. si-PAK-1 transfected 
A431 cells.
A431 cells were transfected with si-GFP or with is-PAK-1 for 48hr, then 
washed and fixed with 3% PFA, followed by washing and immunolabelling 
with PAK-1 antibody. Confocal images shown, represent maximum projection 
images (left) and direct interference contrast (DIC) images (right) of the same 
cells. Scale bars = 20pm.
155
is known that growth factor binding activates the pathway and leads to a 
concomitant increase in the uptake of fluid phase markers such as dextran 
(Dharmawardhane et al. 2000). Therefore, experiments were performed to 
investigate whether an increase in dextran uptake could be observed in both 
HeLa and A431 cells and specifically whether this could be inhibited in PAK-1 
depleted cells. Initially, dextran uptake in EGF treated cells was tested under 
two conditions, serum starvation and non-starvation. Non-starved HeLa cells 
and A431 cells were incubated with either 5 mg/ml FITC-Dextran or 0.2 
mg/ml Alexa488-Dextran with and without 50 nM EGF in Ringer’s buffer for 
0-80 min. Then cells were washed (including acid washing) prior to 
trypsinisation and analysis of internalised dextran by flow cytometry. Figure 
5.4 shows that EGF did not cause an increase in dextran uptake when cells 
were incubated with EGF. The same experiments were then performed in 
serum starved cells (lhr) and here there was a significant increase in dextran 
uptake in serum starved A431 cells incubated with EGF (Fig. 5.5.A). In HeLa 
cells growth factor addition had no effect on the uptake of this probe even 
when they were serum starved (Fig. 5.5B). The results confirms that cellular 
starvation is an essential step to initiate and stimulate EGF induced 
macropinocytosis process, however HeLa cells are not responsive to this 
growth factor in terms of macropinocytosis and as discussed later this may be 
due to the low levels of EGFR in this cell line.
5.3.3. Effect o f depleting PAK-1 expression on macropinocytosis
Initially, A431 cells were transfected with 50 nM of siRNA against GFP and
PAK-1 for 48 hrs. Cells were then starved for 1 hr prior to incubation with 5
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mg/ml of FITC-dextran with or without EGF as previously described. The cells 
were subsequently washed and trypsinised prior to analysis of dextran uptake 
by flow cytometry. The results in Figure 5.6 show that by depleting PAK-1, the 
EGF stimulated uptake of dextran is inhibited by 25% approximately after 40 
min and by ~30 % at 80 min but not at earlier time points and there was also a 
very minor inhibition in the basal uptake of dextran but this was not 
statistically significant (Figure 5.6.A). The uptake of FITC-dextran was also 
examined in PAK-1 depleted HeLa cells, without EGF stimulation (Figure 
5.6.B). The data again shows some inhibition in the basal uptake of dextran but 
this was not significant as P > 0.05. From these experiment it was decided to 
use the A431 cells as a macropinocytosis model allowing for comparison of the 
effects of EGF vs CPPs.
Macropinocytosis is actin-dependent and therefore the distribution of actin in 
PAK-1 depleted cells was investigated by confocal microscopy. A431 cells 
were transfected for 48 hrs with si-PAK- 1-B and - GFP as previously described 
and then fixed with and incubation with with rhodamine-phalloidin, to stain 
actin. As shown in Figure 5.7 actin in control cells is localized to long 
filaments and also on the periphery of the cells. However in PAK-1 depleted 
cells there is a lack of filamentous actin and the staining is concentrated on the 
periphery of the cells and also in a perinuclear region. The cells are also 
significantly smaller than control
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Figure 5.4. Effect of EGF stimulation on dextran uptake in serum non­
starved cells.
HeLa cells (A & B) and A431 cells (C) were incubated with either 5mg/ml 
FITC-dextran or 0.2mg/ml Alexa488-Dextran +/- 50nM EGF at 37° C, prior 
washing and analysis by flow cytometry. Results represent data from three 
independent experiments (n=3).
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Figure 5.5. Effect of EGF stimulation on dextran uptake in serum starved 
cells.
A431 cells (A) and HeLa cells (B) were serum starved in Ringer’s buffer for 1 
hr then incubated with 5mg/ml FITC-dextran +/- 50nM EGF at 37° C, prior 
washing and analysis by flow cytometry. Results represent data from three 
independent experiments.
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Figure 5.6. Evaluation of dextran internalisation in PAK-1 depleted cells.
A431 cells (A) and HeLa cells (B) were transfected with si-GFP or si-PAK-1 
for 48hr, then incubated for the indicated time points with 5mg/ml FITC- 
dextran +/- 50 nM EGF at 37° C before washing and analysis by flow 
cytometry. The data represents cell associated fluorescence for three 
independent experiments (n=3).
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5.3.4. Characterisation o f the requirement fo r  PAK-1 in cellular uptake o f  
Alexa488-R8 and -Tat 
Previous studies have reported that macropinocytosis is involved in the 
endocytic uptake of CPPs and this is mainly based on the use of 
pharmacological inhibitors such as EIPA (Nakase et al. 2004; Wadia et al. 
2004). Thus, the uptake of both Alexa488-R8 and -TAT were investigated 
further using siRNA depletion of PAK-1 compared with pharmacological 
inhibition.
The two cell-lines were transfected with si-PAK-l-B or with control -GFP for 
48 hrs, then incubated with 2pM Alexa488-R8 or -TAT for different periods 
prior to trypsinisation, heparin washing and flow cytometry (Figure 5.8). The 
data in HeLa cells (Figure 5.8 A-B) show a slight reduction in uptake of both 
peptides but this was not significant but in A431 cells the there was a much 
stronger inhibition and this was statistically significant at P<0.05 (Figure 5.8 
C-D). Traditionally results from these types of experiments are presented as 
percentage of controls and Figure 5.8.C shows how this same data set would 
appear as a comparison for each time point of the equivalent siRNA control. 
The uptake of Alexa488-R8 was inhibited approximately 50 % at early time 
points < 20 min and by 30-40 % after 20 min (Figure 5.8.E). Alexa488-Tat 
uptake was inhibited by 30 % for early rime point <20 and at later time point 
the percentage inhibition increased to 55% and then decreased; again the 
inhibition was significant at P <0.05 (Figure 5.8.F).
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5.3.5. Analysing the capacity o f CPPs to induce uptake o f dextran.
The previous experiments had shown that the uptake of R8 and Tat could be 
inhibited in PAK-1 depleted cells but the capacity of these two peptides to 
stimulate macropinocytosis was yet to be determined. To investigate this 
effect, two different types of neutral dextran conjugates were used: 40 KDa 
FITC-, and 70 KDa TMR-dextran at 5mg/ml and 0.75 mg/ml respectively. 
Initially, cells were incubated for 1 h at 37°C in serum-free Ringer’s buffer 
(serum starved), then incubated in Ringer’s buffer containing the dextran 
conjugate and either 2pM unlabeled R8 or Tat for different incubation periods. 
Figure 5.9.A (HeLa cells) and Figure 5.9.B (A431 cells) shows no-significant 
increase in FITC-dextran uptake as a result of CPP incubation. When A431 
cells were incubated with CPPs and 70 KDa TMR dextran both were able to 
promote significant uptake of the probe (Figure 5.9.C). The results from this 
experiment are also represented as percentage of controls (Figure 5.9.D).
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si-GFP s i -PAKl
Figure 5.7 Effect of depleting PAK-1 on cellular actin distribution.
A431 cells were transfected with si-GFP or si-PAK-1 for 48hr, then washed 
fixed and labelled with rhodamine-phalloidin prior to confocal microscopy. 
Scale bars = 20pm.
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In order to investigate this further, similar experiments were performed with 
cells plated on 35mm imaging dishes and analysis by confocal microscopy. 
A431 cells were seeded 24 hrs before the experiment in 35 mm dish for live 
cell imaging. Cells were serum starved for 1 hr before incubation for a further 
1 hr with 0.75 mg/ml TMR-dextran +/- 50 nM EGF, or 2pM unlabeled R8 or 
Tat. Then cells were washed and immediately analyzed by confocal 
microscopy (Figure 5.10). For control cells it was rather difficult to observe 
clear staining suggesting that only low amounts of this probe was entering the 
cells. However some staining was observed in punctate structures and in the 
main these were observed close to the plasma membrane. EGF increased 
uptake dramatically and now clear TMR labeled vesicles could be observed 
throughout the cell. There was also an obvious increase in cell associated 
TMR-Dextran labeling in R8 treated cells but a significant portion of this was 
localized on or very close to the plasma membrane. The increase in dextran 
uptake was less apparent in Tat treated cells. EGF also causes a clear effect on 
the morphology of the cells that are more rounded at the end of the incubation 
period and a similar but less pronounced effect was seen in cells incubated with 
R8 or TAT.
5.3.6. The effect o f pharmacological inhibitors on macropinocytosis and on 
the uptake o f CPPs
Pharmacological inhibitors cytochalasin D (CytD), blebbistatin (Blebb) and 5- 
(N-Ethyl-N-isopropyl) amiloride (EIPA) have been used to study 
macropinocytosis and CPP uptake section 2.3.5.4. These drugs were used here 
to investigate their effects on uptake of both dextran and CPPs.
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5.3.6.1.Cvtochalasin D (CvtD)
Cytochalasin D (CytD) is an effective inhibitor of actin polymerization as it 
binds with high affinity to growing ends of actin nuclei and filaments (F-actin), 
and prevents addition of monomers (G-actin) to these sites. A431 cells were 
pre-incubated with 10 pM CytD for 15 min then incubated with 2 pM 
Alexa488-R8 or -Tat in the presence of the drug for the indicated time points. 
Then the cells were washed with PBS, trypsinized and heparin washed prior to 
analysis with flow cytometry (Figure 5.11). The uptake of Alexa488-R8 and - 
Tat was significantly inhibited by up to 50% and 35% in CytD treated cells 
respectively.
The same experiment was then performed with three different dextran 
conjugates: 40KDa FITC-Dextran, lOKDa Alexa488-Dextran or 70 KDa 
TMR-dextran. Surprisingly, the uptake of all these conjugates was increased to 
different extents in CytD incubated cells (Figure 5.12) and this was most 
apparent at longer incubation periods. For FITC Dextran this was investigated 
further using confocal microscopy and here A431 cells were pre-incubated for 
15 min in the absence (Control) or presence (CytD) of lOpM CytD at 37° C, 
prior to washing and incubation with 5mg/ml FITC-Dextran at 37° C for the 
indicated time points. Cells were then washed and processed for live-cell 
imaging (Figure 5.12.F & G) or fixed and actin stained with rhodamine- 
phalloidin (Figure 5.12.D & E). Figure 5.12.F shows that FITC-dextran in 
control cells is enriched in a perinuclear region, while cells treated with CytD 
there was the expected breakdown of actin (Figure 5.12.E ) but the dextran was 
scattered throughout the cell and there was little evidence of enrichment in the 
perinuclear region (Figure 5.12.D).
165
120
HeLa
100S'£
Ia
0 20 40 SO 80
E
Tlm» (rrin)
Time (rrin)
.K-GFP 
■ *4>AK1
B 250 HeLa
S  200
150
100
200 40 60 80
-« G F P  
. li-PAKI
T imo (min)
D
1M
A431
5 « 
1
0 40 •0
-I^ GFP 
—+ • tt*AK1
A431
2 40
<  10
0 « « 80
—» «t-orp
—*  • «*-PAK1
Tkn»(iriri)
a .  100
□ »PAK1
□ »i-PAK1
l i r a  h m Tkiw(irin)
Figure 5.8. Uptake of Ale\a488-RL8 and -Tat uptake in PAK-1 depleted 
cells.
HeLa cells (A & B) and A431 cells (C & D) were transfected with si-GFP and 
si-PAK-1 for 48hr, then incubated for the indicated time points with 2 //M 
Alexa488-R8 or -Tat at 370 C for the indicated time points. Cells were washed 
and analysed by flow cytometry. Data obtained from A431 cells are also 
represented as a percentage of control for each time point (E & F). Values 
above obtained from three independent experiments (n=3)
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Figure 5.9. Effect of co-incubating CPPs with different molecular weight 
dextrans.
A431 cells (A, C, D) and HeLa cells (B) were serum starved in Ringer’s buffer 
for 1 hr then incubated with 5 mg/ml FITC-dextran or 0.75 mg/ml TMR- 
dextran +/- 2pM R8 or Tat at 37° C, prior washing and analysis by flow 
cytometry. TMR-dextran data are also represented as a percentage of control 
for each time point (D). Results represent data from three independent 
experiments.
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Figure 5.10. TMR-dextran uptake in the presence of EGF and CPPs.
A431 cells were serum starved for 1 hr, and then incubated with 0.75 mg/ml 
TMR-dextran +/- 50 nM EGF, 2pM unlabeled R8 or Tat for lhr before 
washing and analysis by confocal microscopy. Images are of single sections 
through the middle of cells. Scale bars = 25pm.
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5.3.6.2.Blebbistatin (Blebbl
Blebbistatin is a small molecule inhibitor showing high affinity and selectivity 
toward myosin II, binds to the myosin-ADP-Pj complex with high affinity and 
interferes with the phosphate release process. Thus, the inhibitor blocks myosin 
in an actin-detached state (Kovacs et al. 2004). Blebb is now gaining ground as 
a specific inhibitor for macropinocytosis (Section 2.3.5.5) and was recently 
used to identify this pathway as an uptake mechanism for vaccinia virus 
(Mercer and Helenius 2008). It was, therefore, used in this chapter to 
investigate its effect on CPP and dextran uptake.
Initially the effect of Blebb on the fluid phase uptake of dextran was 
investigated. A431 cells were pre-incubated with or without 100 pM Blebb for 
30 min followed by incubation of 5 mg/ml FITC-dextran for 0-80 min in the 
presence of the drug. Cells then were washed and trypsinized and cellular FITC 
was quantified using flow cytometry. Figure 5.13.A demonstrates that Blebb 
had no effect on uptake of FITC-dextran, thus the drug has no effect on fluid 
phase endocytosis. For the next experiment macropinocytosis was stimulated 
as described in section 2.3.5.5 by treating 1 hr serum starved cells with EGF. 
Cells were serum-starved and stimulated with FITC-dextran +/- EGF +/- 
Blebb, followed by washing and analysis by flow cytometry. As shown in 
Figure 5.13.B Blebb treated cells incubated with EGF were only able to induce 
dextran uptake to levels slightly higher than basal levels. Thus the drug proved 
to be a powerful inhibitor of enhanced fluid phase uptake in response to EGF. 
The effect of Blebb on actin distribution after EGF stimulation was studied 
further by confocal microscopy. A431 cells were serum starved for 1 hr then 
incubated with or without 100 pM Blebb for 30 min followed by incubation
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with 50 nM EGF for 10 min. Then cells were washed and fixed prior to actin 
staining with rhodamine-phalloidin and analysis by confocal microscopy 
(Figure 5.14). There was a clear difference in the distribution of actin in the 
two cell populations. The clear membrane ruffling that was apparent in EGF 
treated cells was not observed in cells pretreated with the drug. The effect of 
this drug on the uptake of the CPPs was then investigated in A431 and in HeLa 
cells. The results show significant inhibition in the uptake of Alexa488-R8 
(Figure 5.15.A) in A431 cells, whereas the uptake of Alexa488-Tat is not 
affected (Figure 5.15.B). The drug has no significant effect on uptake of either 
CPPs uptake in HeLa cells (Figure 5.15.C & D).
5.3.6.3.5-fN-Ethvl-N-isopropvD Amiloride (EIPAf
The amiloride analogue EIPA has been widely used as a macropinocytosis 
inhibitor to study this pathway and its role in the uptake of viruses and CPPs. It 
was used in this chapter to assess its effect on CPPs uptake in A431 and HeLa 
cells, and support the earlier data with other pharmacological inhibitors and 
PAK-1 depletion. Cells were pretreated with lOOpM EIPA, and then incubated 
with 2 pM Alexa488-R8 or -Tat in the continued presence of the drug. The 
cells were then processed for analysis of cell associated fluorescence. Figure 
5.16.A-D reveals that there was no effect of this drug on the uptake of either 
R8 or Tat in either cell line.
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Figure 5.11 Effect of Cytochalasin D on CPPs uptake
Cells were pre-incubated for 15 min in the absence (Control) or presence 
(CytD) of lOpM CytD at 37° C, prior to washing and incubation with 2 //M 
Alexa488-R.L8 (A) or -Tat (B) at 37° C for the indicated time points. Cells 
were washed and analysed by flow cytometry. Results represent data from 
three independent experiments (n=3).
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Figure 5.12 Effects of cytochalasin D on Dextran uptake and actin 
distribution.
A431 cells were pre-incubated for 15 min in the absence (Control) or presence 
(CytD) of lOpM CytD at 37° C, prior to washing and incubation with 5mg/ml 
FITC-Dextran (A), 0.2 mg/ml Alexa488-Dextran (B) or 0.75 mg/ml TMR- 
dextran (C) at 37° C for the indicated time points. Cells were then washed and 
analysed by flow cytometry. Results represent data from three independent 
experiments. Live-cell images of 5 mg/ml FITC-Dextran distribution in A431 
cells after internalising dextran for 60 mins in the presence (G) or absence (F) 
of CytD, and then cells were washed and processed for live cell imaging 
immediately. Actin staining of fixed control A431 cells (D) and CytD pre­
treated cells (E).
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5.3.7. The effect EGF, CPPs and cationic transfection reagents on PAK-1 
distribution inA431 Cells 
EGF treatment was shown to redistribute PAK-1 localisation to the plasma 
membrane in A431 cells (Liberali et al. 2008). As PAK-1 depletion inhibited 
CPP uptake experiments were performed to investigate whether CPPs cause a 
similar redistribution of this protein. As a positive control, cells were initially 
incubated with EGF for 10 min and then fixed, immunolabelled with 
antibodies recognizing PAK-1 and Alexa488 labelled secondary antibodies and 
the actin distribution was also determined by incubating the cells with 
rhodamine-phalloidin. As previously shown in Figure 5.17 PAK-1 antibodies 
in control cells highlighted cytoplasmic structures and the nucleus, however in 
EGF treated cells there was a dramatic redistribution of this protein to the cell 
periphery. Close inspection revealed that the PAK-1 labelling did not 
colocalize with the actin in this region that had also been redistributed in 
response to EGF stimulation (Fig 5.17).
The same labeling was then performed in cells incubated for 10 min with either 
2pM R8 or Tat. In these cells there was also sign of that PAK-1 was being 
redistributed to the plasma membrane but the effects were not as obvious or 
consistent as those observed following growth factor stimulation. To 
investigate whether this was a product of positive charge, A431 cells were 
incubated with the cationic polymers PEI, Oligofectamine™, Lipofectamine™ 
and Fugene6™, all complexed with either plasmid DNA (Fugene6, PEI) or 
siRNA (Oligfectamine, lipofectamine) (Section 2.3.4.6). The cells were then 
labeled as above for PAK-1 and actin. None of these commonly used 
transfection systems had any effect on PAK-1 distribution (Figure 5.17) and in
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the interest of time no further experiments were performed to investigate 
whether these reagents in the absence of siRNA or DNA had effects on cellular 
PAK-1 distribution.
5.4. Discussion
Macropinocytosis is emerging as a difficult pathway to study as no clearly 
identifiable protein has been shown to specifically regulate it, and and an 
endocytic probe that only enters by this pathway has not been identified (Jones 
2007b; Kerr and Teasdale 2009). Some cells are known to use this pathway 
constitutively but it has been most studied following growth factor activation 
by agents such as EGF and PDGF. Here an obvious effect is a stimulation in 
fluid pahse uptake measured using probes that normally enter cells by fluid 
phase endocytosis such as dextran and horseradish peroxidase. It has also been 
shown that pathogens and viruses utilize this pathway to gain access to cells 
(Kalin et al. 2010; Mercer and Helenius 2010)
A role for macropinocytosis in mediating CPP uptake was originally suggested 
based on inhibitor studies with the amiloride analogue EIPA and an ability of 
CPPs to modify the actin cytoskeleton and enhance the uptake of the fluid 
phase marker, 70 KDa dextran. From these studies 70 KDa Dextran has 
emerged as a marker for macropinocytosis suggesting it does not enter cells by 
any other route.
P21 -activated kinase (PAK-1) is a member of the PAK family of 
serine/threonine kinases that are activated by Cdc42/Rac and play roles in cell 
motility migration and in the main this is through interactions with the cell
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cytoskeleton (Arias-Romero and Chemoff 2008). PAK-1 was recently shown 
to be involved in growth factor induced macropinocytosis (Dharmawardhane et 
al. 2000) and in uptake of vaccinia virus (Mercer and Helenius 2008). In 
addition it has been shown that inhibiting endogenous PAK-1 activity using a 
PAK-1 specific auto inhibitory domain blocks growth factor-induced 
macropinocytosis, which indicates PAK-1 requirement in activating 
macropinocytosis (Dharmawardhane et al. 2000). CPPs including R8 and TAT 
were also shown to activate Rac-1 to levels comparable if not exceeding Rac-1 
activation by EGF (Gerbal-Chaloin et al. 2007). It is therefore clear that there 
is a link between the actin cytoskeleton and cationic CPPs but depleting Rac-1 
from cells is likely to have many effects and based on recent data with PAK-1 
and macropinocytosis it was decided to investigate this protein further. In order 
to do this it was very important that a macropinocytosis model could be 
established in the laboratory and that PAK-1 could be effectively depleted. 
A431 cells have been widely used as models for macropinocytosis as they have 
high levels of EGFR (Hamasaki et al. 2004; Liberali et al. 2008). It has been 
reported that the number of EGFR in A431 cells was about 100-fold higher 
than HeLa cells (Masui et al. 1984). This was confirmed in this thesis but in 
addition it was found that PAK-1 levels were also much higher in this cell line. 
Attempts were made to deplete PAK-1 expression in HeLa cells and A431 
cells, but only in the later was effective depletion consistently obtained. This 
was less problematic than predicted as these cells turned out to be the most 
effective models for measuring the effects of macropinocytosis.
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Figure 5.13 Effect of using myosin II inhibitor Blebbistatin on dextran 
uptake in the presence or absence of EGF.
(A) Serum starved cells were pre-incubated for 30 min in the absence (Blebb-) 
or presence (Blebb+) of lOOpM Blebb, prior to washing and incubation with 
5mg/ml FITC-Dextran at 37° C for the indicated time points prior to washing 
and analysis by flow cytometry. (B) Serum starved cells were pre-incubated for 
30 min in the absence (Blebb-) or presence (Blebb+) of lOOpM Blebb, prior to 
washing and incubation with 5mg/ml FITC-Dextran in the absence (-EGF) or 
presence of EGF (+) for the indicated time points. The cells were then analysed 
by flow cytometry Results represent data from three independent experiments.
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Figure 5.14 Effect of Blebbistatin on cellular actin distribution in EGF 
stimulated A431 cells.
A431 cells were serum starved for 1 hr, then pre-incubated with +/- Blebb for 
30 min then incubated with 50 nM EGF for 10 min. The cells were washed, 
fixed and incubated with rhodamine-phalloidin for 10 min and analysed by 
confocal microscopy. Scale bars = 40pm.
The same antibody used for Western blotting also proved to be effective for 
immunofluorescence microscopy revealing the location of the protein in 
vesicles and also tubular structures. It was also obvious that there was a large 
fraction of the protein in the nucleus. This nuclear fraction was shown to be 
increased with EGF stimulation (Singh et al. 2005), but this was not 
particularly noticeable from my experiments. Also documented is the fact that 
this protein is recruited to the plasma membrane by growth factor activation 
and this was also observed here. It was also found that both CPPs to some 
degree caused a reorganisation of this protein to the plasma membrane. It is 
known that EGF causes actin reorganisation and this is in part caused by 
activating the cytoplasmic domain of EGFR to recruit proteins such as PI 3- 
kinase that affect actin reorganisation through Rac and Rho but also through 
activating PAK-1 (Papakonstanti and Stoumaras 2002). PAK-1 is known to 
interact with many proteins that affect the cell cytoskeleton including PI 3- 
kinase, Rac-1 and cdc42 and it is therefore heavily involved with actin 
dynamics (Sells etal. 1997).
As the CPPs studies here are highly cationic some experiments were performed 
whereby transfection agents complexed with DNA or siRNA were incubated 
with cells prior to labelling for PAK-1 and actin redistribution. Neither of 
them showed any evidence of being able to do this even to the extent 
demonstrated by the CPPs. Important to note however is that complexation 
with negative DNA or RNA will reduce the overall charge on these molecules 
and possibly minimising their capacity to redistribute actin and PAK-1. This 
remains to be determined but would make for interesting studies. When A431 
cells were depleted of PAK-1 it was clear that there was a clear effect on the
cell cytoskeleton but this has not been previously documented. Overall from 
these studies a PAK-1 depletion model was generated that could then be used 
to study macropinocytosis induced by EGF and then a role for this pathway in 
the uptake of CPPs.
To characterise growth factor induced macropinocytosis, cells were incubated 
with EGF and then the uptake of FITC-dextran was measured. This uptake is 
known to be dependent on expression of EGF receptor (EGFR), and this 
explains the small increase in the uptake of dextran observed in HeLa cells 
compared to A431 cells. These experiments however showed that the two cell 
lines have a similar relative basal upatke of dextran, however EGF stimulated 
fluid phase endocytosis in A431 is higher than that seen in HeLa cells. 
Identical experiment was performed with TMR-dextran and similar effect has 
been obtained. Though there is a clear difference in the response of these two 
cell lines to growth factor stimulation it has yet to be determined whether 
constitutive macropinocytosis, if it exists, is the same in the two cell variants.
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Figure 5.15 Effect of Blebbistatin on CPPs uptake.
A431 cells (A & B) and HeLa cells (C & D), were pre-incubated for 30 min in 
washing and incubation with 2 pM Alexa488-R.L8 or -Tat at 37° C for the 
indicated time points. Cells were washed and analysed by flow cytometry. 
Results represent data from three independent experiments (n=3).
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Expression of auto inhibitory domain (AID) of PAK-1 have been shown to 
dramatically reduce the uptake of FITC-dextran in presence of PDGF but had 
no effect on basal levels of FITC-Dextran uptake (Dharmawardhane et al. 
2000). In comparison, siRNA depletion of PAK-1 (Figure 5.6), failed to 
completely inhibit the increase in dextran uptake to baseline values and it did 
not affect the overall basal dextran uptake (without EGF stimulation) (Figure 
5.5). Labelling PAK-1 depleted A431 cells with rhodamine phalloidin revealed 
that all the cells had a reorganised cytoskeleton but as described these cells had 
normal levels of dextran uptake but reduced stimulation of dextran caused by 
EGF and interestingly also had lower levels of CPP uptake compared with 
control cells. However it must also be noted that CPP uptake was not totally 
inhibited in PAK-1 depleted A431 cells suggesting a large fraction enters via a 
process that is independent of the requirement for this protein. The data was 
more difficult to interpret in HeLa cells as very high efficiency of PAK-1 
depletion was not achieved.
Dowdy and co-workers show that TAT induces macropinocytic fluid-phase 
uptake in CHO and glycan mutant cells. They co-incubated unlabeled (0.5 and 
2 pM) TAT peptide in the presence of 70 kDa neutral TMR- for 1 h at 37° C, 
and their results suggest that Tat and possibly other cationic CPPs may induce 
macropinocytic uptake and transduction via binding to a protein on the cell 
surface rather than through interactions with glycans or direct interaction with 
the membrane. In addition, the increase in dextran uptake increased with 
increasing the concentration of Tat (Gump et al. 2010). In this thesis two 
dextrans were investigated of molecular weights 40 and 70 KDa under 
conditions and concentrations that have previously been shown to be effective
at demonstrating macropinocytosis (Ellinger and Fuchs 2010; Gump et al. 
2010). Neither R8 or Tat had any effect on uptake of FITC-dextran but both 
peptides were able to stimulate uptake of TMR- 70 KDa dextran. The reason 
for this is unlear and it should be noted that the concentration of the two 
dextrans were quite different. The high costs of TMR-Dextran was prohibitive 
to repeating all the experiments at 5mg/ml as was used for FITC-dextran.
Based on the effects of PAK-1 depletion on the actin cytoskeleton (Figure 5.7) 
it was predicted that cytochalasin D would have some effect on CPP uptake in 
A431 cells. In previous studies this agent has been shown to inhibit CPPs by 
up 45% (Gomez and Matsuyama 2010; Tunnemann et al. 2006). Here CytD 
also proved to be a powerful though not complete inhibitor of the uptake of R8 
and Tat. Interestingly the effects of this drug were only noticeable after 
approximately 15 min and were more apparent for R8 compared with Tat. The 
reason for this delayed response is unclear but may be due to the fact that it is 
only affecting the later macropinocytic engulfment of the peptides into the 
cells. As 70 KDa dextran is regarded as a macropinocytosis marker it was 
predicted that its uptake would also be inhibited in CytD treated cells but this 
was not the case for this probe or 40 KDa dextran. For the later there was a 
dramatic increase in cell associated dextran and the relative effect increased
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Figure 5.16 The effect of EIPA on cellular uptake of R8 and Tat.
HeLa (A) and A431 cells (B) were pre-incubated for 30 min in the absence 
(Cont) or presence (EIPA) of lOOpM EIPA at 37° C, prior to washing and 
incubation with 2 //M Alexa488-R.L8 or -Tat at 37° C for the indicated time 
points. Cells were washed trypsinized and analysed by flow cytometry. Results 
represent data from three independent experiments (n=3).
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Figure 5.17. The effect of cationic lipids, cationic polymers, EGF, and 
CPPs on PAK-1 distribution in A431 Cells.
A431 cells were treated with 50 nM EGF, 2pM unlabelled R8 or Tat or 
transfected with oligofectamine-siRNA, lipofectamine-siRNA, Fugene-6-DNA 
or PEI-DNA (polyplexes) for 10 min, followed by washing and fixation prior 
to immunulabelling with PAK-1 antibody and actin labeling with rhodamine- 
phalloidin. Analysis was then performed by confocal microscopy. Scale bars = 
20pm.
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over time. This was highly unexpected but a search in the literature identified 
other studies showing an increase of dextran in T84 cells (Song et al. 1999) and 
no effect in uptake of dextran in other cell types (Gold et al. 2010). Studies 
investigating CytD on receptor mediated endocytosis have revealed that its 
effects are highly dependant on the choice of cell line and interestingly only 
A431 cells were resistant to CytD with respect to its capacity to inhibit CME 
(Fujimoto et al. 2000). Indeed in parallel studies performed at the Unversity of 
Ghent it was found that CytD inhibited dextran (Oregon Green labeled 70 kDa 
dextran, 0.5 mg/ml) uptake by 40% (Vercauteren et al. 2011). Recycling may 
be an important aspect here and no studies have looked in detail at the 
possibility that CPPs are recycled. However Dextran is known to be recycled 
(Seib et al. 2007) and if an actin cytoskeleton is involved in this it may be the 
case that in CytD treated cells that the fraction of dextran that is internalised is 
not able to recycle and so accumulates. This is similar to the observations 
obtained with ransferrin in CHC depleted cells in Chapter 3.
Blebb inhibits the interaction of actin with myosin II and has been used to 
reduce membrane ruffling and macropinocytosis (Mercer and Helenius 2010). 
The data obtained with this inhibitor were interesting in that it was able to 
reduce EGF stimulated uptake of Dextran to almost basal levels thus proving to 
be more effective than PAK-1 depletion. The morphological effects of this 
drug on actin in EGF treated cells were also clear to see. With regards to CPPs 
it inhibited R8 uptake but had no effects on Tat. Time did not allow for further 
analysis of the effects of this drug on CPP mediated stimulation of fluid phase 
uptake to see if  it was affective as it was in inhibiting this when caused by EGF 
(Figure 5.13).
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Amiloride and the amiloride analogue EIPA are now widely used as 
macropinocytosis inhibitors and have also been shown to inhibit uptake of R8 
and Tat (Nakase et al. 2004; Wadia et al. 2004). However, other studies have 
shown very little effects of this drug on CPP uptake (Al-Taei et al. 2006; Fretz 
et al. 2006). The later study shows that treatment of cells with EIPA affects the 
morphology and subcellular location of early, late endosomes and lysosomes. 
Enlarged early and late endocytic structures were observed in EIPA-treated 
cells, and these organelles accumulated in a perinuclear region. EIPA-treated 
cells were additionally characterized by increased localization of the HIV-TAT 
peptide and octaarginine peptides in the cytosol and that EIPA was without 
major effect on uptake of both peptides in leukaemic K G la cells (Al-Taei et al. 
2006). The results in this thesis clearly show that there were no effects of this 
drug on CPP uptake.
In conclusion it was identified that stimulation of fluid phase uptake by 
cationic CPPs Tat and R8 was highly dependent on the nature of the dextran 
and also the cell line. By generating a model for macropinocytosis it was found 
that the effects on fluid phase uptake could be partially decreased in cells 
depleted of PAK-1 however the majority of the peptide was able to enter cells 
in a PAK-1 independent manner. Studies with the actin disrupting agent CytD 
revealed extensive differences between the requirements for actin between 
CPPs and dextran(s) and it still remains to be determined whether this is at the 
level o f endocytosis or downstream processing including recycling. Overall the 
data show a strong requirement for functional actin for cell entry but it is 
difficult to refute the possibility that actin disruption may also inhibit the direct
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translocation of these peptides across the plasma membrane as well as their 
uptake via endocytic mechanisms.
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Chapter 6: Designing new methods to study the uptake
of CPP-protein conjugates
6.1. Introduction
An ability to deliver intact proteins into cells would have wide ranging 
implications for both academic research and the pharmaceutical industry 
(Futaki et al. 2004; Wadia and Dowdy 2003). Here CPPs have been 
extensively studied through purifying CPP sequences linked at the C- or N- 
terminus of proteins and these conjugates are often simply added to the culture 
media. The researcher can then either analyse the uptake of the protein and 
CPP by microscopy or if the protein has biological activity (e.g. enzymic) then 
this can be measured. Various CPPs have now been shown to be successful for 
delivering protein cargo of molecular weight as large as ~ 150 kDa 
(immunoglobulins and B-galactosidase at 120 KDa (Schwarze et al. 1999). 
Most important here is that there is plenty of evidence to show that the 
delivered proteins retain their functions either as enzymes (B-galactosidase) or 
as regulators of processes such as cell division and signal transduction (Wadia 
and Dowdy 2003). Of the CPPs studied HIV-Tat protein has again been 
prominent and it is known that in this sequence and also in other arginine rich 
peptides that the guanidino moiety plays an important role (Futaki et al. 2001; 
Wender et al. 2000). The group of Pooga has been active in studying the ability 
of biotinylated CPPs such as penetratin, Tat, pVEC and transportan to deliver 
avidin thus representing another mechanism for linking the CPP to the cargo 
(Saalik et al. 2004).
Unless the proteins can complex to the CPP through linkages such as biotin- 
avidin there is most often a requirement to purify the protein and CPP and this 
is most often done in E. Coli and an additional histidine tag is incorporated into 
the expressed protein. Histidine-tagging is based on preparing proteins of
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interest that have usually six residues of histidine at the N- or the C-terminus 
and passing an E. Coli lysate through an immobilized Ni(II), column will trap 
the histidine tagged proteins whereas other molecules that lack histidine tags 
will be eluted (Hochuli et al. 1987). Elution of the tagged protein is then 
achieved using an imidazole-containing buffer. A number of plasmids and kits 
are now available for efficient production and purification of these histidine- 
tagged proteins (Terpe 2003). In addition, this method is not only used for 
protein purification but also for detecting cross-linking between proteins. The 
Futaki group developed this further by making a nitriliotraiacetic acid 
derivatised octaarginine peptide NTA. This forms non-covalent complexes 
with histidine residues and consequently this was shown to enable the peptide 
to bind to His6-EGFP and deliver it into mammalian cells (Futaki et al. 2004)
GFP or EGFP has been widely used as a tool for assessing the capacities of 
CPPs to deliver proteins into cells and this was the protein that first highlighted 
the fixing artefacts associated with CPPs (Lundberg et al. 2003). More 
recently use was made of variants of GFP (green red) and Fluorescence 
resonance energy transfer (FRET) to monitor both uptake and endosomal 
escape and this study highlighted the large fraction of HIV-Tat-GFP that is 
held up in endosomes and lysosomes. Most of the mechanistic studies using 
GFP have been focused on HIV TAT providing evidence for uptake through 
macropinocytosis and also caveolae (Ferrari et al. 2003; Wadia et al. 2004). In 
the main, these studies have focused on using pharmacological inhibitors and 
colocalisation experiments using confocal microscopy however a role for 
macropinocytosis was also demonstrated using the HIV-TAT-Cre system
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developed by the Dowdy group (Gump et al. 2010). More recently the use of 
siRNA depletion was described to suggest that protein delivery by transportans 
is mediated by caveolae. For analysing CPP-protein uptake new techniques are 
also required to gain a better understanding of how they enter cells and then 
escape form the endosomal pathway.
The work described in this Chapter represent the final stages of the thesis 
whereby hsitidine tagged (His6) EGFP-R8 protein was purified from E. coli 
BL21(DE3)pLysS competent cells transformed using a pEV3b plasmid 
encoding for His6-EGFP-R8 and Ampicillin resistance (Figure 6.1) and then 
purified using histidine-tag method. The quantitative uptake of this protein was 
analysed using two different tools flow cytometry and a newly developed tool 
by which the protein uptake quantified directly from SDS Gels following 
electrophoresis under non-denaturing conditions.
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Figure 6.1. His6-EGFP-R8 Plasmid map.
The sequence for His6-EGFP-R8 was inserted between Ndel-Ecorl restrict
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6.2. Methods
As a major aspect here is protein purification the entire methods are provided 
in this chapter rather than under the main Materials and Methods chapter. 
Under all experimental procedures here of protein purification only sterilised 
consumables such as pipette tips and tubes were used. The plasmid DNA used 
was a kind gift of Professor Shiroh Futaki, Kyoto University and was prepared 
as a 1 mg/ml stock solution via a separate project performed in the laboratory. 
Thus no detail of plasmid preparation is provided here.
6.2.1. Preparation o f LBAmp agar plates
35g of LB agar was placed in 1L of dLLO and autoclaved for 50 min. The 
agar was allowed to cool down to ~ 50°C before adding 100 pi of 100 mg/ml 
stock of ampicillin in dFbO. The plates were allowed to set in the biological 
safety cabinet and were stored upside down at 4°C (in the fridge or cold room) 
until required.
6.2.2. Transformation
First the water bath was preheated to 42°C and 200 pi aliquots of competent 
cells (E . coli BL21(DE3)pLysS) were removed from the -80°C freezer and 
transfered to an ice bath to let the cells thaw. Plasmid DNA (no more than 
50 ng in < 10 pi) was then added to the cells and the contents were mixed by 
pipetting up and down very gently. Negative control were also prepared 
containing competent cells only. All tubes were then placed on ice for 30 
minutes and then placed in a preheated 42°C water bath for exactly 90 seconds. 
The tubes were then transferred rapidly to an ice bath to allow the cells to chill
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for 1-2 min. SOC medium (Invitrogen®; containing 2% tryptone, 0.5% yeast 
extract, 10 mM NaCl, 2.5 mM KC1, 10 mM MgCh, 10 mM MgS04, 20 mM 
glucose) was added to each tube (800pl) and the contents were mixed gently 
before sealing the lids with parafilm. The cultures were incubated for 45 
minutes in the orbital shaker at 37° C and lOOrpm. 200 pi of transformed 
competent cells and non-transformed competent cells respectively (negative 
control) was pipetted onto a LBAmp agar plate. The cells were gently spread 
over the surface of the agar plate by using a sterile bent polypropylene rod then 
they were incubated at room temperature for 10-15 min to allow the cells to 
settle in the agar. The plates were then inverted and incubated at 37° C over 
night (16-20 hours). Transformed colonies appear only in the cells incubated 
with plasmid (Figure 6.1). The agar plates were sealed with parafilm and stored 
upside down at 4° C and were used as a supply of colonies for protein 
purification.
6.2.3. Expression o f His6-EGFP-R8 protein
LB broth medium were prepared in 4 sterile McCartney bottles (5ml/bottle), 4 
autoclaved 250 ml conical flasks (20 ml/flask,) and 4 autoclaved 1 L conical 
flasks (490ml/flask) and all were autoclaved and finally stored in room 
temperature. A single colony was picked and added to a 5ml LB bottle 
containing ampicillin at lOOpg/ml and this was incubated for 6 hrs at 37° C at 
100 rpm in the orbital shaker. 0.5 ml of the incubated culture was added to 
each of the 20 ml LBAmp broth and these were incubated overnight on the 
orbital shaker. The following day, 4 x 490 ml culture flasks that containg 
Ampicillin, were inoculated with 10 ml of the overnight noninduced culture
194
and the flasks were incubated in Orbital shaker at 37° C, 200 rpm until an 
O D eoo of ~0.6 was reached. The absorbance was measured after 2 hrs and then 
every 1 hr using the photometer and blank LB broth as a reference. Before 
induction a 1 ml sample from each conical flask was taken and stored at -20° C 
as a marker for non-incuction. Protein expression was induced by adding 250 
pi of 1M IPTG stock (Cf,nai=500pM) to each conical flask and the cultures 
were incubated for an additional 3 hrs. 1 ml sample from the induced flasks 
was taken after every 1 hr and stored at -20° C. At the end of the reaction, the 
flasks were placed in the cold room overnight. The following day the cell 
culture volume was split into four autoclaved 250-ml centrifuge bottles, and 
centrifuged at 4000 x g and 4°C for 20 min on Aventi centrifuge (rotor JS 7.5). 
This step was repeated and each time the supernatant was removed a new 
volume was added to each bottle. Following removal of the last supernatant, 
the pellets were snap-frozen in liquid nitrogen and then thawed for 5 min on 
ice before resuspending them in one centrifuge tube using ice-cold filtered 
solution A (500 mM Tris-HCl, 600 mM NaCl, 1 M Imidazole, 1 protease mix 
inhibitor tablet, complete with ddFLO). The green and thick laysates were 
transferred to 2 sterile 50 ml falcons and sonicated on ice until good cell lysis 
was achieved. The cell debris then was then centrifuged on the JA 14 rotor at 
10,000 x g at 4°C for 30 min. The supernatants were the transferred to a sterile 
falcon tube and kept on ice.
6.2.4. Purification o f His6-EGFP-R8 protein
An experimental set-up as shown in Figure 6.2 was arranged for the final 
purification steps after washing the peristaltic pump with 50 ml of sterile water
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and then with 70% ethanol. The Ni-Nitrilotriactetic acid (NTA) superflow 
material was equilibrated with solution A then the cold E. Coli preparation 
(lysate) was pumped slowly to the column at a rate of approximately xml/min. 
It is important that the flow is not so strong as to rise the level above the 
column to > 0.5 cm above the first filter with flow rate 2-4 x 10. Once all the 
sample was passed down the column the His6-EGFP-R8 protein was eluted 
with 8 ml ice cold filtered solution B (500 mM Tris-HCl, 500 mM NaCl, of 1M 
Imidazole, complete with dd H2O). The eluted sample was then collected in 
eppendorf tubes. The column was washed with 0.5 M NaOH and stored with 
30% ethanol at 4° C to inhibit microbial growth. The eluted fraction was then 
dialysed in the cold room for 24 hrs against 3x 2L of PBS using dialysis tubing 
with a 10 KDa molecular weight cut off. The concentration of the dialysed 
protein was then determined with the BCA assay (section 2.3.6) and was 
typically around 10 mg/ml. This was then immediately aliquoted and stored at - 
80°C. To assess purity it was then loaded on to 12% SDS PAGE gels.
This CPP protein conjugate was then available for analysis with cells to 
investigate it uptake and also to design methods for analysing the fraction that 
was intracellular.
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Figure 6.2. An experimental set-up of the peristaltic pump and column 
used to purify the protein.
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6.2.5. Uptake o f His6~EGFP-R8 in HeLa cells (Live cell imaging)
HeLa cells were seeded into glass-bottomed, 35 mm culture dishes and allowed 
to adhere for 24 h. The cells were washed 2x with PBS before incubating with 
either 2pM (A) or 5pM (B) of His6-EGFP-R8 in DMEM media for 1 hr. The 
cells were washed 3x with PBS and 2x imaging media, before being processed 
to live cell imaging analysed via confocal microscopy on the 37° C temperature 
stage.
6.2.6. Uptake o f His6-EGFP-R8 in +/- CytD pretreated HeLa cells
HeLa cells were seeded in DMEM media, 24 hrs before the experiment at a 
seeding density 220,000 cells/well in 6-well plates, then the cells were PBS 
washed and pre treated +/- 10 pM CytD for 15 min. Then 2 pM of His6-EGFP- 
R8 in DMEM media was added to the cells in presence or absence of 10 pM 
CytD for 0, 30, 60 and 90 min at 37° C or for 60 min at 4° C. The 0 time point 
here refer to cells incubated for a few seconds with the protein that was then 
immediately removed from the cells. The cells were then washed with ice cold 
PBS, followed by addition of lysis buffer (50mM Tris-HCl, 150mM NaCl, dd 
H2O and pH to 8.0 using 5M HC1, 1%) on ice for 5 min. Then cell lysates 
were removed and centrifuged at 13,000 x g for 10 min at 4° C. The 
supernatant was removed protein concentration detected using BCA method. 
A volume equivalent to 20 pg of protein was then mixed with sample buffer 
+/- DTT and loaded in 12 % gel SDS-PAGE as shown in section 2.3.7. DTT 
was omitted so that a non-denaturing gel could be run that retained the integrity 
of the GFP and also its fluorescence. The non-denatured gel was scanned on 
the Typhoon Variable Mode Imager while the denatured gel was processed
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further by electrophoresis and immunoblotting method as shown in section 
2.3.8.
6.3. Results
A typical preparation from 4 L of E.coli yielded 10 mg of protein that was 
highly fluorescent (Figure 6.3). During purification, samples were retained and 
Figure 6.4 highlight the appearance of a very prominent band at 30 KDa in the 
induced cells. Passing the supernatant through the column identified this to be 
the retained protein from loading up to 20 pg of this protein on gels no other 
band appeared suggesting this was a very pure preparation.
To analyse the protein sample 20 pg of protein either denatured or 
nondenatured was loaded on to gels and following electrophoresis these were 
immediately scanned on the Typhoon analyser. Only the non denatured protein 
was observed (Figure 6.4A) as a clear band of 30 KDa. However when the 
same gel was stained with Coomassie Brilliant Blue both bands were observed 
(Figure 6.5.B).
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Figure 6.3. Purified and highly fluorescent His6-EGFP-R8 Protein.
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6.3.1 His6-EGFP-R8 protein concentration and analysis 
For microscopy experiment, HeLa cells were washed with PBS before 
incubation under tissue culture conditions with 2 or 5 pM of His6-EGFP-R8 
protein for 1 hr. Then the cells were then processed for live cell imaging 
confocal microscopy (section 6.2.5). The results in (Figure 6.7.A), show that at 
2 pM EGFP labelled vesicles were observed but were very faint against the 
background labelling, whereas at 5 pM (Figure 6.7.B), the vesicles are much 
easier to observe and were prominent throughout the cytoplasm.
In order to attempt to quantify His6-EGFP-R8 the protein was similarly 
incubated, for 60 min in 6 well plates with HeLa cells at external 
concentrations of 4 and 8pM. The cells were then washed with PBS and 
trypsinized followed by heparin washing and flow cytometry analysis.
The cell associated fluorescence (Figure 6.6) was very low compared to an 
equal molarity of Alexa-R8 shown in other chapters and it was impossible to 
then compare this control uptake with those whereby different endocytic 
pathways have been inhibited. Alternative methods was therefore investigated 
based on loading cell lysates from His6-EGFP-R8 treated cells on SDS gels and 
then either scanning the gels on the Typhoon imager or alternatively by 
transferring the proteins from gels on to nitrocellulose membranes that were 
then probes with anti-EGFP antibody and HRP conjugated secondary 
antibodies.
HeLa cells were incubated with 2 pM of His6-EGFP-R8 for 0, 30, 60, and 90 
min at 37° C or for 60 min at 4° C. The cells were then washed and trypsinized 
then washed 3X with PBS before being lysed using lysis buffer containing 
protease inhibitors and trypsin inhibitor. Following quantification of the lysate
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20pg was loaded on to 12% gel followed by transfer and immunolabelling with 
antrEGFP antibody. The results in Figure 6.8.A show that at 0 min (Cont) and 
with incubations performed at 4° C, no band was detected. However, clear 
EGFP bands were detected for 30 and 60 min time points but surprisingly the 
signal at 90 min was significantly lower. The same experiment was repeated 
,excluding 4° C point, and identical data was obtained including a reduced 
signal from 60 to 90 min. Samples from these uptake experiments were also 
analysed via direct scanning of the gels on the Typhoon analyser and similar to 
results shown in Figure 6.8A and B an increased uptake was observed between 
30 and 60 minutes and then a reduction at 90 min (Figure 6.8.C). Here another 
band was also observed at 50 KDa in all lanes except the control but this did 
not appear to decrease between 60 and 90 min.
6.3.2. His6-EGFP-R8 Uptake in HeLa cells
For microscopy experiment, HeLa cells were washed with PBS before 
incubation under tissue culture conditions with 2 or 5 pM of His6-EGFP-R8 
protein for 1 hr. Then the cells were then processed for live cell imaging 
confocal microscopy (section 6.2.5). The results in (Figure 6.7.A), show that at 
2 pM EGFP labelled vesicles were observed but were very faint against the 
background labelling, whereas at 5 pM (Figure 6.7.B), the vesicles are much 
easier to observe and were prominent throughout the cytoplasm.
In order to attempt to quantify His6-EGFP-R8 the protein was similarly 
incubated, for 60 min in 6 well plates with HeLa cells at external 
concentrations of 4 and 8 pM. The cells were then washed with PBS and 
trypsinized followed by heparin washing and flow cytometry analysis.
2 0 2
The cell associated fluorescence (Figure 6.6) was very low compared to an 
equal molarity of Alexa-R8 shown in other chapters and it was impossible to 
then compare this control uptake with those whereby different endocytic 
pathways have been inhibited. Alternative methods was therefore investigated 
based on loading cell lysates from His6-EGFP-R8 treated cells on SDS gels and 
then either scanning the gels on the Typhoon imager or alternatively by 
transferring the proteins from gels on to nitrocellulose membranes that were 
then probes with anti-EGFP antibody and HRP conjugated secondary 
antibodies.
HeLa cells were incubated with 2 pM of His6-EGFP-R8 for 0, 30, 60, and 90 
min at 37° C or for 60 min at 4° C. The cells were then washed and trypsinized 
then washed 3X with PBS before being lysed using lysis buffer containing 
protease inhibitors and trypsin inhibitor. Following quantification of the lysate 
20pg was loaded on to 12% gel followed by transfer and immunolabelling with 
anti EGFP antibody. The results in Figure 6 .8.A show that at 0 min (Cont) and 
with incubations performed at 4° C, no band was detected. However, clear 
EGFP bands were detected for 30 and 60 min time points but surprisingly the 
signal at 90 min was significantly lower. The same experiment was repeated 
excluding the 4° C point and identical data was obtained including a reduced 
signal from 60 to 90 min. Samples from these uptake experiments were also 
analysed via direct scanning of the gels on the Typhoon analyser and similar to 
results shown in Figure 6.8A and B an increased uptake was observed between 
30 and 60 minutes and then a reduction at 90 min (Figure 6.8.C). Here another 
band was also observed at 50 KDa in all lanes except the control but this did 
not appear to decrease between 60 and 90 min.
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Figure 6.4. Steps towards purification of His6-EGFP-R8
Samples were loaded on to SDS PAGE gels, stained with Coomassie Brilliant 
Blue and then destained. (1) Molecular weight markers (2) Noninduced E. Coli 
lysates, (3) induced lysates (4-6) 5, 10, 20 pg of the purified protein.
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Figure 6.5 Analysis of denatured and non denatured His6-EGFP-R8 using 
electrophoresis and Typhoon laser scanning.
20 pg of His6-EGFP-R8 was mixed with SDS sample buffer +/-DTT and +/- 
boiling and then loaded on to a 12% SDS PAGE gel. Following electrophoresis 
the fluorescence of the samples was measured directly from the gel on the 
scanner (A) and the same gel was then stained with Coomassie brilliant blue 
stain for and destained (B)
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6.3.3. Internalisation o f His6-EGFP-R8 uptake and analysing the effect o f CytD 
on its uptake
To study the effect of CytD on uptake of His6-EGFP-R8, HeLa cells were 
washed with PBS and pre treated +/- 10 pM CytD for 15 min. Then 2 pM of 
His6-EGFP-R8 was added to the cells in presence or absence of 10 pM CytD 
for 1 hr at 37° C. The cells were then washed with ice cold PBS, followed by 
adding lysis buffer on ice for 5 min. Following protein quantification 20 pg of 
lysate was analysed by non denaturing electrophoresis and the gel was then 
immediately scanned by the Typhoon imager. The results show an inhibition in 
uptake in CytD treated cells but the quality of the data was poor and time did 
not allow for follow up experiments to assess whether this method could be 
used to analyse the uptake of this protein under conditions which affect 
endocytic pathways (Figure 6.9).
6.4. Discussion
CPPs have been shown to be able to promote the delivery of several different 
types of proteins that have also been shown to retain their activities inside cell. 
The ability of HIV TAT to deliver P-galactosidase protein into several mouse 
tissues following IV injection triggered the initial interest in this field and 
increased the importance of CPPs as potential delivery vectors (Fawell et al. 
1994; Schwarze et al. 1999). Generally, researchers couple CPPs to proteins 
via either covalent bonds, avidin-biotin affinity or via fusion constructs 
(Deshayes et al. 2008; Gros et al. 2006; Jones 2010; Patel et al. 2007). R8 as 
shown here in this work has previously been shown to deliver GFP to the cells 
(Lundberg et al. 2003; Takeuchi et al. 2006). In the later study the distribution
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Figure 6.6. His6-EGFP-R8 uptake in HeLa cells
HeLa cells were incubated with 0, 4, 10 pM of His6-EGFP-R8 in SFM for 1 hr 
at 37° C. Then the, cells were washed with PBS and trypsinized followed by 
heparin washing and flow cytometry analysis (n=3).
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Figure 6.7 Subcellular distribution of His6-EGFP-R8 in HeLa cells
HeLa cells were washed and incubated with either 2pM (A) or 5pM (B) of 
His6-EGFP-R8 in DMEM media for 1 hr, washed and analysed by confocal 
microscopy on the 37° C temperature stage. Shown are fluorescence and bright 
field images.
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of R8-EGFP was not shown by microscopy but in the earlier study and in this 
thesis it was shown to bind strongly to the plasma membrane. (Lundberg et al. 
2003).
In Figure 6.7 it is seen that plasma membrane labelling is also accompanied by 
vesicular labelling and overall this suggests, for this CPP and others, a basic 
mechanism of endocytosis followed by endosomal escape for at least a fraction 
of the internalised protein. The exact mechanism by which these CPP 
conjugates enter cells in the first place and then escape from the endosomal is 
largely unknown. Studying protein delivery, as found in this thesis, is much 
more difficult than studying the uptake of fluorescent peptides. But in this 
chapter some preliminary experiments were performed to assess alternative 
methods for quantifying the uptake of EGFP-R8 protein in cells.
It was clear that by using the flow cytometry equipment available that 
quantifying uptake through this method would be difficult. The signal 
following al hr incubation was barely above baseline and this makes further 
experiments with inhibitors or siRNA treated cells very difficult. It should also 
be noted that trypsinisation was used here to detach the cells and to remove 
plasma membrane bound protein and thus may explain the further the signal 
weakness. One alternative would be to label the cells with a fluorescent 
antibody recognising EGFP and add this to cells treated with this conjugate.
Alternative methods were then investigated and successful attempt were made 
at measuring the uptake of the protein using electrophoresis of cell lysates from 
cells incubated with His6-EGFP-R8. The intact and internalised protein was
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then identified either by directly scanning the fluorescence of the gel on the 
Typhoon analyser with 488nm excitation or alternatively through 
immunolabelling the protein with an anti-EGFP antibody. The data shows that 
initially a time dependent and temperature dependent uptake but surprising was 
the fact that at 90 mins the signal was reduced compared with 60 min 
suggesting a high degree of degradation that was occurring at a higher rate than 
the rate of internalisation. It may also be due to the fact that degradation was 
accompanied by recycling thus further reducing the signal.
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Figure 6.8 Measuring the uptake of His6-EGFP-R8 Uptake into HeLa 
cells
Cells were incubated with 2 pM of His6-EGFP-R8 for 60 min at 4° C or for 0, 
30, 60, and 90 min at 37°C (A) and the same experiment was repeated but 
without the 4° C point (B). The cells were then washed and lysed and 20 pg of 
the cell lysates was then loaded on to 12% SDS PAGE transferred on to 
nitrocellulose papers that were then probed with a anti EGFP antibody and a 
HRP conjugated secondary antibody. Tubulin was detected as an internal 
control for protein loading; samples obtained from
experiment B were also loaded as non denatured proteins on to gels that 
following electrophoresis were scanned on the Typhoon analyser at 488nm 
excitation (C).
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The requirement for energy for uptake of this conjugate was also observed by 
the'Futaki group when the cells were treated with R8-NTA-Ni(II)/His6-EGFP 
(Futaki et al. 2004).
The same experiment of live cell imaging of His6-EGFP-R8 uptake in HeLa 
cells (Figure 6.7) was done by Anja Schermann in our lab. Her results revealed 
that at higher concentrations such as 10 or 20 \iM the protein is clearly 
internalised and very well distributed inside the cells in a vesicular manner.
From the repeat experiments shown there was a large variation in the EGFP 
signal obtained -  compare Figure 6.7 A and B. For A it would have been very 
difficult to perform timed uptake experiments of the sort shown for the peptide 
but the signal in B is sufficiently high to suggest this could have been done. 
There may be a possibility that the six histidine residues lying at the N- 
terminus to the protein were affecting uptake and could also influence 
endosomal escape. The vector was obtained from the Futaki group and was 
designed that the His6 portion should be cleaved via thrombin cleavage site 
engineered between the Hise and the EGFP. The intention was to perform 
thrombin cleavage and then re-purify the EGFP-R8 through dialysis; the His6 
portion would have been very small and would easily flow through a lOKDa 
dialysis membrane. However is a separate project performed in the laboratory 
it was discovered that there was a mutation at this site and that the thrombin 
would not have cleaved this purification tag from the EGFP-R8.
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Time did not allow for full optimisation of the methods for quantification but 
an experiment was conducted to investigate whether the uptake of this probe is 
as sensitive to actin disruption as shown in chapter 5 for the fluorescent peptide 
and also for Tat-EGFP or Tat-Cre. Under microscopy the TAT-EGFP/Cre 
conjugates in cytochalasin D treated cells are shown lining the plasma 
membrane but there is very little evidence o f intracellular vesicular structures 
(Tunneman, Ferrari). As observed with CPPs in chapter 5 treatment with this 
agent causes massive disruption of cell morphology and it is no surprising that 
this effects uptake of both CPPs as fluorescent probes and also CPP-protein 
conjugates.
The data in Figure 6.9 is of rather low quality but does suggest that the uptake 
is reduced in the Cytochalasin D treated cells thus suggesting that this method 
with further optimisation could be used to analyse the uptake of this protein 
and others provided they are fluorescent or that there are suitable antibodies 
available to detect them following transfer from gels. It would be interesting to 
now test the siRNA models developed in other chapters to see if there is parity 
between results for peptide uptake compared with protein uptake.
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Figure 6.9 Studying the effect of CytD on His6-EGFP-R8 Uptake
HeLa cells were treated +/- 10 pM CytD for 15 min prior to incubation with 2 
pM of His6-EGFP-R8 in presence or absence of 10 pM CytD for 1 hr at 37° C. 
The cells were then washed lysed and 20 pg undenatured protein was then 
separated by electrophoresis and the gel was scanned on the Typhoon analyser.
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Chapter 7: General Discussion
7.1. General Discussion
A major obstacle to successful delivery of macromolecular therapeutics is 
getting membrane impermeable drugs such as peptides, proteins, and 
nucleotides to the inside of cells and defined intracellular locations. Therefore, 
over last 20 years, considerable effort has been invested in the design of new 
technologies to improve cellular uptake, of therapeutic compounds (Jarver and 
Langel 2004; Torchilin 2005b). Although, many non-viral strategies have been 
introduced, including lipid-, polymeric-, nanoparticle- and peptide-based 
methods (Morris et al. 2000; Ogris and Wagner 2002; Torchilin 2005b), only a 
few of these methods have shown promise in vivo and progressed into clinical 
trials. The major limitations of these technologies are the poor stability of the 
complexes and the rapid degradation of the cargo, as well as an insufficient 
ability to reach the intracellular target.
Researchers are constantly looking for new vectors to deliver therapeutics into 
cells and prominent candidates during the last 20 years have been CPPs 
(Moschos et al. 2007). They are attractive as they have been shown to 
efficiently improve intracellular delivery of several types of macromolecules, 
including plasmid DNA, oligonucleotides, siRNA, PNA, proteins and peptides, 
liposomes and nanoparticles. Further, the they have been developed to 
overcome both extracellular and intracellular limitations,, and to improve the 
movement of a cargo across the cell membrane into the cytoplasm and 
intracellular trafficking to reach its target (Foerg and Merkle 2008; Johnson et 
al. 2011; Morris et al. 2000; Snyder et al. 2005). This is important as so many
vectors are able to gain access into cells but then are poor at endosomal escape
>
and this is necessary especially if the therapeutic is sensitive to enzymes that
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are found in lysosomes. It is clear that some CPPs (HIV-Tat and R8) are also 
delivered to lysosomes (Al-Taei et al. 2006) but numerous studies have shown 
that a large enough fraction of the cargo is delivered to mediate a biological 
response. There is still controversy regarding the uptake mechanism itself and 
even less is understood regarding the mechanism by which they traverse the 
endosomal membranes. It should not .be forgotten that data is strong for a 
mechanism by which endosytosis is not required and this is especially the case 
where the cargo is small such as a fluorophore and the extracellular peptide 
concentration is relatively high at > 5 pM. Here only R8 and Tat were studied 
for the reason that most o f the work from the laboratory has focused on these 
two CPPs and that it would have been difficult to study more CPPs in this kind 
of detail. In this study a concentration of 2 pM was chosen for all studies as it 
was found here, and others have published, that uptake at this concentration, 
for these peptides, can be inhibited by at least 85 % by performing the Uptake 
experiments on ice. This allowed for studies performed here to investigate in 
detail the endocytic pathways that CPPs use to gain access with minimal 
influence from direct plasma membrane penetration.
The organization of mammalian cells is however highly complex and this 
system is maintained through the organization of the cytoplasm into multiple 
intracellular structures and each of these structures has their own specific 
identity and function (Bonifacino and Glick 2004). Endocytic pathway controls 
the transport of molecules, such as receptor ligands and solutes entering the 
cells (Maxfield and McGraw 2004). But these systems are also highly complex
involving hundereds of different proteins and lipids (Doherty and McMahon
)
2009). For drug delivery research that is interested in using endocytosis for
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cellular delivery it is important that this complexity is appreciated and that 
tools are in place to study the different entry routes. This was one of the main 
objectives of this thesis as a failure to understand this may lead to insufficient 
cell entry or intracellular traffic to an inappropriate cell location or 
alternatively into the recycling pathway leading to exit from the cell. Cell 
biologists are mainly focused on studying specific pathways or even a single 
protein mediating endocytosis but for drug delivery it is often required to be 
able to study several endocytic pathways at once or at least be able to study the 
involvement of one pathway in the uptake of a candidate drug delivery system. 
Thus especially important for the drug delivery researcher is tools that can be 
used to pinpoint the type of endocytic pathway(s) that a cell uses, to internalise 
a vector. These need to be simple, reproducible, affordable methods and most 
importantly they need to be specific for a particular pathway. By far the most 
commonly used tools are pharmacological or chemical inhibitors. As 
mentioned previously, there are several advantages to using these inhibitors 
over the more sophisticated molecular biological tools, however, they suffer 
enormously from toxicity and lack of specificity (Ivanov 2008; Vercauteren et 
al. 2010). Introducing a mutant protein into a cell system can also be used and 
this was not studied in this thesis but the problem here is controlling expression 
levels and maintaining that the protein does not then sequester other proteins in 
the cell that may be needed. Alternatively, the possibility now exists whereby 
single proteins can be depleted from cells using siRNA targeting and this was 
the main focus of this thesis. Previously in the lab this method was not used 
but now cells models are in place that allow for depletion and phenotypic
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characterisation of cells depleted in several endocytic pathways and this was 
theonain achievement of the thesis.
Targeted pathways were those regulated by CHC, Flot-1, DNM2, Cav-1 and 
PAK-1 and I successfully depleted each protein and then identified probes that 
could be used to show the effects on one or more aspect of endocytosis. Unlike 
most studies using pharmacological inhibition or siRNA depletion, 
experiments using single time points were not employed and rather I have 
developed assays whereby uptake was studies for various periods of time. This 
was more of an experimental challenge but very useful information was gained 
from this approach including showing the effects of CHC depletion on 
transferrin recycling and also that the effects of CytD on CPP was not 
immediate but occurred after an initial phase where uptake was identical. This 
approach was however difficult for analyzing the role of cavaeolae in 
endocytosis of BODIPY-LacCer as the probe penetrated into the plasma 
membrane and required extensive washing to remove this fraction so that the 
internalised fraction could be measured. This suggests ah alternative probe is 
required for this pathway and the same is true for the pathway regulated by 
Flot-1. Here anti-CD59 was used but only one type of antibody proved 
suitable for these studies. During the course of these studies the effect of Flot- 
1 depletion on uptake of the cationic polymer polyethylenimine was shown 
(Payne et al. 2007) and the group in Ghent also identified that Flot-1 depletion 
also affected uptake of disulphide-based polyamidoamine polyplexes 
(Vercauteren et al. 2011) suggesting these may also be used as novel probes for 
the flotillin pathway. It is however important to note that Cav-1 and Flot-1 are 
known to organize domains on the plasma membrane thus depleting these
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proteins form cells may change the landscape of the membrane completely and 
affect other endocytic pathways. This needs further experimentation.
DNM2 proved to be the most difficult protein to deplete and it is most famous 
for regulating uptake through the clathrin pathway. However, one study led us 
to believe that depleting this protein could also help answer the roles that fluid 
phase endocytosis had in CPP uptake (Cao et al. 2007). Eventually, and only in 
A431 cells the protein was depleted but I could not see any effect on fluid 
phase uptake in cells depleted of this protein, yet uptake through clathrin was 
significantly reduced. This, together with the data using Dynasore questions 
the role of this protein in fluid phase endocytosis and there is still a need for a 
suitable protein marker fro this pathway that could be depleted with a siRNA 
sequence.
To cell lines HeLa and A431 were used throughout this thesis and ideally all 
the work would have been performed in a single cell line. But this was not 
possible because of the work required to study macropinocytosis and to deplete 
DNM2. Macropinocytosis proved difficult to study and it was important that 
a protein was available to deplete with a siRNA sequence and also that a good 
assay was available to study this process. Adding EGF to cells proved to be 
very effective for measuring growth factor induced macropinocytosos but the 
HeLa cell line proved to deficient for this. This was due to the known fact that 
they express low levels of EGFR but I also discovered that expression of PAK- 
1 is also very low in this line and thus it became very difficult to study the 
effects of depleting this protein on macropinocytosis. Thus the skin epithelia
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A431 cell-line was chosen to extensively study this pathway, as there is a lot of 
literature on its capacity to perform this process; especially in response to 
addition of EGF. The choice of probe for this pathway was also a problem as 
there is no macropinocytosis specific probe. I eventually used the concept of 
EGF stimulation, in which the cells increase the fluid phase uptake of a fluid 
phase marker, such as dextran, which then reflects on their capacity to perform 
macropinocytosis. Consequently, inhibiting PAK-1, that was shown to regulate 
macropinocytosis, inhibited the increase in dextran uptake thus a model for this 
pathway was in place to study the role of this pathway in uptake of R8 and Tat. 
No single siRNA sequence or pharmacological inhibitor completely inhibits 
the uptake of the two peptides studied here thus further questioning whether 
even at these low concentrations, the role endocytosis has to play. It may be 
that a fraction, and in a temperature dependent manner, moves directly across 
the plasma membrane or it may be that the roles of simple fluid phase uptake, 
independent of DNM2, is mediating uptake. This requires further 
characterization.
Of all the siRNAs tested only the one targeting PAK-1 had any effect on 
uptake of CPPs and this was significant but not complete. During the studies it 
also became clear that PAK-1 depleted cells also had strange distribution of the 
actin cytoskeleton thus it may be that the effects of PAK-1 depletion may be on 
the cell cytoskeleton that then indirectly effects uptake of the CPPs. The work 
clearly showed that actin disruption with CytD also inhibited uptake but this 
drug causes huge effects on cell morphology and again this may be the reason 
as to why it is such a strong inhibitor of CPP entry rather than being a specific
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inhibitor of macropinocytosis. During these studies, I also identified some 
rather unexpected findings regarding the role of action or the effects of CytD 
on uptake of dextran. Rather than finding an inhibition in uptake I found that 
the drug increased uptake of several variants of this probe but a search of the 
literature identified other examples of this (Gold et al. 2010; Song and Schmid 
2003). This may be due to its effects on recycling but more work on other cell 
lines is required to better understand the mechanism by which it is doing this 
and these are underway.
The project finally moved to look at the capacity of R8 to internalise a much 
larger cargo into cell namely EGFP. Time did not allow for extensive studies 
here and progress was much slower due to the fact that the protein had to be 
purified from E. Coli before it could be loaded on to cells. In order to compare 
R8-fluorophore uptake with R8-protein uptake it was decided to keep the 
extracellular concentration at 2pM. However in my hands uptake of the protein 
at this concentration was difficult to detect using both microscopical methods 
and more quantifiable methods. However the use of the Typhoon analyser 
showed that the intact protein could be detected in cells thus allowing for the 
future developments of an assay that not only measures uptake but also 
degradation. This could be performed by combining detection systems 
measuring fluorescence of EGFP and also EGFP (whole and degraded) using 
an antibody and ECL. Overall however though there was evidence that the 
method could be used to show again that CytD affected uptake time did not 
allow for a screen of the siRNAs and pathways that were developed for 
investigating peptide uptake.
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The methods developed in this thesis have already revealed some very 
important issues relating to the uptake of CPPs but the hope is that they can 
now be used to prepare a manuscript and then study a host of other drug 
delivery systems. This would be to gain a better understanding of their mode of 
internalisation, intracellular traffic and endosomal escape thus allowing them 
easier progression from the laboratory to the clinic.
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siRNA Inhibition of Endocytic Pathways for Studying Cellular 
Uptake of Cell Penetrating Peptides:
Al-Sorai M: Watkins C; Jones A T
Welsh School o f  pharmacy, Redwood Building, King Edward VII Avenue, Cardiff, 
Wales, UK, CF10 3NB
Plasma membrane represents an impermeable barrier for most 
macromolecules, however, some peptides such as cell-penetrating 
peptides (CPPs) translocate cells efficiently, but the mechanism of entry 
is still unresolved. Of particular interest, they are able to deliver cargoes 
up to 100 times their own size. It has been shown that different 
endocytic pathways contribute to the import of these molecules, for 
example clathrin-mediated endocytosis (CME), macropinocytosis and 
cavoelae-mediated endocytosis. In this study, we have used RNA 
interfering tool to silence endocytic pathways by knocking down 
proteins, such as clathrin heavy chain (CHC), to investigate the 
mechanism of the uptake of arginin peptide (R8) and Tat peptide. 
Different incubation periods were tested for both R8 and TAT. Alexa- 
488 Transferrin was used as a marker for CME, since its uptake is 
predominately via CME a reduction in cell associated fluorescence 
would indicate successful transfection.
2- Poster Abstract for the 3th Intracellular Delivery of Therapeutics 
Molecules: From Bench to Bedside Montpellier, France, August 
31st - September 2nd 2009 (PRIZE WINNER)
siRNA Inhibition of Endocytic Pathways for Studying Cellular 
Uptake of Cell Penetrating Peptides
Monerah H. Al-Sorai1. Catherine L. Watkins1, Dries Vercauteren2, Stefaan De 
Smedt2, and Arwyn T. Jones1
1 Welsh School o f Pharmacy, Cardiff University, Cardiff, Wales,CF10 3NB 
2Laboratory o f General Biochemistry & Physical Pharmacy, Ghent University, 
Harelbekestraat 72 (2ndfloor), B-9000 Ghent, Belgium
Cell-penetrating peptides (CPPs) have the potential to deliver several 
different types of therapeutic macromolecules into cells including 
peptides, proteins, and nucleic acids. Endocytosis is thought to be of 
significant importance for allowing access of CPP-cargo molecules but 
there is currently little consensus regarding the exact uptake mechanism 
used by different CPPs. A single cell can endocytose via multiple 
pathways and uptake of CPPs has been documented to occur through 
clathrin coated vesicles, cavaeolae and via macropinocytosis. This work 
aims enhance the use of cell penetrating peptides as intracellular 
delivery vectors by further characterizing their uptake mechanisms and 
the contribution of endocytosis to this. Traditionally the uptake of CPPs 
and other drug delivery vectors has been performed using chemical 
inhibitors of endocytosis but these lack specificity and can be toxic. In 
this study, we have used siRNA technology to silence critical endocytic 
proteins such as clathrin heavy chain, flotillin-1 and dynamin isoforms 
to inhibit distinct endocytic pathways. The success of this approach is 
dependent on depleting cells of specific proteins but also on identifying 
marker proteins whose uptake is limited to one specific pathway and a 
series of experiments have been performed to better define markers for 
alternative pathways to that regulated by clathrin. Our data shows that 
siRNA could effectively deplete expression of clathrin heavy chain, 
flotillin-1 and dynamin II but whereas uptake of markers such as 
transferrin was reduced in some of these cells the uptake of CPPs 
octaarginine and HIV-TAT was relatively unaffected. Comparative 
analysis of these experiments with those performed using traditional 
endocytosis inhibitors were also performed and highlight the difficulty 
in interpretation of data from these studies compared to siRNA 
depletion. In conclusion, the study demonstrated the usefulness and 
pitfalls of using siRNA technology, compared with endocytosis
inhibitors, to study the internalization of drug delivery vectors and their 
associated cargoes.
3- Paper contribution for the 11th European Symposium on
  _ aL
Controlled Drug Delivery Egmond aan Zee, The Netherlands, 6 - 
9th April 2010.
siRNA Inhibition of Endocytic Pathways for Studying Cellular 
Uptake of Cell Penetrating Peptides.
Monerah H. Al-Sorai1, Catherine L. Watkins1, Dries Vercauteren2, 
Stefaan De Smedt2, Kevin Braeckmans2 and Arwyn T. Jones1 
'Welsh School of Pharmacy, Cardiff University, Cardiff, Wales, UK, CF10 3NB 
laboratory of General Biochemistry & Physical Pharmacy, Ghent University, 
Harelbekestraat 72 (2nd floor), B-9000 Ghent, Belgium
Abstract Summary: The debate, regarding the main mechanism of 
uptake of cell penetrating peptides (CPPs), is still unresolved. Different 
endocytic pathways has been shown to be contributed, for example 
clathrin-mediated endocytosis (CME), macropinocytosis and clathrin 
and cavoelin independent endocytosis. In this study, we have used RNA 
interfering tool to silence different proteins, such as clathrin heavy 
chain (CHC), flotillin-1 and PAK-1 to investigate the mechanism of the 
uptake of arginin-rich peptides such as R8 and HIV-Tat.
Introduction: Cell-penetrating peptides (CPPs) have the potential to 
deliver a host of therapeutic macromolecules into cells including 
peptides, proteins, and nucleic acids. Endocytosis is thought to be of 
significant importance for allowing access of CPP-cargo molecules but 
identifying the uptake mechanisme of different CPPs is still debatable1. 
Multiple pathways has been reported to contribute in CPPs uptake, such 
as clathrin dependent, cavaeolin and clathrin-independent and via 
macropinocytosis2. This work aims enhance the use of cell penetrating 
peptides as drug delivery vectors by investigating and studying their
mechanisms of uptake. Traditionally the uptake of these molecules and 
other drug delivery vectors has been performed using chemical 
inhibitors of endocytosis but there are often toxic and lack specificity3,4.
In this study, we have used siRNA technology to silence critical 
endocytic proteins such as clathrin heavy chain5, flotillin-16 and PAK- 
l 7 to inhibit distinct endocytic pathways.
Experimental Methods: For cell culture HeLa cells and A431 cells 
were grown in DMEM-GlutaMAX-I media containing 10% FBS and 
100 U/ml penicillin and lOOpg/ml streptomycin. 24 hrs prior to 
transfection cells were seeded onto 6- or 12-well plates, and were 50%- 
60% confluent on the day of transfection. Clathrin heavy chain (CHC), 
Flotillin-1 (Flot-1) Caveolin-1 (Cav-1) and P21 -activated kinase 1 
(PAK-1) were depleted using siRNA and siRNA against GFP is used as 
a control. Uptake of endocytic pathways markers and CPPs was 
measured by a FACS Calibur Flow Cytometer. Protein depletion was 
assessed by western blot and 25 pg of protein lysate was loaded in a 10% 
or 11% SDS-PAGE gel. CHC, flot-1, Cav-1, PAK-1 and oc-tubulin was 
detected by enhanced chemiluminescence using anti-CHC and anti-flot- 
1 (BD Biosciences) , anti-Cav-1 (Cell signalling), anti-PAK-1 
(Santacruz) and anti-oc-tubulin (Sigma) antibodies respectively 
followed by HRP conjugated secondary antibody (Pierce).
Results and Discussion: The success of this approach is dependent of 
identifying marker proteins whose uptake is limited to one specific 
pathway and a series of experiments have been performed to better 
define markers for alternative pathways to that regulated by clathrin. 
Our data shows that siRNA could effectively deplete expression of 
clathrin heavy chain, flotillin-1 and PAK-1 but whereas uptake of 
markers such as transferrin was reduced in some of these cells the 
uptake of CPPs octaarginine and HIV-TAT was relatively unaffected. 
Moreover, depleting flotillin-1 shows 30-35% inhibition in the uptake 
of anti-CD59 antibody, which was used as a marker for flotillin-1
dependent uptake6 and no inhibition has been found in R8 uptake. 
Comparatively, the uptake of R8 and HIV-Tat shows a dependency on 
PAK-1, whereas depleting PAK-1 has no effect on fluid phase 
endocytosis of FITC-Dextran. The results also show depleting PAK-1 
inhibits the increase in the uptake of FITC-Dextran following EGF 
ruffling stimulation in A431 cells. Comparative analysis of these 
experiments with those performed using traditional endocytosis 
inhibitors were also performed, and the results show that the uptake of 
R8 is inhibited following actin depolymerization with cytochalasin D. 
Whereas, no effect has been shown following chlorpromazine, and 
EIPA treatment.
Conclusion: The study aimed to determine the requirement for CHC, 
flot-1 and PAK1-dependent endocytosis in the uptake of CPPs that are 
of interest as vectors for intracellular delivery of therapeutic 
macromolecules. The data shows that clathrin mediated and flotillin-1 
dependent endocytosis are not the main route of internalization for 
Alexa-488-R8 peptide and contradicts previous studies using endocytic 
inhibitors . On the other hand, the cellular uptake of R8 and Tat peptide 
is reduced by 25% by depleting PAK-1. Similar methods of targeting 
other endocytic proteins that regulate alternative uptake routes can now 
be utilized to further study CPP uptake. These will also provide us with 
tools to study the uptake of other candidate drug delivery vectors. In 
conclusion, the study illustrates the usefulness of using siRNA 
technology, compared with endocytosis inhibitors, to study the 
internalization of CPPs and their associated cargoes.
Paper contribution for the 3rd International Cellular Delivery of 
Therapeutic Macromolecules Symposium (CDTM) 26th- June -  29th 
June 2010, Welsh School of Pharmacy, Cardiff University, UK.
Monerah H. Al-Sorai1. Catherine L. Watkins1, Dries Vercauteren2, 
Stefaan De Smedt2, Kevin Braeckmans2 and Arwyn T. Jones1
1 Welsh School o f Pharmacy, Cardiff University, Cardiff, Wales, UK, CF10 3NB 
2Laboratory o f General Biochemistry & Physical Pharmacy, Ghent University, 
Harelbekestraat 72 (2ndfloor), B-9000 Ghent, Belgium
Cell-penetrating peptides (CPPs) have the potential to deliver numerous 
therapeutic macromolecules into cells including peptides, proteins, and 
nucleic acids. Under defined conditions endocytosis is thought to be of 
significant importance for CPP entry but identifying the exact uptake 
mechanism and pathway(s) involved has been difficult. Multiple 
pathways have been reported to contribute to uptake, including 
macropinocytosis and those regulated by clathrin and cavaeolin-1. This 
project aims enhance the use of cell penetrating peptides as drug 
delivery vectors by developing new technologies to study their 
mechanisms of uptake. Traditionally studies investigating the uptake of 
these molecules, and other drug delivery vectors, have been performed 
using chemical inhibitors but these are often toxic and lack specificity 
(1). We have developed siRNA-based assays to silence endocytic 
proteins that have previously been shown to regulate distinct endocytic 
pathways. The effect of depleting these proteins was then assessed to 
investigate their roles in mediating the uptake of well characterised 
endocytic probes and CPPs.
Two cell lines were predominantly used, HeLa (cervical cancer 
epithelial) and A431 (human epithelial carcinoma). Endocytic proteins 
clathrin heavy chain, flotillin-1, dynamin II, caveolin-1 and P21- 
activated kinase (PAK-1) were depleted using single siRNA sequences; 
siRNA against GFP was used as a control. In siRNA treated cells the 
uptake of fluorescent endocytic markers including; Alexa488- 
transferrin (Clathrin mediated endocytosis), 40KDa FITC Dextran 
(fluid phase uptake and macropinocytosis), FITC conjugated anti-CD59 
antibody (Flotillin-1 dependent uptake) and the uptake of Alexa488 
CPPs (RRRRRRRRGC-Alexa488-R8, and GRKKRRQRRRPPQ- 
Alexa488-HIV-TAT) were measured by flow cytometry. Protein 
depletion was assessed from protein lysates using SDS PAGE and 
Western blotting.
The overall data shows that siRNA transfection method could 
effectively reduce expression of clathrin heavy chain, caveolin-1 and 
flotillin-1 from HeLa cells and this then allowed for us to study effects 
on endocytosis of various probes. PAK-1 has been shown to regulate 
macropinocytosis and we show that the induction of macropinocytosis 
and PAK-1 expression are highly cell line dependent. Paralleled with 
this was our findings that cationic CPPs induce an increase in fluid 
phase uptake of dextran and the extent of this was cell line dependent. 
Comparative analysis of these experiments with those performed using 
pharmacological inhibitors, allowed us to determine the usefulness of 
this approach for drug delivery research.
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Fig. 2. Partide size and zeta potential of complexes of siRNA with SS-PAA copolymers 
having various w-hydroxyalkyl chains, as determined by DLS.
None of the polym ers are toxic during the transfection. This w as 
derived from the  rem aining luciferase expression after treatm ent w ith  
non coding siRNA com plexes (Fig. 3b). To zoom in on the cytotoxicity of 
the m aterials, H1299 Fluct cells w ere treated  for 2 h (sim ilar to 
transfection protocol) w ith  polym er solutions of concentrations ranging 
from 1.5 to 800 p g /m l and tw o days later their proliferation w as 
m easured using XTT (Fig. 4a). All polym ers show a similar toxicity 
profile, except for the  ABOL polymer, w hich is tolerated by the cells up to 
m uch higher concentrations. The toxicity may be related to the ability to 
lyse the m em brane of the  cells; therefore the hemolytic activity of the 
polym ers w as investigated  against hum an erythrocytes (Fig. 4b). 
Although the  total lysis is relatively low, increasing hydrophobicity 
leads to m ore disruption of th e  lipid m em brane. This is best represented 
at the highest polym er concentration. Interestingly, the AHOL polym er 
differs significantly from the o thers in giving m uch higher lysis.
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Fig. 3. Knockdown of firefly luciferase in H1299 Fluct cells in the absence of serum by 
(a) anti-Luc siRNA and (b) non coding siRNA. Luciferase knockdown is corrected for 
the cell viability and Lipofectamine 2000 was used as a positive control.
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Fig. 4. (a) Cell viability of H1299 Fluct cells two days after treatment with polymer 
solutions; (b) hemoglobin leakage from human erythrocytes after 30 min incubation 
in a polymer solution.
Cellular up take is generally favored by (hydrophobic) m em b ran e  
interactions, a lthough  too heavy interactions m ay lead to cell lysis. It 
may be possible th a t AHOL gives an early cytotoxicity by dam aging  
the cell m em brane, w hich  is in accordance w ith  the hem olysis 
experim ent. The cytotoxicity o f the o th er polym ers may be a ttr ib u ted  
to post-endocyto tic  effects, bu t m ore detailed studies are necessary  to 
elucidate these effects.
Conclusion
Five analogous SS-PAAs w ere synthesized w ith  ethylene d iam ine 
in the m ain chain and o>-hydroxyalkyl chain side chains of d ifferen t
chain lengths. All polym ers show ed excellent gene silencing proper­
ties in H I299 Fluct cells. The polym er w ith  the  co-hydroxybutyl side 
chain appeared  to be th e  least toxic gene carrier and is a very 
prom ising m aterial for siRNA delivery in th e  near future.
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Abstract sum m ary
The exact m echanism  by w hich  cell penetrating  peptides (CPPs) 
en te r  cells is still debated . Direct translocation and d ifferent endocytic 
p a thw ays have b een  sh o w n  to  con tribu te , including clath rin - 
m ed ia ted  endocytosis (CME), m acropinocytosis, uptake through 
caveolae and  clathrin  and cavoelin independen t pathw ays. In this 
study, w e show  com parative d ata  from  the  use of siRNA depletion of 
endocy tic  p ro te in s  v ersu s th e  use o f endocy tic  inh ib ito rs to 
investigate the  m echanism  of the uptake of arginine-rich CPPs R8 
and HIV-Tat.
Introduction
C ell-penetrating pep tides (CPPs) have the potential to deliver a 
host o f therapeu tic  m acrom olecules into cells including peptides, 
proteins, and nucleic acids. U nder defined conditions endocytosis is 
though t to be of significant im portance for allowing CPP entry  but 
identifying th e  exact uptake m echanism  and pathw ay(s) involved has 
been  difficult [1 ]. M ultiple pathw ays have been reported  to  contribute 
to uptake, including m acropinocytosis and those regulated by clathrin 
and  cavaeolin [2], This w ork aim s to enhance the use of cell penetrating  
pep tides as drug delivery vectors by investigating and studying their 
m echanism s of uptake. Traditionally studies investigating the  uptake 
of th ese  m olecules and o th er drug  delivery vectors have been 
perform ed using chem ical inhibitors b u t there are often toxicity and 
lack of specificity [3,4]. In this study, w e have used siRNA technology to 
silence endocytic p roteins such as clathrin  heavy chain [5], flotillin-1 
[6] caveolin-1 and PAK-1 [7] th a t have previously been show n to 
regulate  d istinc t endocytic pathw ays. The effects of depleting  these 
proteins w ere  then  assessed to investigate the ir roles in m ediating the 
up take o f CPPs and well characterised  endocytic probes.
Experim ental m ethods
Cell lines HeLa (cervical cancer epithelial) and A431 (hum an 
epithelia l carcinom a) w ere  grow n in DMEM-GlutaMAX-1 m edia 
con tain ing  10% FBS and 100 U/ml penicillin and 100 pg/ml s trep to ­
mycin. 24  h prior to transfection cells w ere seeded onto 6- o r 12-well 
plates, and  w ere 50%-60% confluent on the day of transfection. 
Clathrin heavy chain (CHC), Flotillin-1 (Flot-1) Caveolin-1 (Cav-1) 
an d  P21-activated kinase 1 (PAK-1) w ere depleted  using single siRNA 
sequences; siRNA against GFP w as used as a control. siRNA (50 nM)
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were delivered to cells using Oligofectamine according to manufac­
turers’ recommendations. In siRNA treated cells the uptake of 
fluorescent endocytic markers Alexa488-transferrin (CME), 40 KDa 
FITC Dextran (fluid phase uptake arid macropinocytosis), BODIPY® FL 
C5-ceramide complexed to BSA (caveolin dependent endocytosis), 
FITC conjugated anti-CD59 antibody (Flotillin-1 dependent uptake) 
and Alexa488 CPPs RRRRRRRRGC-Alexa488 (R8), GRKKRRQRRRPPQ- 
Alexa488 (HIV-TAT) was measured by flow cytometry. Protein 
depletion was assessed from protein lysates using SDS PAGE and 
Western blotting using anti-CHC, anti-Flot-1 (BD Biosciences), anti- 
Cav-1 (Cell signalling), anti-PAK-1 (Santa Cruz) antibodies and anti- 
«-tubulin antibody (Sigma); the latter was used as a loading control.
Result and discussion
The success of this siRNA approach to study endocytosis is 
dependent of identifying marker proteins that regulate specific 
pathways and that probes are available to effectively assess uptake 
through a defined pathway. We were successful in depleting clathrin 
heavy chain, caveolin-1 and flotillinl from HeLa cells and this then 
allowed us to study the effects on endocytosis of various probes. We 
find that critical to these studies is performing multiple time point 
experiments as opposed to using a single time point and this is 
especially true if the endocytic probe or vector to be measured is 
recycled — transferrin. The uptake of transferrin was effectively 
inhibited in cells incubated with siRNA targeting CHC and we were 
also able to inhibit uptake of FITC-CD59 antibody in Flot-1 depleted 
cells. But cells depleted of CHC and Flot-1 had normal uptake rates of 
CPPs R8 or HIV-TAT.
PAK-1 has been shown to regulate macropinocytosis and our 
preliminary studies show that the induction of macropinocytosis is 
cell line dependent We find that PAK-1 expression or macropinocy­
tosis is not essential for uptake of these CPPs. Paralleled with this was 
our findings that the well described CPP induced increase in fluid 
phase uptake of dextran was also cell line dependent
We were also unable to see any effect on CPP uptake in cells 
depleted of Cav-1. The involvement of this protein and caveolae in 
mediating uptake of BODIPY® FL C5-ceramide complexed to BSA was 
also analysed thus testing its suitability as a probe for uptake via 
caveolae.
Comparative analysis of these experiments with those performed 
using traditional endocytosis inhibitors was also performed and the 
results show that CPP uptake is inhibited by approximately 50% 
following actin depolymerization with cytochalasin D. In line with the 
siRNA data there was however no effect on uptake using the 
macropinocytosis inhibitor EIPA or chlorpromazine, an inhibitor of 
CME.
Conclusions v
The study aimed to determine the requirement for distinct 
endocytic pathways in the uptake of CPPs that are of intense interest 
as vectors for intracellular delivery of therapeutic macromolecules. The 
data shows that macropinocytosis, clathrin mediated and flotillin-1, 
caveolin-1 dependent endocytosis are not the main routes of 
internalization for two cationic variants R8 and HIV-TAT. However 
specifying a requirement for a particular endocytic protein for 
mediating the uptake of a defined probe is not a trivial undertaking 
for a number of less well characterised pathways. Our studies continue 
to assess the roles for endocytic proteins regulating alternative uptake 
routes such that these methods can be utilized to further study CPP 
uptake. These technologies will also provide us with a mechanism to 
study in more detail the uptake of other candidate drug delivery 
vectors. In conclusion, the study illustrates the usefulness of using 
siRNA technology, compared with endocytosis inhibitors, to study the 
internalization of CPPs and their associated cargoes.
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Abstract summary
Here we apply a recently proposed programmed packaging 
strategy to develop a novel multicomponent envelope-type nano­
particle system (MENS). To this end, we took specific advantage of 
using multicomponent liposomes that have recently exhibited 
intrinsic endosomal rupture properties that allow plasmid DNA to 
escape from endosomes and to enter the nucleus with extremely 
high efficiency. Transfection efficiency experiments on N1H 3T3 
mouse fibroblasts indicate that MENS is a promising transfection 
candidate.
Introduction
Non-viral DNA delivery systems have been developed to facilitate 
gene entry into mammalian cells. The cell presents multiple barriers 
to DNA/vector complexes en route to the nucleus. Very early steps in 
the transfection process involve binding of the vector to the cell 
surface and its internalization via multiple mechanisms. Once in the 
cell, plasmid DNA must be able to escape endosomal trafficking. If 
DNA is not released from endosomes, it is shuttled to the lysosomes, 
where it is degraded by the abundant nucleases and transfection may 
fail. An efficient nanocarrier should therefore incorporate different 
functional devices, but it is difficult to integrate them into a single 
system and to have each function exerted at the appropriate time and 
correct place. Recently, a new programmed packaging concept in 
which various tools that control intracellular trafficking are packed 
into single nanoparticles has been proposed [1 ]. Here we apply such a 
novel strategy to develop a multicomponent envelope-type nano­
particle system (MENS) for overcoming intracellular membrane
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50% silencing efficiency w hereas incubation w ith pHPMA-MPPM and 
TMC polyplexe m ade at N/P ratios of 8 and 16 showed 30-40% gene 
silencing. Incubation of cells w ith branched PEI polyplexes led to 25-30% 
silencing of luciferase. The XTT cell viability assays show low cytotoxicity 
of the polym er complexes (except PE 1) made at an N/P ratio of 8 (less 
than  15%) and by increasing the N/P ratio to 16, cytotoxicity level is 
increased. In the case of pDMAEMA, pHPMA-MPPM and TMC the 
cytotoxicity of the polyplexes a t the N/P ratio of 16 is about tw o folds 
higher than  the N/P ratio of 8 which is correlated to the  increased 
concentration of the polymers in the formulations and subsequently in 
the culture m edium  (Fig. 5).To facilitate the endosomal release of the 
siRNA complexes, photochemical internalization (PCI) was applied. PCI is 
a technique based on the  use of a photosensitizer that photochemically 
destabilizes endosom al m em branes after illumination (6]. By application 
of PCI, the silencing efficiency of the pDMAEMA polyplexes m ade a t N/P 
ratios of 8 and 16 increased up to 70% and 60% respectively w hereas for 
both N/P ratios of 8 and 16, the silencing efficiency of the pHPMA-MPPM 
and TMC—33% polyplexes increased up to 70% and 80% respectively.
The gene silencing efficiency of PEI polyplexes, after application of 
PCI show ed a slight increase (5%) w hich is not significant and is probably 
due to the  intrinsic endosom olytic properties of PEI w hich m akes it 
independent o f PCI [7]. In the case of lipofectamine, the silencing 
efficiency of the com plexes increased up to 60% after application of PCI 
(Fig. 4). These results show  th a t biodegradable polym ethacrylates and 
TMC polym ers are m uch m ore in favor of PCI as an endosom e disruptive 
technique. For all form ulations, th e  observed increase in gene silencing 
efficiency w as not due to PCI-associated cytotoxicity (Fig. 5).
Fig. 4. Luciferase gene silencing after incubation of H1299 cells with polyplexes in 
medium without serum, with and without application of PCI (mean ±  standard 
deviation (n =  3)).
Fig. 5. Cell viability as measured by XTT assay after incubation of siRNA complexes in 
medium without serum with and without application of PG (mean ±  standard 
deviation (n =  3)). In all formulations, the left and the right bars show the silencing 
efficiency without and with PCI respectively.
Conclusion
B iodegradable pHPMA-MPPM and TMC (33%) polym ers are 
efficient and safe vectors for siRNA delivery and gene silencing, 
w hich  by facilitating th e ir  endosom al escape, show  a prom ising gene 
silencing efficiency.
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Abstract sum m ary
In vitro endocytosis o f gene com plexes com posed of a bioreducible 
polyam idoam ine CBA ABOL and  plasm id DNA, in cells of the retinal 
p igm ent ep ithelium  (RPE) w as studied, the latter being an interesting 
targ e t for ocular gene therapy. We found th a t cationic CBA ABOL DNA 
polyplexes a ttach  to cell surface proteoglycans of these RPE cells and 
g et subsequently  in ternalized  via a phagocytosis-like m echanism , as 
w ell as Flotillin d ep en d en t endocytosis.
In troduction
P roper delivery of th erap eu tic  genes to designated cells and the ir 
availability a t th e  in tracellu lar site o f action are crucial requirem ents 
for successful gene therapy. To th is end, typically sub-m icron sized 
particles are m ade by com bining th e  therapeutic genes w ith  a carrier 
m aterial, such as cationic polym ers, th a t aid in delivering the genes to 
the  ta rg e t site. In this w ork, for th e  first time, w e have evaluated the 
ability  o f th e  highly prom ising bioreducible polym er carrier cystam in 
b isacrylam id am inobutanol (CBA ABOL) [1] (Fig. 1) to deliver plasm id 
DNA in cultu red  cells o f th e  retinal pigm ent epithelium  (ARPE-19) 
and  characterized  in vitro th e  cellular interactions w ith  these  target
elOO Abstracts /  Journal o f Controlled Release 148 (2010) e85-e!01
cells. These studies are of crucial importance since the further design 
and functionalization of polymeric gene carriers depend strongly on 
our understanding of the mechanisms involved in cellular adhesion, 
intracellular uptake and intracellular processing of the polyplexes.
Experimental methods
ARPE-19 cells (retinal pigment epithelial cell line; ATCC number CRL- 
2302) were cultured in DMEM:F12 supplemented with 10% fetal bovine 
serum, 2 mM 1-glutamine, and 2% penicillin-streptomycin. All cells were 
grown at 37 °C in a humidified atmosphere containing 5% C02. CBA ABOL 
gene complexes with an average hydrodynamic diameter of 130 nm and 
an average zeta potential of +45 mV in 20 mM HEPES buffer were 
obtained by adding the polymer in a mass ratio of 48/1 in 20 mM HEPES 
to the plasmid and vortexing the mixture for lOmin. For every 
transfection, fresh polyplexes were prepared and applied to the cells 
within 30 min after complexation. For all uptake studies, YOYO-1 ™ 
( \ ex=491 nm, \e m=509 nm, Molecular Probes, Merelbeke, Belgium) 
labeled pGL4.13 plasmid (Promega, Leiden, The Netherlands) was used. 
For all transfection studies, gWiz™GFP plasmid (Aldevron, Freiburg, 
Germany) was used. siRNAs were all purchased from pharma con and 
transfected in cells with the help of LipofectaminRNAiMAX (Invitrogen, 
Merelbeke, Belgium). Protein knockdown was assessed on Western Blot. 
Uptake of polyplexes or endocytic markers or GFP expression was 
measured on a FACS Calibur Flow Cytometer (Beckton Dickinson, 
Erembodegem, Belgium). For genetic labeling of endosomes, cells were 
transfected with GFP-fusion proteins.
For fluorescence colocalization studies with GFP labeled cellular 
structures, cells were transfected with GFP-fusion proteins using 
Lipofectamin2000 (Invitrogen, Merelbeke, Belgium) and 24 h later 
exposed to red fluorescent labeled polyplexes. For this, CBA ABOL was 
complexed with pGL4.13 plasmid, covalently labeled with Cy5 (Label IT 
Nucleic Acid Labeling Kit, Mirus Bio Corporation, Wl, USA). Live cell 
fluorescence colocalization was then performed on a custom built laser 
epi-fluorescence microscope set-up. A Nikon Plan Apo VC lOOx 1.4 NAoil 
immersion objective lens (Nikon Belux, Brussels, Belgium) was used for 
imaging. GFP and Cy5 were excited with 491 nm and 636 nm laser light 
and emission was detected on an EMCCD camera (Roper Scientific, 
Nieuwegein, The Netherlands). For live cell imaging the cells were placed 
in a stage top incubation chamber (Tokai Hit, Shizuoka, Japan), set at 37 °C, 
5% C02 and 100% humidity.
Result and discussion
First, we found evidence that these net positively charged CBA 
ABOL polyplexes adhere to the negatively charged heparan sulfate 
proteoglycans (HSPGs) at the cell surface and that polyplex 
internalization is blocked by antibodies against Toll-like receptor 9.
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Fig. 1. Comparison of transfection efficacy of different gene delivery vehicles carrying the GFP 
reporter gene in ARPE-19 cells. Cells were incubated for 2 h in OptiMEM with different gene 
carriers: Lipofectamin2000, CBA ABOL Exgen500 (linear PEI) and Adeno Associated Virus 
(AAV). Transfection analysis was performed 24 h later with flow cytometry. The square data 
points represent the percentage of transfected (GFP expressing) cells, the grey bars represent 
the amount of expression (average GFP fluorescence intensity) per cell. It appears that the 
performances for CBA ABOL in RPE cells are in.these conditions competitive to ExgenSOO and 
AAV mediated transfection and even with Lipofectamin2000 lipofection.
Second, in an extensive study on the characterization of the endocytic 
pathways that are involved in the cellular internalization of these 
polyplexes, we learned by the use of endocytic inhibitors [2] that 
polyplex uptake is for a large part very similar to the uptake of Escherichia 
coli, which indicates a substantial contribution by phagocytosis. We also 
learned from these studies that clathrin dependent endocytosis is not 
involved and that the internalization of polyplexes is highly dependent 
on actin, dynamin, cholesterol and tyrosine kinase activities. In a 
complementary study, where we used RNAi to knock down specific 
key endocytic proteins, not only we could confirm that polyplex uptake is 
independent of clathrin, but also of Caveolin-1, ArfB, PAK1 and GRAF-1. 
On the other hand we did find a dependency on Dynamin-2 and Flotillin- 
1. This indicates that, next to phagocytosis, probably a second endocytic 
pathway dependent on Flotillin-1 [3] is involved, which is in agreement 
with what has been reported for gene complexes based on the polymer 
polyethylenimine [4]. Finally, using live-cell dual colour fluorescence 
colocalization microscopy, we could confirm the involvement of Flotillin 
during polyplex internalization at early time-points while no colocaliza­
tion was found with Caveolin-1 containing vesicles.
Conclusion
In conclusion, we learned by combining three different methodological 
approaches that these polyplexes stimulate their own cellular uptake and 
are rapidly internalized in RPE cells via two endocytic pathways, being 
Flotillin mediated endocytosis and phagocytosis. We would like to note 
that this conclusion was only possible by combining the use of chemical 
inhibitors, siRNA downregulation of essential endocytic proteins and live 
cell colocalization microscopy. By getting a detailed insight into the uptake 
and subsequent intracellular processing of these polyplexes, we want to 
provide the knowledge necessary for a further rational optimization of the 
design and composition of this polymer carrier.
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C ell-penetra ting  p e p tid e s  (CPPs) have 
th e  p o te n tia l to  de liver n u m ero u s  th e ra ­
p e u tic  m acro m o lecu les  in to  cells inc lud ing  
p e p tid e s , p ro te in s, a n d  nucleic  acids. U nder 
d e fin e d  co n d itio n s  en d o cy to sis  is th o u g h t  to  
b e  o f  s ign ifican t im p o r tan c e  for CPP e n try  b u t 
iden tify ing  th e  ex ac t u p ta k e  m ech an ism  a n d  
pathw ay(s) involved has b e en  difficult. M ultiple 
p a th w ay s have  b e e n  re p o rte d  to  c o n tr ib u te  
to  up take , inc lud ing  m acrop inocy tosis  a n d  
th o s e  re g u la te d  by  c la th rin  a n d  cavaeo lin -1 . 
This p ro je c t a im s e n h a n c e  th e  use  o f  cell p e n ­
e tra tin g  p e p tid e s  as d ru g  delivery  v ec to rs  by 
d e v e lo p in g  n ew  te c h n o lo g ies  to  s tu d y  th e ir  
m ech an ism s  o f u p tak e . Traditionally s tu d ie s  
in v estigating  th e  u p ta k e  o f  th e se  m olecules, 
a n d  o th e r  d ru g  delivery  vectors, have b e en  
p e rfo rm ed  using  chem ical inh ib ito rs  b u t 
th e s e  a re  o f te n  toxic a n d  lack specificity [1].
W e have d e v e lo p ed  siRNA-based assays to  
s ilence  e n d o cy tic  p ro te in s  th a t  have previously  
b e e n  sh o w n  to  reg u la te  d is tin c t e n d o cy tic  
p a th w ay s. The e ffec t o f  d e p le tin g  th e s e  p ro ­
te in s  w as th e n  a sse ssed  to  in v estig a te  th e ir  
ro les in m e d ia tin g  th e  u p tak e  o f well ch a rac ­
te rised  e n d o cy tic  p ro b es  a n d  CPPs. Two cell 
lines w e re  p re d o m in an tly  used , HeLa (cervical 
c an ce r ep ithelia l) a n d  A431 (hum an  e p ith e ­
lial carcinom a). Endocytic p ro te in s  cla th rin  
heavy  chain , flotillin-1, d y n am in  II, caveolin- 
1 an d  P 21-ac tiva ted  k inase  (PAK-1) w ere  
d e p le te d  u sing  sing le  siRNA seq u en ces ; siRNA 
ag a in s t GFP w as u sed  as a con tro l. In siRNA 
tre a te d  cells th e  u p tak e  o f  flu o rescen t e n d o ­
cytic m arkers includ ing ; A lexa488-transferrin  
(clathrin  m e d ia te d  endocy tosis), 40  kDa FITC 
D extran  (fluid p h a se  u p ta k e  a n d  m acrop inocy ­
tosis), FITC c o n ju g a te d  anti-C D 59 an tib o d y  
(flotillin-1 d e p e n d e n t  up tak e) a n d  th e  u p tak e  
o f A lexa488 CPPs (RRRRRRRRGC-Alexa488-R8, 
a n d  GRKKRRQRRRPPQ-Alexa488-HIV-TAT) w ere  
m ea su red  by flow  cy tom etry . P ro tein  d e p le tio n  
w as a sse ssed  from  p ro te in  lysates using  SDS 
PAGE an d  W estern  b lo ttin g . Overall, th e  d a ta  
show s th a t  siRNA tran sfec tio n  m e th o d  cou ld  
effectively red u c e  e x p ress io n  o f  c la th rin  heavy 
chain, caveolin-1 a n d  flotillin-1 from  HeLa cells 
an d  th is  th e n  a llow ed  for us to  s tu d y  effec ts  o n  
en d o cy to sis  o f  various p ro b es . PAK-1 has b e en  
show n  to  re g u la te  m acro p in o cy to sis  a n d  w e 
sh o w  th a t  th e  in d u c tio n  o f  m acrop inocy tosis  
an d  PAK-1 ex p re ss io n  a re  highly  cell line d e p e n ­
d e n t. Paralleled w ith  th is  w as o u r  find ings th a t  
cation ic  CPPs in d u ce  a n  inc rease  in fluid p h ase  
u p ta k e  o f  d ex tra n  a n d  th e  e x te n t o f  th is  w as 
cell line d e p e n d e n t.  C om para tive  analysis o f 
th e se  ex p erim en ts  w ith  th o s e  p e rfo rm ed  using 
pharm aco log ica l inhib itors, a llow ed  us to  d e te r ­
m ine  th e  u sefu lness  o f  th is  a p p ro a ch  for d ru g  
delivery  research .
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The e n d o th e liu m  re p re sen ts  a n  im p o r­
ta n t  th e ra p e u tic  ta rg e t  b e ca u se  its p ivotal 
role in m any  d isea ses  su ch  as ch ron ic  inflam ­
m atio n  a n d  can c e r a n d  its accessib ility  for 
system ic ad m in is tra tio n . RNA in te rfe ren ce  by 
sm all in te rfering  RNA (siRNA) has b e co m e  
in th e  last d e c a d e  a very  pow erfu l too l in 
basic  research , a n d  has h u g e  p o te n tia l to
b e c o m e  a n  im p o r tan t new  class o f  th e ra ­
p eu tic s  fo r h u m an s. However, d u e  to  th e ir  
size a n d  ch arg e , siRNAs have n o  b ioavailab il­
ity to  e n te r  u n p e r tu rb e d  cells. To o v e rco m e  
th is  p ro b le m , o u r lab o ra to ry  d e v e lo p e d  a 
non-viral lip id -based  ta rg e tin g  d ev ice  w hich  
e fficiently  a n d  specifically delivers siRNA in to  
e n d o th e lia l cells. M olecular d e te rm in a n ts  
e x p re sse d  o n  th e  su rface  o f in flam m ation- 
a c tiv a ted  e n d o th e lia l cells, like certa in  a d h es io n  
m o lecu les  a n d  rec ep to rs  involved in e n d o ­
cytosis, a re  ex ce llen t c a n d id a te s  to  increase  
c a rrie r-m ed ia ted  siRNA u p tak e . T herefore  
w e  co n ju g a ted  m o n o c lo n a l anti-E -selectin  
a n tib o d ie s  to  th e  ca tio n ic  am p h ip h ilic  lipid, 
1-m ethyl-4-(cis-9-d io leyl)m ethyl-pyrid in ium - 
ch lo ride  (SAINT-18) w h ich  w as  co m p lex ed  
in a 1:2000 m o lar ra tio  w ith  th e  tra n sfec ­
tio n  a g e n t  SAINT-MIX (SAINT:DOPE, 1:1), a n d  
siRNA, resu lting  in a siRNA c o n ta in in g  lipoplex 
called  anti-E-selectin-SAINTarg [1]. O ur findings 
d e m o n s tra te  th a t  anti-E-selectin-SAINTargs 
m a in ta in ed  th e  a n tig e n  rec o g n itio n  capac ity  o f 
th e  p a ren ta l a n tib o d y  a n d  s h o w e d  increased  
siRNA u p ta k e  in o th e rw ise  d ifficu lt-to -transfec t 
p rim ary  h u m an  um bilical ve in  en d o th e lia l 
cells (HUVEC) as  c o m p a re d  to  n o n -ta rg e te d  
SAINT-MIX. M oreover, anti-E-selectin-SAINTargs 
su p erio r b in d in g  a n d  u p ta k e  efficiency w as cor­
ro b o ra te d  by  im p ro v ed  silencing  o f  b o th  g e n e -  
a n d  p ro te in  ex p ress io n  o f  V E-cadherin in acti­
v a te d  HUVEC. T he V E-cadherin g e n e  expression  
cou ld  b e  silenced  u p  to  95%  by V E-cadherin 
specific siRNA, a t  low  siRNA co n ce n tra tio n s  
(3 0 p m o l/m l). F u rth erm o re , n o  non-specific  
silencing  by scram b led  o r  V E-cadherin sp e ­
cific siRNA w as o b se rv ed . To o p tim ize  siRNA 
delivery  in to  a c tiv a te d  en d o th e lia l cells w e 
a lso sy n th esized  anti-VCAM-1-SAINTargs w hich  
w ere  a s  e ffic ien t in V E-cadherin silencing as 
anti-E-selectin-SAINTargs. B ecause o f  th e  h e t­
e ro g e n e o u s  ex p re ss io n  o f  ad h es io n  m o lecu les 
o n  in flam m atio n -ac tiv a ted  e n d o th e lia l cells 
in vivo, a c o m b in a tio n  o f  th e se  tw o  SAINTargs 
m ay resu lt in e n h a n c e d  siRNA effects. Taken 
to g e th e r , SAINTargs d e m o n s tra te  specific a n d  
effic ien t ta rg e tin g  to  in flam m ation -ac tiva ted  
d ifficu lt-to -transfec t prim ary  en d o th e lia l cells 
a n d  resu lts  in s tro n g  siRNA specific g e n e  silenc­
ing a t  low  siRNA co n cen tra tio n s .
Reference
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Extensive research is currently performed on designing safe and efficient non-viral carriers for gene delivery. 
To increase their efficiency, it is essential to have a thorough understanding of the mechanisms involved in 
cellular attachment, internalization and intracellular processing in target cells. In this work, we studied in 
vitro the cellular dynamics of polyplexes, composed of a newly developed bioreducible poly(amido amine) 
carrier, formed by polyaddition of N,N-cystamine bisacrylamide and l-amino-4-butanol (p(CBA-ABOL)) on 
retinal pigment epithelium (RPE) cells, which are attractive targets for ocular gene therapy. We show that 
these net cationic p(CBA-ABOL)/DNA polyplexes require a charge-mediated attachment to the sulfate groups 
of cell surface heparan sulfate proteoglycans in order to be efficiently internalized. Secondly, we assessed the 
involvement of defined endocytic pathways in the internalization of the polyplexes in ARPE-19 cells by using 
a combination of endocytic inhibitors, RNAi depletion of endocytic proteins and live cell fluorescence 
colocalization microscopy. We found that the p(CBA-ABOL) polyplexes enter RPE cells both via flotillin- 
dependent endocytosis and a PAK1 dependent phagocytosis-like mechanism. The capacity of polyplexes to 
transfect cells was, however, primarily dependent on a flotillin-1-dependent endocytosis pathway.
© 2011 Elsevier Ltd. All rights reserved.
1. Introduction
Efficient delivery of therapeutic nucleic acids into designated 
cells and subsequent availability at the intracellular site of action 
are crucial requirements for successful gene therapy. It is generally 
accepted that gene carriers are internalized through endocytic 
vesicles which are then trafficked to other regions of the cell. Thus, 
the mechanisms that direct cell attachment, endocytosis, intracel­
lular trafficking and release of the nucleic acids from the carrier 
strongly determine transfection efficiency. Most of these processes 
are generally dictated by the nature of the gene carrier. It is known 
that for non-viral gene delivery vehicles both cellular entry and 
intracellular release of therapeutic nucleic acids is significantly less 
efficient compared with viral vectors, and non-viral gene therapy 
thus generally suffers from low transfection efficiencies [1]. They 
are, however, attractive alternatives to viral carriers, because they 
are safer to use, are less immunogenic, can be more easily
* The work is done in Chent, Belgium.
* Corresponding author. Tel.: -t-32 (0) 9/2648098; fax: +32 (0) 9/2648189. 
E-mail address: kevin.braeckmans@UCent.be (K. Braeckmans).
0142-9612/$ — see front m atter © 2011 Elsevier Ltd. All rights reserved. 
doi:10.1016/j.biomaterials.2010.12.045
chemically modified and are easier to produce at large-scale. In 
order to design safe and efficient non-viral carriers for gene 
delivery, we need a better understanding of the mechanisms 
involved from cell uptake to intracellular fate. In this respect, cell 
surface targets need to be identified and evaluated to improve cell 
attachment and vector internalization to deliver the gene through 
transfection-efficient pathways. This knowledge will allow further 
improvements in the design and functionalization of the delivery 
vehicle with the intention of developing target-specific, effective 
and safe carriers for nucleic acid delivery.
Currently, the mechanisms behind the cellular processing of 
non-viral gene complexes remain poorly understood since the 
highly dynamic character of these processes makes these studies 
very complex. In addition, the interaction between the target cell 
and the gene complex might be highly cell-type specific for the type 
of particle being studied. Therefore, little consistency is found in 
the scientific literature. The situation is further complicated due to 
the fact that a single cell can harbor a number of different endocytic 
pathways and because of interconnections and interdependences 
between these endocytic processes. However, a common endocy­
tosis classification based on recent reviews distinguishes phagocy­
tosis, macropinocytosis, clathrin-dependent endocytosis (CDE) and
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clathrin-independent endocytosis (CIE) [2]. Phagocytosis is char­
acterized by the engulfment of large solid particles of at least 1 pm in 
size, typically restricted to specialized cells such as macrophages. 
Macropinocytosis is an induced and transient bulk internalization 
process, that is typically characterized by the formation of 
membrane ruffles and the engulfment of large volumes of fluid and 
membrane into large uncoated vacuoles [3,4]. In addition, some cell 
types like immature dendritic cells and macrophages exhibit 
constitutive macropinocytosis, constantly surveying their environ­
ment for foreign material [4]. Possibly the best-studied endocytic 
pathway to date is CDE, which is characterized by the formation of 
clathrin-coated pits [5]. CIE includes several pathways which all 
share a dependency on cholesterol [6]. Some of the currently known 
CIE pathways are caveolin mediated endocytosis (Cav-ME) [7], flo­
tillin mediated endocytosis (Flot-ME) [8], and the pathway clathrin- 
independent carriers - GPl-enriched endocytic compartments 
(CLIC/GEEC) [9]. It is clear from recent literature that the use of 
different endocytic routes is strongly dependent on the cell type, 
gene carrier and nucleic acid [10—12]. It is also becoming apparent 
that some endocytic pathways will allow a higher transgene 
delivery and thus efficiency of transfection than others. For example, 
polyplex uptake is reported to occur via MP, CDE as well as via CIE 
[13—15]. And although no consensus yet exists on the description of 
the exact endocytic pathway that would lead preferentially to 
transfection, some reports seem to agree that CDE is less preferable 
for polyplex mediated gene transfer [12,16-18].
Studying endocytic pathways is typically done by attempting to 
selectively inhibit different endocytic pathways and then quanti­
fying the remaining internalized gene complexes. These studies are 
often carried out with the help of pharmaceutical endocytic 
inhibitors [19,20]. However, due to problems of low specificity, 
alternative methods such as RNA interference (RNAi), transfection 
of cells with mutant proteins and fluorescence colocalization 
microscopy have been employed as alternative tools [14]. In this 
work we have combined these approaches to study endocytosis of 
a polymeric carrier in retinal pigment epithelium (RPE) cells. These 
cells form in vivo a monolayer of highly specialized cells, interposed 
between the neurosensory retina and the choroid [21 ]. This light- 
absorbing epithelium functions as a blood-retina barrier, regulating 
the transport of nutrition to the retina [21 ]. RPE cells are attractive 
targets for ocular gene therapy because they are involved in several 
ocular genetic defects such as retinitis pigmentosa and choroidal 
neovascularization (e.g. AMD) which could conceivably be cured by 
altering the expression profile in these cells [22,23]. The polymeric 
vector in this study is p(CBA-ABOL), a linear poly(amido amine) 
with repetitive disulfide linkages in the main chain, prepared by 
Michael-type polyaddition of 4-aminobutanol (ABOL) to N,N'-cys- 
taminebisacrylamide (CBA) [24]. This polymer contains tertiary 
amines that are partially protonated around physiological pH, 
which makes the polymer positively charged and suitable to form 
positively charged polyplexes by electrostatic interaction with 
anionic nucleic acids. The disulfide bonds in the polymeric back­
bone are prone to rapid cleavage into sulfhydryl groups once the 
polymer has arrived in the reductive intracellular environment 
due to the presence of thioredoxin reductases and high glutathione 
concentrations. This identifies this polymer as a “bioreducible 
polymer” that is rapidly degraded in the intracellular milieu, 
thereby releasing the DNA from the polymer/DNA complex [25].
The purpose of this work was to gain insight into the mechanisms 
of attachment and internalization of p(CBA-ABOL)/DNA polyplexes 
in ARPE-19 cells. We initially evaluated the transfection efficacy and 
uptake kinetics of p(CBA-AROL) polyplexes in primary RPE cells and 
ARPE-19 cells and also investigated the attachment of the poly­
plexes to RPE cells. Secondly, we studied endocytic uptake of p(CBA- 
ABOL)/DNA polyplexes by using a library of different endocytic
inhibitors. Thirdly, as a complementary strategy, we utilized RNAi to 
downregulate specific proteins that play key roles in endocytic 
processes to block the corresponding endocytic events. Finally, we 
performed fluorescence colocalization microscopy studies to 
confirm association of the polyplexes with endocytic proteins.
2. Materials and methods
2.1. Materials
Heparinase III, trypan blue, Cpz, MpCD, genistein, nocodazole, dynasore, rottlerin, 
Lucifer Yellow CH dilithium salt (LY), (defatted) bovine serum albumin (BSA) and 
sodium chlorate were purchased from Sigma-Aldrich (Bornem, Belgium). Dulbecco's 
modified Eagle’s medium (DMEM), OptiMEM, L-glutamine, fetal bovine serum (FBS), 
penicillin-streptomycin solution (5000 lU/ml penicillin and 5000 pg/ml streptomycin) 
(P/S), and phosphate-buffered saline (PBS) were supplied by GibcoBRL (Merelbeke, 
Belgium). CytoD, human Transferrin (hTf)-AlexaFluor488, BSA-complexed BODIPY FL 
C5-Lactosylceramind (LacCer), Oregon Green labeled 70 kDa dextran and FITC labeled 
Escherichia coli Bioparticles™ (ECs) were purchased from Invitrogen (Merelbeke, 
Belgium). Sequences of siRNAs and manufacturer are given in Supplementary. Table. 1. 
Antibodies against heparan sulfate were purchased from Millipore (Brussels, Belgium). 
Antibodies for W estern blotting are listed in Supplementary. Table. 2. JetPEI™ was 
purchased from Polyplus (Leusden, The Netherlands). Lipofectamin2000™ for gene 
transfection and LipofectaminRNAiMAX™ for transfection of siRNA were purchased 
from Invitrogen (Merelbeke, Belgium). All other reagents were purchased from Sig­
ma—Aldrich (Bornem, Belgium) unless otherwise stated.
22 . Cell culture
ARPE-19 cells (retinal pigment epithelial cell line; ATCC number CRL-2302) were 
cultured in DMEM:F12 supplem ented with 10% FBS. 2 mM L-glutamine, and 2% P/S. 
All cells were grown at 37 °C in a humidified atmosphere containing 5% CO2. Primary 
bovine RPE cells were isolated from fresh bovine eye bulbs and prepared for culture 
as previously described [81], Briefly, after cleaning the fresh eyes from fat, muscle 
and connective tissue, the eye bulb was dissected around the pupil. The lens and 
vitreous liquid were then removed and the remaining eyecup was washed in PBS 
with 4% P/S until the retina detached from the underlying RPE and choroid. After 
removal of the retina, the eyecup was washed twice with 6 ml of 0.25% w/v trypsin 
and 1 mM EDTA in PBS for 30 min at 37 °C to detach RPE cells from the underlying 
choroid. The cells were diluted in cell culture media w ith 20% FBS and after 
centrifugation they were seeded in 25 cm2 culture flasks (SPL Life Sciences, Pocheon, 
Korea). After 24 h of culture, the adherent cells were washed to discard remaining 
blood cells. Primary bovine RPE cells were used between passages 6 and 10. All cells 
were grown a t 37 °C in a humidified atmosphere containing 5% C02-
2.3. Plasmids
The plasmid construct pEGFP-Flot2 was a kind gift from B. Nichols (Cambridge 
University, UK) and pEGFP-Cavl was a kind gift from M. Gumbleton (Cardiff 
University, UK). Plasmids were all transformed in single step (KRX) competent cells 
(Promega, Leiden, The Netherlands) according to the manufacturer's instructions. 
The transformed bacteria were then selected for kanamycin resistance and grown to 
OD of 1.5. The plasmids were isolated with a QlAfilter Plasmid Giga Kit (Qiagen, 
Venlo, The Netherlands) and concentrations determined by UV absorption at 
260 nm. Finally, the plasmids were suspended and stored in 20 mM HEPES, pH 7.4.
For all plasmid uptake studies, pGL4.13 plasmid (Promega, Leiden, The 
Netherlands), labeled with the nucleic acid stain YOYO-1™ ( ^  = 491 nm, 
Aem =  509 nm. Molecular Probes. Merelbeke, Belgium) was used. This is a 4641 base 
pair (bp) construct and contains a luciferase 2 expression cassette under control of 
the cytomegalovirus (CMV) promoter, next to a sequence for ampicillin resistance. 
YOYO-1 (1 mM in DMSO) iodide was added to the plasmid at a mixing ratio of 0.15:1 
(v:w) ratio of (dye/base pair), resulting in a theoretical labeling density of 1 YOYO- 
dye molecule per 10 bp. The mixture was incubated at room temperature for 1 h in 
the dark. To remove the DMSO and free YOYO-1, the complex was precipitated 
adding 2 volumes of ice-cold ethanol and 0,1 volume of 5 m  NaCl. After incubation for 
30 min a t 4  °C, centrifugation (17.000 g, 10 min) and washing with ice-cold 70% 
ethanol, fluorescently labeled plasmid was finally resuspended in 25 mM HEPES, pH
7.2. The concentration of the plasmid was again determined by UV absorption at 
260 nm. For microscopy colocalization studies with GFP labeled structures, pGL4.13 
plasmid was labeled with Cy5 (Label IT Nucleic Acid Labeling Kit, Mirus Bio 
Corporation, WI, USA), according to the manufacturer’s instructions at a 1:2 (v:w) 
ratio of Label IT Tracker Reagent and plasmid. For all transfection studies, gWiz™- 
GFP plasmid (Aldevron, Freiburg, Germany) was used, consisting of 5757 bp and 
containing the GFP expression cassette under control of the CMV promoter, next to 
CMV introns and kanamycin resistance.
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2.4. Polyplexes
p(CBA-ABOL)/DNA complexes were obtained by adding a polymer solution of 
0.6 mg/ml to a plasmid solution of 0.05 mg/ml in a final mass ratio of 48/1 in 25 mM 
HEPES buffer pH 7.2 and vortexing the mixture for 10 s. These gene complexes have 
an average hydrodynamic diameter of 120 nm and an average zeta potential of 
+40 mV (See Supplementary. Fig. 3). This was measured in undiluted samples of the 
polyplexes on a NanoZS zetasizer (Malvern Instruments. Hoeilaart, Belgium). For 
every transfection, fresh polyplexes were made and used within 30 min after 
complexation and were diluted 5x in OptiMEM™ during the addition to the cells.
JetPEI polyplexes were prepared according to the manufacturer’s instructions. In 
summary, 4 pg of pDNA and 8 pi of JetPEI were first separately diluted till 100 pi w ith 
a 150 mM NaCl solution. The JetPEI dilution was then added to the pDNA solution, 
shortly vortexed and used within 30 min after the mixing step. Before adding the 
polyplexes to the cells, the polyplexes were first diluted lOx in OptiMEM™.
2.5. Pretreatments with pharmacological endocytic inhibitors
For all inhibition studies, 2 x 105 cells were seeded in six-well plates to, 24 h 
later, reach 70% confluency. The cells were subsequently pre-incubated w ith 
endocytic inhibitor in OptiMEM™ 15 pg/ml Cpz, 400 pm genistein and 3 mM M(3CD 
for 2 h, 10 pm rottlerin, 5 pg/ml nocodazole and 5 pg/ml CytoD for 1 h or 80 pm 
dynasore for 30 min. All endocytic inhibitors were freshly used and fresh inhibitor 
was also added during uptake period w ith fluorescently labeled endocytic markers 
or polyplexes. MfiCD and chlorpromazine solutions were filter sterilized through 
a 0.22 pm pore size filter before use.
2.6. siRNA mediated depletion o f endocytic proteins
Cells were seeded at 2 x 10s cells per well in six-well plates and 24 h later trans­
fected with 150 pmol siRNA (See Supplementary. Table. 1) and 7 pi Lip- 
ofectaminRNAiMAX™ per well in serum free OptiMEM™ for 4 h according to the 
manufacturer’s instructions. As a negative control, cells were transfected with Negative 
Control siRNA (Eurogentec, Seraing, Belgium) (Supplementary. Table. 1). Cells were 
subsequently left in growth medium for 20 h before detachment with trypsin and 
seeding them in 75 cm2 culture flasks. After another 24 h, cells were transfected for 
a second time in the culture flask w ith 1.25 nmol siRNA and 58 pi Lip- 
ofectaminRNAiMAX™ in OptiMEM™ for 4 h. After 20 h, cells were detached again and 
seeded in six-well plates in full growth medium and incubated for 12 h before per­
forming endocytosis and transfection assays or cell lysis for assessing depletion (below).
2.7. Immunodetection o f proteins following siRNA depletion
Following transfection with siRNA, the cells were washed and incubated for 
5—10 min with ice-cold lysis buffer (50 mM Tris-base, 150 mM NaCl, pH 8.0,1% Triton 
X-100) containing protease inhibitor cocktail (Roche, Vilvoorde, Belgium). The lysate 
was centrifuged a t 13,000g (4 °C) for 10 min and supernatants were collected for 
protein analysis w ith the BCA protein assay kit (Pierce, Erembodegem, Belgium). 
Then, 20 pg protein was resolved by SDS-PAGE and transferred to nitrocellulose 
membranes, which were then blocked for 45 min a t RT with (TBS containing 5% 
dried skimmed milk) then probed with CHC, Flotl, Cavl, DNM2, GRAF1, ARF6 and 
PAK1 antibodies (Supplementary. Table. 2), washed and then incubated w ith 
horseradish peroxidase-conjugated anti mouse, anti-rabbit or anti-goat antibodies 
(Pierce, Northumberland, UK). Protein bands were visualized by the enhanced 
chemiluminescence detection system (Thermo Fisher, Scientific, Leicestershire. UK). 
Equal protein loading was confirmed using antibodies recognizing a-Tubulin or CHC.
2.8. Flow cytometry ^
Cell-associated fluorescence was analyzed with a 5-color FACS Calibur (Beckton 
Dickinson, Erembodegem, Belgium) equipped with an Argon laser (excitation 
488 nm) and a red diode laser (excitation (535 nm). For quantification, all experi­
ments were performed in.triplicate and for each sample 1 x 104 events were 
collected by list-mode data that consisted of side scatter, forward scatter and fluo­
rescence intensities in different channels. Fluorescence emission of AF488, Oregon 
Green, LY, FITC and Bodipy FL was detected with a 530/30 nm bandpass filter (FL1) 
and emission of trypan blue was detected w ith a 670 long pass filter (FL4). Cellquest 
software (Beckton Dickinson, Erembodegem, Belgium) was used for analysis. 
Appropriate gating was applied to the scatterplot of untreated cells to select for 
intact cells. FL1 and FL4 signals were measured for all gated cells.
2.9. Quantification o f uptake o f endocytic markers or polyplexes
Control or inhibitor pre-treated cells, seeded 24 h earlier in six-well plates a t 
2 x 105 cells per well, were incubated with fluorescently labeled endocytic m arker 
or gene complexes in OptiMEM™. Due to the presence of hTf in OptiMEM, DMEM 
was used as an alternative hTf free medium. The concentration and incubation time 
for the different endocytic markers were applied under following conditions: 
16.7 pg/ml hTf for 15 min, 0.81 pm LacCer for 15 min, 5 mg/ml LY for 1 h, 0.5 mg/ml
70 kDa dextran for 3 h and 0.2 mg/ml ECs for 3 h. Polyplexes of p(CBA-ABOL) and 
YOYO-1 labeled pGL4.13 were incubated with the cells for 2 h at an amount corre­
sponding to 4 pg plasmid per well. For quantification of the internalized fraction of 
endocytic marker or gene complexes w ith flow cytometry, it is imperative to remove 
the fraction that was not internalized and is still associated w ith the plasma 
membrane. For hTF and LacCer we applied an acid wash and back exchange protocol, 
respectively, as described previously [19]. The fluorescence of the plasma membrane 
associated fraction of FITC labeled ECs, Oregon Green labeled dextran, LY or YOYO-1 
labeled pDNA was quenched with a 0.2% trypan blue solution in PBS for 5 min at 
room temperature. After thorough washing steps with PBS, cells were detached with 
trypsin, centrifuged and resuspended in ice-cold PBS with 0.1% azide and 1% BSA. 
Mean fluorescence values of triplicates were analyzed with flow cytometry and used 
as a measure for uptake of the endocytic markers or gene complexes. For inhibition 
experiments, mean fluorescence values were corrected for a 0% uptake (negative 
control) and normalized to a 100% uptake (positive control). The 0% uptake was 
determined from cells which were incubated with the fluorescent endocytic 
markers or complexes at 4 °C and underwent the same acid wash, back exchange or 
quenching. Uptake corresponding to 100% was determined from cells which were 
not treated w ith any inhibitor or w ith control siRNA.
2.10. Analysis o f transfection efficiency
Cells were seeded into 6-well plates (2 x 105 cells per well) and allowed to 
attach overnight. Subsequently, the culture medium was removed and gene 
complexes, composed of gWiz™-GFP pDNA and gene carrier, were added to the well 
(4 pg of DNA per well). After 2 h, cells were washed with PBS and incubated for 22 h 
in full cell culture medium, unless stated differently. The average GFP expression of 
the total gated population of cells and the amount of GFP-positive cells in the same 
gate were subsequently measured by flow cytometry. As a negative control, cells 
were transfected w ith pGL4.13 plasmid since luciferase expression does not produce 
a detectable signal in the FL1 channel of the flow cytometer. A cell was considered 
GFP-positive and therefore successfully transfected if the average fluorescence was 
above the threshold T, defined as the 99.5 percentile of the negative control sample. 
For inhibition experiments, GFP values were corrected for negative control (0% 
transfection) and normalized to the positive control (100% transfection), the latter 
being cells that were not treated w ith any inhibitor or with control siRNA.
2.11. Fluorescence colocalization microscopy
ARPE-19 cells were seeded at a concentration o f300.000 cells per well on sterile 
MatTek coverslips (1.5)-bottom dishes (MatTek Corporation, MA, USA). The next day, 
cells were transfected w ith plasmids coding for the EGFP constructs (pEGFP-Flot2 and 
pEGFP-Cavl) using Lipofectamin2000™ (Invitrogen, Merelbeke, Belgium) according 
to the manufacturer's description. The staining with pEGFP-Flotl not satisfactory, and 
therefore omitted in this study. Briefly, for every Petri dish, 7 pi of Lipofectamin2000™ 
was mixed w ith 4 pg plasmid in 500 pi OptiMEM™ and after 30 min, these lipoplexes 
were added to 1500 pi OptiMEM™ on top of the cells. After 4 h, the lipoplex containing 
medium was removed and replaced with full cell culture medium  24 hr later, the cells 
were incubated with p(CBA-ABOL) polyplexes, 5x diluted in 2 ml OptiMEM™. rep­
resenting 4 pg Cy5-labeled pGL4.13 plasmid per well. Mixing the polyplexes with 
OptiMEM™ induces the formation of micrometer sized polyplex aggregates. There­
fore, after 15 min, polyplexes were washed away and replaced with cell culture 
medium to reduce the amount of bright, non-intemalized polyplex aggregates that 
can cause high background intensity in the fluorescence images. Cells were finally 
placed in a stage top incubation chamber (Tokai Hit, Shizuoka, Japan), on the micro­
scope, set at 37 °C, 5% CO2 and 100% humidity. GFP transfected cells were chosen for 
imaging based on a relatively low expression level of GFP-constructs. Cells were 
imaged on a custom built wide field fluorescence microscope set-up using a TE2000-E 
inverted microscope equipped with a Plan Apo VC 100 x 1.4 NA oil immersion 
objective lens (Nikon Belux, Brussels, Belgium). GFP was excited with a 491 nm laser 
line (Cobolt, Stockholm, Sweden), while CJr5 was excited with a 636 nm diode laser 
(IQ1C, Power Technology, Little Rock, AR). GFP emission was captured in a spectral 
range between 500 and 600 nm and Cy5 between 655 and 745 nm. GFP and Cy5 
fluorescence images were registered simultaneously on separate halves of the chip of 
an EMCCD camera (Roper Scientific, Nieuwegein, The Netherlands) and the overlay of 
the two channels was obtained with custom developed software.
3. Results
3.1. In vitro evaluation ofp(CBA-ABOL) as a carrier fo r  gene delivery
Linear disulfide-containing poly(amido amine) polymers such 
as p(CBA-ABOL) are promising carriers for nucleic acid delivery as 
disulfide-containing polymers have shown to offer higher average 
transgene expression and lower cytotoxicity, compared to poly- 
ethylenimine (PEI) which is typically considered as the standard
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refe ren ce  for p o lym er based  g en e  delivery  [24,26—29]. To ev a lu a te  
th e  tran sfec tio n  efficiency o f p(CBA-ABOL) in RPE cells, w e  
co m p ared  tra n sg e n e  exp ression  o f p(CBA-ABOL) po lyp lexes w ith  
com m ercia lly  available linear PEI v ecto r JetPEI™ an d  th e  lipid b ased  
tran sfec tio n  ag en t L ipofectam in2000™ . This w as d o n e  b o th  in 
ARPE-19 cells, a con tin u o u s h u m an  cell line o f th e  RPE, as w ell as 
in p rim a ry  bov ine  RPE cells (BRPE). RPE cells w ere  tra n sfe c te d  in 
se ru m  free OptiMEM™ for 2 h w ith  4 pg o f  gWiz™ -GFP p lasm id , 
co m plexed  w ith  th e  d ifferen t carriers. The p e rcen tag e  o f  GFP- 
positive  cells an d  th e  average GFP expression  w ere  d e te rm in e d  by 
flow  cy tom etry , 24  h p o st-tran sfec tio n  (Fig. 1). This tim e  p o in t w as 
chosen , b ecau se  analysis o f GFP expression  for u p  to  5 days a f te r  
tran sfec tio n  in ARPE-19 cells w ith  p(CBA-ABOL) polyp lexes sh o w ed  
th a t  m ax im u m  GFP exp ress io n  is reached  a fte r  24  h 
(Supp lem en ta ry . Fig. 1). In th e  case o f ARPE-19 cells, p(CBA-ABOL) 
p o lyp lexes w e re  ab le  to  tran sfec t 80% of th e  cell p o p u la tio n  (Fig. 1, 
b lack  do ts), w h ich  w as sim ila r to  L ipofectam in2000™  lipoplexes, 
b u t significantly  h ig h e r th a n  JetPEI™. S im ilar o b se rv a tio n s w ere  
o b ta in ed  for average  GFP exp ress io n  (Fig. 1, black bars).
To fu rth e r  assess th e  tran sfec tio n  capacity  o f p(CBA-ABOL) 
com plexes, w e  also  p e rfo rm ed  e x p e rim en ts  on  p rim ary  bov ine  RPE 
cells. S im ilar tre n d s  w e re  o bserved , a lth o u g h  th e  p e rc e n ta g e  o f 
tran sfec ted  cells an d  average  GFP expression  w as co n sisten tly  less, 
co m p ared  to  ARPE-19 cells. In add itio n , w e  assessed  im m ed ia te  
cy to tox icity  in  ARPE-19 cells o f  th e  p(CBA-ABOL) tran sfec tio n  for 
d iffe ren t p(CBA-ABOL)/DNA m ass ratios (S upp lem en ta ry . Fig. 2). 
H igher m ass ra tio s  g en era lly  re su lted  in h ig h er tran sfec tio n  effi­
ciencies, b u t th e se  w ere  also  m o re  toxic to  th e  cells [24]. As a tra d e  
off, a m ass ra tio  o f  48/1 w as ch o se n  for all fu rth e r  e x p e r im e n ts  since 
th is  ratio  did n o t cause an y  s ig n ifican t cy to tox icity  a f te r  2 h ex p o ­
su re  to  th e  cells (S u p p lem en ta ry . Fig. 2), w h ile  still sa tu ra tin g  th e  
ce llu lar u p tak e  m ach in ery  (S u p p le m e n ta ry . Fig. 3) an d  lead in g  to 
h igh  tran sfec tio n  efficiencies (Fig. 1). From  th e se  e x p e r im e n ts  w e  
conclude  th a t  u n d e r  defined  c o n d itio n s  p(CBA-ABOL) is a safe  an d  
highly effic ien t polym eric  c a rr ie r  for DNA delivery  to  th e  RPE.
3.2. Role o f  anionic cell surface proteoglycans in p(CBA-ABOL) 
polyplex a ttachm en t and internalization
In o rd e r  to  s tu d y  th e  in te rac tio n  o f  p(CBA-ABOL)/DNA po ly ­
p lexes w ith  th e  p lasm a m em b ran e , w e  investiga ted  th e  ro le  o f 
h igh ly  an ion ic  cell surface h ep a ran  su lfa te  p ro teog lycans (HSPGs).
Cell su rface HSPGs m ak e  up  a g rea t deal o f th e  ex tracellu lar m atrix  
(ECM) o f d iffe ren t cell ty p es [30] and  it is know n  th a t  th ey  can  
fu n c tio n  as p rim ary  co -recep to rs  for cellular en try  o f lipop ro te ins 
[31], p a th o g en ic  bacteria , cell p en e tra tin g  p ep tid es [32], v iruses 
[33] an d  also non-v ira l g en e  com plexes [14,34,35], For th is  reason, 
w e  investig a ted  th e  ro le  o f HSPGs in a tta c h m e n t and  su b seq u en t 
u p tak e  o f  p(CBA-ABOL) po lyplexes in ARPE-19 cells. First, w e  
a tte m p te d  to  in te rfe re  w ith  th e  charge in terac tio n  b e tw een  th e  
ca tion ic  polyplexes an d  an ion ic  HSPG chains by add ing  exogenous 
h e p a ra n  su lfa te  analogs [31 ]. For this, ARPE-19 cells w ere  exposed  
for 2 h  to  YOYO-1 labeled  p(CBA-ABOL) polyplexes in OptiMEM in 
th e  p re sen c e  o f  10 m g/m l heparin . The p resence  o f h ep arin  led to  an 
in crease  in size o f  th e  polyplexes and  caused  a charge reversal o f 
th e  po lyp lexes to  - 6 0  mV (See also S upp lem entary . Fig. 4). After 
th is  2 h  exposu re , th e  cells w ere  w ash ed  an d  th e  fluorescence o f th e  
m e m b ra n e  b o u n d  frac tion  o f polyplexes w as q u en ch ed  w ith  try p an  
b lue. In teresting ly , since try p an  b lue fo rm ed  com plexes w ith  th e  
n o n -in te rn a liz e d  polyplexes d u rin g  th e  quen ch in g  step, try p an  
b lue  fluo rescence  could  be u sed  as a m easu re  o f p lasm a m em brane 
a ssocia ted  polyplexes, o r  in o th e r  w o rd s cellu lar a ttach m en t. Both 
ce llu la r a tta c h m e n t (Fig. 2, black bars) an d  endocy tosis (Fig. 2, gray 
b ars) o f  th e  p(CBA-ABOL) polyplexes w ere  quan tified  by flow 
cy tom etry . T he p resen ce  o f h ep arin  and  co n seq u en t charge reversal 
o f  th e  polyp lexes com p le te ly  b locked cellu lar adhesion  and  up tak e  
o f th e  po lyplexes (Fig. 2). This h igh ligh ts th e  charge-based  n a tu re  o f 
th e  in te rac tio n  b e tw e e n  p(CBA-ABOL) polyplexes and  th e  cell 
surface. W e no te  th a t  sim ilar effects w ere  observed  w h en  incu­
b a tin g  th e  polyplexes in th e  p resen ce  o f 10% FBS, probably  because 
o f  sim ilar b ind ing  o f th e  a b u n d a n t se ru m  p ro te in  album in  and 
o th e r  p ro te in s to  th e  po lyplexes (d a ta  n o t show n).
In a co m p lem en ta ry  ex p erim en t, w e a tte m p te d  to  in terfere  w ith  
ce llu lar su lfa tion  by  inh ib itin g  ATP-sulfurylase, th e  enzym e th a t 
m ain ta in s  th e  cellu lar su lfate  pool. Here, ARPE-19 cells w ere  p re ­
tre a te d  for 24  h w ith  80 mM o f sod ium  ch lo ra te  as th is  tre a tm e n t is 
r e p o rte d  to  re su lt in a s tro n g  red u c tio n  o f th e  su lfation  o f th e  HSPGs 
(Keller, 1989). S odium  ch lo ra te  trea ted  cells w ere  th en  incubated  
w ith  YOYO-1 labeled  p(CBA-ABOL) polyplexes an d  th e ir  cell 
a tta c h m e n t an d  u p tak e  w ere  m easu red  a fter 2 h. As a contro l 
e x p e rim en t, u p tak e  o f hTf an d  LY afte r  ch lo ra te  tre a tm e n t w as also 
a ssessed . hTf is specifically  in ternalized  via CDE afte r b ind ing  to  th e  
tra n sfe rrin  recep to r [5] an d  LY, a sm all an ion ic  hydrophilic 
m e m b ra n e  im p erm e ab le  f luo rescen t m olecule, is in ternalized  via
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Fig. 1. Comparison of transfection efficacies between different gene carriers p(CBA-ABOL), JetPEI and Lipofectamin2000. Cells were transfected with a GFP reporter plasmid using 
three different carriers and subsequently washed with cell culture medium. Transfection levels were determined 24 h after transfection using flow cytometry showing the 
percentage of fluorescent cells (dots) and the average transgene GFP expression (bars). Transfection was assessed on both a continuous cell line (ARPE-19, in black) and primary 
bovine RPE cells (BRPE, in gray). Experiments were performed in triplicate and error bars represent standard deviations.
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Fig. 2. Cellular attachment and uptake of p(CBA-ABOL)/DNA gene complexes is 
mediated by cell surface heparan sulfate proteoglycans. Cell attachment (black bars) 
and internalization (gray bars) of p(CBA-ABOL) polyplexes in ARPE-19 cells are shown. 
The remaining cell attachment or uptake is expressed as a relative percentage, 
normalized to untreated cells (represented by the dashed horizontal line). Experiments 
were performed in triplicate and error bars represent standard deviations.
this indicates the necessity of sulfate groups on the cell surface for 
polyplex attachment and subsequent internalization.
Finally, as a third complementary strategy, the effect of heparan 
sulfate hydrolysis on polyplex attachment and endocytosis was 
examined through treatment with Heparinase III, a heparan sulfate 
lyase that exclusively cleaves heparan sulfate (37). ARPE-19 cells 
were pretreated with this enzyme for 2 h in OptiMEM. p(CBA- 
ABOL) polyplexes were then added for 2 h in OptiMEM containing 
fresh Heparinase III. As shown in Fig. 2, this treatment significantly 
reduced polyplex attachment and to a comparable extent, polyplex 
uptake. However, in comparison to sodium chlorate treatment, the 
effect on polyplex internalization is less pronounced. The effect of 
Heparinase III treatment, however, confirms the particular 
involvement of heparan sulfate moieties of HSPGs for cell attach­
ment of a significant fraction of p(CBA-ABOL) polyplexes in serum 
free conditions. Overall, we find that the electrostatic interaction 
between the cationic p( CBA-ABOL) polyplexes and the negatively 
charged HSPGs on the cell surface promotes efficient polyplex 
attachment and uptake.
3.3. Unraveling the invo lvem ent o f  endocytic  pa thw ays: chemical 
inhibitors
fluid phase endocytosis [36], We observed no inhibitory effect of 
sodium chlorate treatment on fluid phase endocytosis, nor on CDE 
(data not shown), demonstrating the specificity of this treatment. 
In contrast, desulfation of HSPGs reduces cell attachment of p(CBA- 
ABOL) polyplexes by more than 60% (Fig. 2) and consequently, cell 
uptake of the polyplexes is almost completely inhibited. Overall
To unravel the involvement of known endocytic pathways in the 
internalization of p(CBA-ABOL) polyplexes, we inhibited endocytic 
processes using chemical inhibitors: chlorpromazine (Cpz), genis- 
tein, nocodazole, methyl-fi-cyclodextrin (M(3CD), cytochalasin D 
(CytoD), dynasore and rottlerin (Fig. 3). Drug induced cytotoxicity, 
the extent of inhibition and specificity of these endocytic inhibitors 
is cell-type-dependent [19] and we therefore first characterized the
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Fig. 3. Internalization of fluorescently labeled endocytic markers (transferrin, LacCer, 70 kDa dextran and ECs) and p(CBA-ABOL) polyplexes, and transfection efficiency following 
treatment with endocytic inhibitors in ARPE-19 cells. Measurements were performed by flow cytometry. The remaining cell uptake is expressed as a relative percentage, normalized 
to untreated cells (represented by the dashed horizontal line). Transfection of GFP reporter gene was quantified 24 h later as the average expression per cell and as the percentage of 
positively transfected cells, again both normalized to the fluorescence of untreated cells (dashed line). Experiments were performed in triplicate and error bars represent standard 
deviations. (Cpz: chlorpromazine; M{5CD: methyl-P-cydodextrin; CytoD: cytochalasin D).
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effect of these inhibitors on several possible endocytic uptake 
routes in ARPE-19 cells using four fluorescently labeled endocytic 
markers: hTf, LacCer, dextran and ECs, Fluorescently labeled hTf is 
used as a marker for CDE. The glycosphingolipid LacCer resides 
preferably in lipid rafts and is reported to be internalized via Cav- 
ME [38] and is used here as a marker for CIE. Because of the lack of 
unique macropinocytic markers [39], fluid phase endocytosis of 
70 kDa dextran molecules has often been measured as a marker for 
this process. Dextran uptake in unstimulated cells represents 
a combination of constitutive fluid phase endocytosis and possible 
constitutive macropinocytosis that is known to operate in some cell 
types. To qualitatively check ARPE-19 cells for constitutive macro­
pinocytosis, they were incubated for 3 h with fluorescently labeled 
70 kDa dextran. Supplementary. Fig. 5 demonstrates that a fraction 
of the cells contained intracellular pm-sized vacuoles, likely to be 
macropinosomes, resulting from constitutive macropinocytosis. 
This suggests that at least a part of the dextran is internalized via 
constitutive macropinocytosis. As a marker for phagocytosis, we 
used fluorescently labeled E. coli Bioparticles™ (ECs). The effects on 
the endocytic markers after inhibitor treatment in ARPE-19 cells is 
shown in Fig. 3 (Blue, red, green and orange bars), including the 
effect of the same inhibitors on polyplex uptake (dark purple bars). 
To correlate endocytosis route with gene delivery efficiency, we 
transfected cells with non-fluorescent polyplexes carrying the GFP 
reporter gene in the presence of endocytic inhibitors. Transfection 
efficiency is expressed both as percentage of fluorescent cells, and 
as average fluorescence level per cell (Fig. 3, two last light purple 
bars). Results from experiments with each type of inhibitor are 
discussed in turn below.
3.4. Depleting plasma membrane cholesterol
To assess the role of plasma membrane cholesterol, ARPE-19 
cells were incubated with MpCD, a cyclic oligomer of glucopyr- 
anoside that inhibits cholesterol-dependent endocytic processes by 
reversibly extracting the steroid out of the plasma membrane [40]. 
MPCD is regularly used to determine whether endocytosis is 
dependent on the integrity of lipid rafts but has also been shown to 
inhibit CDE [40]. As can be seen from the results in Fig. 3, MPCD 
affected all endocytic markers as well as polyplex uptake and 
transfection. As can be expected, uptake of LacCer was reduced the 
most. However, all other endocytic markers were also affected by 
this treatment, which demonstrates the lack of specificity of this 
inhibitor for blocking subtypes of endocytic pathways. Despite this, 
the results indicate that the presence of cholesterol in the plasma 
membrane is indispensable for uptake of p(CBA-ABOL) polyplexes 
and their capacity for effective transfection.
3.5. Blocking actin and microtubule dynamics
CytoD is a fungal alkaloid that binds the barbed, fast growing 
plus ends of actin microfilaments and therefore blocks further 
polymerization and elongation of actin [41,42]. Actin disruption 
was visually confirmed on confocal microscopy images by staining 
the actin network in paraformaldehyde fixed cells with AF488 
labeled phalloidin (results not shown). Data in Fig. 3 clearly show 
that actin polymerization is necessary for CDE, fluid phase endo­
cytosis and phagocytosis; CIE is also affected, although to a lower 
extent. Interestingly, polyplex internalization is only partially (50%) 
dependent on actin polymerization, despite the substantial 
decrease of GFP expression. This suggests that actin polymerization 
is essential for successful intracellular processing of the internal­
ized polyplexes.
Nocodazole induces depolymerization of the microtubules, 
which impairs the molecular motor-driven transport of vesicles on
these tubular cytoskeletal structures [43]. Nocodazole treatment 
strongly inhibits the uptake of 70 kDa dextran but has only minor 
effects on the other endocytic probes including polyplexes (Fig. 3). 
This drug also had pronounced inhibitory effects on transfection 
efficiency. According to the proton sponge theory, endosomal 
acidification is necessary to enable polyplexes, composed of poly­
mers with high buffer capacities around physiological pH, to escape 
from the endosomes into the cytoplasm and to cause successful 
gene transfer [44]. It is known that microtubule integrity is 
necessary for maturation of early/sorting endosomes to late 
endosomes with the accompanying drop in luminal pH [45,46]. 
These results suggest that nocodazole probably inhibits endosomal 
escape of the polyplexes by inhibiting the luminal acidification of 
the endosomes.
Overall, these results suggest that p(CBA-ABOL) polyplexes are 
internalized in ARPE-19 cells via an endocytic mechanism that relies 
on local actin polymerization but not on microtubule integrity.
3.6. Role o f  CDE
To investigate the involvement of CDE, we applied Cpz, a cationic 
amphiphilic drug which is believed to inhibit clathrin-coated pit 
formation by a reversible translocation of clathrin and its adapter 
proteins from the plasma membrane to intracellular vesicles [47], 
As expected, Cpz treatment inhibits hTf uptake, an established CDE 
marker (See Fig. 3). In contrast, it does not inhibit LacCer uptake, nor 
polyplex uptake or transfection. This indicates that CDE does not 
play a significant role in polyplex uptake. This conclusion is 
corroborated by the genistein data (See Fig. 3). Genistein, a well- 
characterized inhibitor of tyrosine kinase mediated signal trans­
duction [48], has only a slight effect on CDE, while clearly inhibiting 
fluid phase uptake, phagocytosis, CIE and completely blocking 
polyplex uptake. From the Cpz and genistein data we conclude that 
polyplex uptake is primarily independent of CDE.
3.7. Blocking dynamin Junction w ith dynasore
Because dynamin is a regulatory protein for several endocytic 
pathways, we assessed its role in cell uptake of the polyplexes. This 
large GTPase forms a helical polymer around the neck of a newly 
invaginated endosome and catalyzes upon GTP hydrolysis the 
fission of the vesicle from the plasma membrane. Dynamin has 
been shown to regulate CDE, Cav-ME and phagocytosis [49]. To 
assess the role of dynamin in polyplex uptake, ARPE-19 cells were 
incubated with dynasore, an inhibitor of the GTPase activity of both 
dynamin-1 and 2 isoforms [50]. Dynasore, as predicted, inhibited 
EC uptake and 50% of hTf uptake (Fig. 3) and reduced, though to 
a lower extent, uptake of both 70 kDa dextran and LacCer. Dynasore 
treated cells were unable to internalize polyplexes, indicating that 
dynamin function is essential for p(CBA-ABOL) polyplex endocy­
tosis in ARPE-19 cells.
3.8. Inhibition o f PKC signaling
To investigate the role of macropinocytosis, we treated the cells 
with rottlerin, a polycyclic aromatic compound inhibiting protein 
kinases C (PKC) [51 ] and reported to be a fairly selective inhibitor of 
constitutive macropinocytosis [52]. Fig. 3 demonstrates that rot­
tlerin slightly inhibited the uptake of hTf and LacCer and exhibited 
a pronounced inhibition of polyplexes, ECs and fluid phase uptake 
of 70 kDa dextran molecules. Since rottlerin seems to affect both 
fluid phase endocytosis and phagocytosis, it does not provide 
further information on the possible specific involvement of mac­
ropinocytosis on polyplex internalization.
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How ever, th e  resp o n se  o f  th e  polyplexes and  d e x tra n  to  in h ib ­
ito rs like d y n aso re  an d  nocodazole w as very  d ifferen t. In p articu lar, 
a f te r  nocodazo le  tre a tm e n t, com p le te  inh ib ition  o f  70 kDa d ex tran  
u p tak e  w as o b se rved , w hile  u p tak e  o f  th e  com plexes w as s im ila r to  
u n tre a te d  cells (Fig. 3). In case o f dynasore, polyplex  u p ta k e  w as 
com plete ly  inh ib ited , w hile  70 kDa d ex tran  u p tak e  w as re d u ced  by 
on ly  40%. T his w o u ld  suggest th a t  fluid ph ase  u p tak e  a n d  co n s ti­
tu tiv e  m acrop inocy tosis is n o t co rre la ting  w ith  p(CBA-ABOL) p o l­
yp lex  u p tak e  in ARPE-19 cells. In con trast, th e  resu lts  in  Fig. 3 
g enera lly  sh o w  a s tro n g  co rre la tion  b e tw een  EC an d  po lyp lex  
en d ocy tosis in re sp o n se  to  th ese  pharm acological inh ib ito rs . This 
suggests phagocy tosis as a po ten tia l up tak e  rou te  for p(CBA-ABOL) 
polyp lexes in ARPE-19 cells.
3.9. Unraveling the involvem ent o fen d o cy tic  pathw ays: RNAi
To co m p le m e n t th e  chem ical inh ib ito r s tud ies, RNAi w as 
im p lem en ted  in th is  w o rk  to  d o w n reg u la te  exp ression  o f  key  
endocy tic  p ro te in s th u s  inh ib iting  specific endocytic  pa thw ays. The 
ta rg e te d  p ro te in s w e re  c la th rin  heavy  chain  (CHC), caveolin-1 
(C av l), flotillin-1 (F lo tl) , GTPase reg u la to r associated  w ith  focal 
a d h es io n  k inase  (GRAF1), ADP ribosy lation  fac to r 6  (Arf6), d y n a - 
m in -2  (DNM2) a n d  se rin e /th re o n in e -p ro te in  k inase (PAK1). A list o f  
th e  co rre sp o n d in g  siRNA sequences , u sed  in th is  w ork , is g iven  in 
Supplementary. Table. 1. D ow nregu la tion  w as assessed  by W este rn  
b lo ttin g  (Fig. 5). T he sam e flow  cy to m etry  m e th o d s  w ere  used  to  
e v a lu a te  th e  effects o n  endo cy tic  u p ta k e  an d  transfec tion  o f th e  GFP 
re p o rte r  gen e  (Fig. 4).
3.10. Role o f  heavy chain clathrin
As expected , d ep le tin g  th e  ex p ress io n  o f  c la th rin  heavy chain  
in h ib ited  tran sfe rrin  up tak e  by  80% (Fig. 4), h o w ev er w e  w ere  
su rp rised  to  o b se rv e  th a t  th e  sa m e  d e p le tio n  caused  an  in d u c tio n  in
th e  u p tak e  o f all o th e r  end o cy tic  m arkers , includ ing  polyplexes. In 
any  case, th is  con firm s th a t  in te rn a liza tio n  o f p(CBA-ABOL) poly­
plexes in  ARPE-19 cells is in d e p e n d e n t o f CDE. The d ep le tio n  in 
ex p ress ion  o f  CHC w as clearly  confirm ed  by W este rn  b lo ttin g  
(Fig. 5A).
3.11. Role o fD N M 2 function
To confirm  th e  invo lv em en t o f d y n am in  in polyplex  up take , w e 
d o w n reg u la ted  DNM2 expression  w ith  th e  help  o f  RNAi (53] an d  
W este rn  b lo ttin g  d e m o n s tra te d  a t least a p artia l red u c tio n  in 
p ro te in  ex p ress ion  (Fig. 5B). In a g re e m e n t w ith  th e  d y n aso re  data , 
DNM2 d o w n reg u la tio n  significantly  inh ib ited  hTf, EC an d  polyplex 
u p tak e  (Fig. 4), a lth o u g h  LacCer an d  70 kda d ex tran  u p tak e  w as n o t 
inh ib ited , d e sp ite  th e  significant inh ib ito ry  effect o f  dynaso re . 
Indeed , it w as p rev iously  rep o rted  th a t  selective knock d o w n  o f 
DNM2 m ay  still p e rm it CIE o f  cho lera  tox in  su b u n it B (CtxB) an d  
fluid p h ase  endocy tosis, possibly because  DNM1 a d o p ts  th e  ro le  o f  
DNM2 for vesicle fission [54]. Finally, Fig. 4  also  sh o w s th a t  DNM2 
d ep le tio n  resu lts  in substan tia l red u c tio n  o f tra n sg e n e  exp ression , 
ind ica tin g  th a t  th e  endocytic  pa th w ay s th a t  lead  to  successfu l 
tran sfec tio n  a re  dyn am in  d ep en d en t.
3.12. Role o f  Cavl and Flotl
C om bined, th e  ex p e rim en ts  w ith  chem ical en d o cy tic  inh ib ito rs 
suggested  th a t  CDE is n o t involved in po lyp lex  up tak e . H ow ever, th e  
in h ib ito rs  d id  n o t a llow  us to  d is tin g u ish  b e tw e e n  d ifferen t 
subc lasses o f  CIE pathw ays. To ev a lu a te  th e  specific in vo lvem en t o f 
Cav-ME an d  Flot-ME, tw o  know n  subc lasses o f  CIE, w e  u sed  RNAi to  
d o w n reg u la te  th e  exp ression  respec tive ly  o f  C avl an d  F lotl. 
D epletion  o f  th e se  tw o  p ro te in s w as again  con firm ed  by  W estern  
b lo ttin g  (Fig. 5C). As sh o w n  in Fig. 4, Cavl do w n reg u la tio n , as 
p red ic ted , inh ib ited  a frac tion  o f  LacCer u p take , b u t th e re  w as no
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Fig. 4. Internalization of fluorescently labeled endocytic markers (transferrin, LacCer, HMW dextran and ECs), p(CBA-ABOL) polyplexes, and transfection efficiency after siRNA 
mediated depletion of endocytic proteins in ARPE-19 cells. Measurements were performed by flow cytometry. The remaining cell uptake is expressed as a relative percentage, 
normalized to cells, treated with NC siRNA (represented by the dashed horizontal line). Transfection of the GFP reporter gene was measured again 24 h later and was both quantified 
as the average expression per cell and as the percentage of positively transfected cells, again both normalized to the cell population, transfected with negative control siRNA. 
Experiments were performed in triplicate and error bars represent standard deviations. (CHC: clathrin heavy chain; Cavl: caveolin-1; Flotl: flotillin-1; GRAF1: GTPase Regulator 
Associated with Focal Adhesion Kinase; Arffi: ADP ribosylation factor 6; DNM2: dynamin-2; PAK1: Serine/threonine-protein kinase).
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Fig. 5. Protein expression after siRNA downregulation, visualized by Western blotting. In all cases, the control cells were treated with negative control siRNA (Supplementary. Table. 
I ). For (A). (B), (D) and (F) the expression of a-Tubulin served as an internal control for equal protein loading, while CHC expression levels were used as a reference in (C) and (E). In 
(E), the PAK1 band of 60 kDa is marked with a black arrow. (CHC: clathrin heavy chain; Cavl: caveolin-1; Flotl: flotillin-1; CRAF1: GTPase regulator associated with focal adhesion 
kinase; Art6: ADP ribosylation factor 6; DNM2: dynamin-2; PAK1: Serine/threonine-protein kinase).
effect on uptake of any of the other endocytic markers or poly­
plexes. Interestingly, transfection was clearly less successful in the 
absence of Cavl, suggesting a crucial role for this protein in gene 
transfer with p(CBA-ABOL) polyplexes. The observed role of Cavl in 
gene transfer may here be indirect, and not related to endocytosis. 
noting that Cavl knockdown appears not to inhibit polyplex 
endocytosis. Conversely, Flotl downregulation inhibited both pol­
yplex uptake and transfection. We therefore conclude that Flot-ME 
is not only involved in p(CBA-ABOL) polyplex endocytosis in ARPE- 
19 cells, but also contributes to successful transfection. This 
demonstrates the importance of Flot-ME as a portal to the cell for 
successful gene transfer.
3.73. Role o f  the CLIC/GEEC pa thw ay
A recently defined CIE pathway, independent of Cavl and Flotl, 
is the CLIC/GEEC pathway. This portal plays a major role in the 
endocytosis of certain GPI linked proteins [55]. The cargoes are 
collected in tubular invaginations, called dathrin-independent 
carriers (CLIC’s), and are trafficked to Rab5-independent endo- 
somes, called GPl-enriched endosomal compartments (GEEC’s). 
Other cargoes like Cholera toxin subunit B (CtxB), Simian Virus 40 
(SV40) and Shiga toxin were also found to be internalized via this 
pathway [53]. This pathway is also reported to be responsible for 
a major fraction of fluid phase uptake and is independent of DNM2 
[56]. We therefore investigated its role in entry of the endocytic 
markers and polyplexes by depleting GRAF1, a protein shown to 
regulate this pathway [57]. Efficient GRAF1 depletion was 
confirmed by Western blotting (Fig. 5D). Downregulation of GRAF1 
didn’t decrease polyplex internalization (Fig. 4), suggesting a lack of 
involvement of the CLIC/GEEC pathway. Interestingly, we observed
that GRAF1 knockdown stimulated both polyplex and phagocytosis 
uptake, but not transgene GFP expression.
3.14. R o leo fP A K l and Arf6
To further elucidate the possible involvement of macro- 
pinocytosis, we depleted expression of PAK1 and Arf6, two proteins 
that have been shown to regulate this process [39,58]. PAK1 is 
a serine/threonine kinase, regulating cytoskeleton dynamics and 
motility; upon activation, it relocates to the plasma membrane 
where it activates a variety of effectors, such as BARS, needed for 
ruffling, blebbing and macropinosome formation [59]. Knockdown 
of PAK1 kinase expression in ARPE-19 cells was successful 
according to Western blot analysis (Fig. 5E). Two other bands were 
also observed with the anti-PAK1 antibody but their expression was 
insensitive to PAK1-siRNA. Fig. 4 shows that PAK1 downregulation 
had no effect on hTf internalization, while cell uptake of polyplexes 
and fluid phase marker 70 kDa dextran were reduced by 50%. 
Surprisingly, PAK1 downregulation also decreased EC uptake, sug­
gesting an additional role for this protein in ARPE-19 phagocytosis. 
Despite PAK1 having a significant role in polyplex endocytosis. 
transfection was not inhibited (Fig. 4). We conclude that, while 
either macropinocytosis or phagocytosis contributes to endocytosis 
of our polyplexes, this PAK1- dependent pathway does not 
contribute to successful gene transfer.
Arf6 is a member of the Arf family of small GTPases, which are 
involved in the regulation of membrane structure and transport 
[60], and is known to be a positive modulator of MP [39]. Successful 
knockdown of this protein (Fig. 5F) led to a decrease in 70 kDa 
dextran uptake, while endocytosis of both ECs and p(CBA-ABOL) 
gene complexes was induced (Fig. 4). This suggests that constitutive
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Fig. 6. Colocalization of p(CBA-AB0L) polyplexes with flotillin or caveolin containing vesicles in living ARPE-19 cells. Cells transfected with (A) Cavl-ECFP and (B) Flot2-EGFP were 
exposed to p(CBA-ABOL) Cy5-pDNA polyplexes for 15 min. After washing, the cells were transferred in a stage top incubator and imaged on a wide field fluorescence microscope in 
OptiMEM. Fluorescence images, selected from livecell time-lapse movies show colocalization of the polyplexes at early timepoints with Flot2 (B1 and 2), which disappears at later 
timepoints (B3). The white arrows show colocalizing signals. Very little colocalization is observed between the Cy5-labeled plasmids and Cavl, either at early (Al) or at later 
timepoints (A2 and 3). Scale bar is 5 pm.
m acro p in o cy to s is  is n o t involved in th e  in te rn a liz a tio n  o f p(CBA- 
ABOL) po lyp lexes.
3.15. Live cell fluorescence  colocalization microscopy
A side from  in h ib itin g  en d o cy tic  p a th w ay s w ith  ch em ica l in h ib ­
ito rs  an d  siRNA d e p le tio n , f luo rescence  m icroscopy  w as u tilized  to  
p ro b e  fu r th e r  th e  in v o lv em en t o f  Cav-ME o r Flot-ME in th e  in itia l 
u p ta k e  o f p(CBA-ABOL) po lyplexes. Cells w ere  tra n sfe c te d  w ith  
p la sm id s  en co d in g  EGFP-Flot2 o r  EGFP-Cavl for v isu a liza tio n  o f 
flo tillin  o r  caveo lin  co n ta in in g  en d o so m es, respectively . It is
b e liev ed  th a t  co assem b ly  o f  b o th  F lo tl a n d  FIot2 is necessa ry  for 
F lot-M E to  o ccu r (61 ]. C aveolin  c o n ta in in g  e n d o so m es are typically  
te rm e d  cavicles an d  cav e o so m e s [7], GFP fusion p ro te in s w e re  
c learly  ex p re sse d  a f te r  2 4  h a n d  th e y  w e re  th e n  in cu b a ted  w ith  
p(CBA-ABOL) po ly p lex es co n ta in in g  C y5-labeled  p lasm ids. A fter 
15 m in  o f in cu b a tio n  w ith  th e  po lyp lexes, cells w e re  w ash ed  w ith  
OptiM EM  an d  o b se rv e d  as live cells o n  a stag e  to p  in cu b a to r  by 
f lu o rescen ce  m icroscopy. W e c lea rly  o b se rv ed  co localization  w ith in  
30  m in  b e tw e e n  p o lyp lexes a n d  flo tillin -2  (Fig. 6B1 an d  2), w h ich  
g en era lly  d isa p p e a re d  a b o u t 150 m in  a f te r  in itial in cu b a tio n  w ith  
p o lyp lexes (Fig. 6B3). In co n tra s t, v irtu a lly  no  co localiza tion  w as
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observed between polyplexes and caveolin-1 (Fig. 6A1-3). These 
observations provide further evidence that p(CBA-ABOL) polyplexes 
are internalized in flotillin-vesicles rather than caveosomes.
4. Discussion
The RPE is an attractive target for treating diseases such as AMD 
or retinitis pigmentosa with non-viral nucleic acid carriers 
following subretinal or intravitreal injection. However the effi­
ciency of subcellular delivery of therapeutic nucleic acids into these 
cells remains low. The carrier defines the mechanisms that direct 
cell attachment, subsequent endocytosis and intracellular traf­
ficking and therefore strongly determines transfection efficiency. 
A better understanding of these mechanisms will help to improve 
the design of efficient CBA based polymeric carriers since little 
information is currently available on cellular adhesion, intracellular 
uptake and intracellular processing of p(CBA-ABOL) polyplexes in 
RPE cells. Here, we studied cell attachment and endocytosis of 
polyplexes, composed of the novel bioreducible polymer p(CBA- 
ABOL) and plasmid DNA. We first focused on cell attachment and 
proceeded with characterizing the endocytic pathways that are 
involved in their subsequent uptake by using a combination of 
pharmacological inhibitors, RNAi knockdown and live cell fluores­
cence colocalization microscopy.
4.1. In vitro evaluation ofp(CBA-ABOL) as a carrier fo r  gene delivery 
in RPE cells
First, we compared the in vitro transfection potential of different 
carriers on both a continuous RPE cell line and primary bovine cells 
(BRPE). Overall, the data showed p(CBA-ABOL) to be a promising 
transfection agent in both cultured and primary cells, out­
performing linear PEI and equaling commercial liposome based 
systems. JetPEI polyplexes transfected only 50% of the cells, which 
we believe is a consequence of significantly lower cell uptake (4 -5  
times) during the 2 h exposure time, when compared with the 
other carrier systems (See Supplementary. Fig. 6). In primary cells, 
transfection efficiency was lower for all carriers and this is probably 
due to general lower internalization rates, because we observed 
that only about half of the amount of p(CBA-ABOL) and Lip- 
ofectamin2000™ complexes are internalized in BRPEs cells 
compared to the RPE cell line (ARPE-19) (See Supplementary. 
Fig. 6). This is possibly due to their lower metabolic, and there­
fore lower endocytic activity. In line with this, we observed 
significant lower cellular growth rates for the primary RPE cells.
4.2. Role o f anionic cell surface proteoglycans in p(CBA-ABOL) 
polyplex attachm ent and internalization
We identified that the interaction between cationic polyplexes 
and cell surface HSPGs is essential for efficient internalization. This 
is in agreement with reports for other types of cationic complexes 
and can be easily explained by the electrostatic interaction between 
the positively charged gene carrier and negatively charged heparan 
sulfate chains [14,34,62,63]. In order to ascertain the rate of poly­
plex internalization and identify optimal incubation times for cells 
with the polyplexes, we also evaluated their uptake kinetics in 
ARPE-19 cells (Supplementary. Fig. 3). Similar to what was found 
for other gene delivery vehicles, viral and non-viral [1,15], we 
observed that p(CBA-ABOL) polyplexes are rapidly taken up in 
ARPE-19 cells and that this internalization is saturated after 2 h. The 
internalization kinetics follow a sigmoid-like function which is 
typical for an endocytic uptake pattern because of saturation of the 
endocytic machinery. These results suggest that general cellular
uptake as such is not the bottle neck for efficient transfection, at 
least in the absence of anionic biopolymers.
4.3. p(CBA-ABOL) polyplex uptake via a PAK1 dependent 
phagocytosis-like mechanism
As a first strategy to identify the endocytic pathway(s) utilized by 
p(CBA-ABOL) complexes to enter ARPE-19 cells, we made use of 
chemical endocytic inhibitors. We have recently shown that 
chemical endocytic inhibitors should be used with care as their 
effect is highly cell-type-dependent and not as specific as they are 
often reported to be [19]. Therefore, alongside our polyplexes, we 
evaluated the effect of these inhibitors on several types of endocytic 
markers. These results suggested that polyplex uptake does not 
involve CDE but is strongly dependent on cholesterol, tyrosine 
kinase activity and dynamin as well as on actin and PKC activity. 
Several reports link HSPG mediated endocytosis to macro- 
pinocytosis [32,64,65], also in cellular uptake of cationic gene 
delivery vehicles [15,65—67]. However, Kopatz et al. discovered 
close similarities between HSPG-dependent phagocytosis in 
epithelial cells and endocytosis of PEI/DNA polyplexes [62]. More­
over, it has previously been suggested that viruses like HSV-1 can 
infect both professional and non-professional phagocytes via 
a phagocytosis-like mechanism after heparan sulfate binding [68]. 
Despite the difficulties of distinguishing between the involvement 
of macropinocytosis and phagocytosis in nanomedicine uptake, 
since there are no chemical inhibitors that are specific for either of 
them, we were able to come to some conclusions on this matter 
based on several observations. First, using nocodazole and dynasore, 
we found marked opposite inhibitory effects for uptake of poly­
plexes and 70 kDa dextran, the latter often being used as a marker 
for constitutive macropinocytosis. Interestingly, we found a strong 
correlation between cellular internalization of the polyplexes and E. 
coli particles, the latter being an established marker for phagocy­
tosis. Second, while actin, tyrosine kinases and PKC, all appear to be 
required for polyplex uptake in ARPE-19 cells and are known criteria 
for macropinocytosis [39], these proteins also regulate phagocytosis 
(Fig. 3) [39] and therefore do not exclude the involvement of 
a phagocytosis-like mechanism. Third, dynamin is often known to 
play a redundant role in macropinocytosis [69], though its function 
is essential for phagocytic cup closure [39]. Using dynasore to block 
all dynamin isoforms, this study showed a noticeable dependence 
on dynamin function during polyplex endocytosis, which is again in 
favor of the involvement of a phagocytosis-like mechanism.
As a second strategy to identify the involvement of endocytic 
pathway(s) during polyplex endocytosis, we depleted key endo­
cytic proteins with the help of RNAi. By depleting DNM2, we could 
confirm the involvement of this protein for polyplex uptake. 
Furthermore, when depleting PAK1 and Arf6 which are both 
reported to regulate macropinocytosis [39], we observed that Arf6 
did not have any inhibitory effect on polyplex uptake, providing 
further evidence that macropinocytosis is probably not involved in 
p(CBA-ABOL) polyplex endocytosis. The involvement of PAK1 
during polyplex endocytosis could then be attributed to its 
involvement in phagocytosis in ARPE-19 cells. Indeed, it has been 
previously reported that PAK1 plays a role in actin rearrangements 
during phagocytosis [70,71 ]. The effect of PAK1 knockdown on 
polyplex uptake could therefore be assigned to the inhibition of 
phagocytic uptake of the polyplexes.
Finally, it should be noted that our polyplexes have the tendency 
in physiologic media of high ionic strength to form spherical 
aggregates with sizes up to 5 pm (Supplementary. Fig. 7). Therefore, 
the cells were exposed to polyplexes with a wide distribution of 
sizes. Since the RPE is in vivo  the most active phagocytic tissue in 
humans [21 ], it is unsurprising that these large aggregates were
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observed to be internalized in ARPE-19 cells. Taken together, 
despite the inability to specifically inhibit phagocytosis, our 
observations suggest that a PAK1 dependent, phagocytosis-like 
mechanism is involved in the cellular internalization of p(CBA- 
ABOL) polyplexes in ARPE-19 cells.
4.4. p(CBA-ABOL) polyplex uptake via flotillin-dependent 
endocytosis
Despite excluding a role for CDE in polyplex uptake, the chem­
ical inhibitors could not differentiate between the various CIE 
routes. CIE like Cav-ME is often reported to be involved in inter­
nalization of non-viral gene delivery vehicles [13]. To discriminate 
between different CIE pathways, we employed siRNA depletion 
studies and found no involvement of Cav-ME, the CLIC/GEEC 
pathway, nor ArfB-dependent endocytosis for polyplex uptake. 
However, p(CBA-ABOL) polyplex internalization was found to be 
dependent on DNM2, Flotl and PAK1. As discussed above, the 
involvement of PAK1 can be related to phagocytic uptake. Inter­
estingly, however, the strong dependency on Flotl suggests Flot- 
ME as an important alternative entry route. To verify this, we 
investigated the colocalization of flotillin-2 positive vesicles and 
the polyplexes using livecell dual color fluorescence microscopy. 
Polyplexes resided within flotillin-2 positive vesicles within 30 min 
after transfection, but there was no evidence of their association 
with caveolin and thus caveolae. This is in agreement with a recent 
study on, the uptake of PEI polyplexes and Lipofectamine™ lip- 
oplexes in HeLa cells [14], where a link was found between the 
attachment of gene complexes to cell surface HSPGs and subse­
quent Flot-ME of HSPG bound gene complexes. Knowledge of HSPG 
endocytosis is still quite limited, despite its essential role in the 
internalization of some viruses, bacteria and cationic peptides [31]. 
After interacting with heparan sulfate binding ligands, HSPGs are 
reported to cluster in cholesterol-dependent micro-environments 
that are internalized in endocytic vesicles deficient of caveolin-1 
and clathrin, but positive for flotillin-1. This process requires an 
intact actin cytoskeleton tyrosine kinase activity, PKC activity, 
dynamin and activated Rac [72]. This is in strong agreement with 
our findings here. Whether DNM2 is required for Flot-ME seems to 
depend on the nature of the internalized cargo. For example, DNM2 
is not required for HSPG mediated internalization of eosinophil 
cationic protein in Beas-2B cells [64], but was shown to be required 
for HSPG mediated uptake of PEI polyplexes in HeLa cells [14]. This 
is in good agreement with our findings for p(CBA-ABOL) polyplexes 
in RPE cells. We conclude that, apart from phagocytosis, the p(CBA- 
ABOL) polyplexes enter ARPE-19 cells through Flot-ME.
It is accepted that nanoparticle size can have a substantial 
influence on endocytic uptake of nanomedicines [73], which is 
attractive in the sense that it would offer possibilities to target for 
preferred endocytic pathways simply by engineering the size of the 
nanomedicines. In this study we have found that the p(CBA-ABOL) 
polyplexes aggregate when suspended in OptiMEM. This could be 
easily demonstrated using fluorescence single particle tracking (see 
Supplementary. Fig. 7) [74]. In an attempt to study the influence of 
size on uptake, we have performed extra experiments in which the 
polyplexes were first incubated for 30 min in OptiMEM before 
adding them to the cells. This will increase the extent of aggregation 
and could give some preliminary insight if the identified endocytosis 
pathways depend on the size of the complexes. As summarized in 
Supplementary. Fig. 8, while the polyplex uptake and transfection 
was increased when pre-incubated in OptiMEM, we could not find 
a shift in endocytosis pathways, at least as far as the PAK1 and flo­
tillin-1-dependent or Flot-1-dependent routes are concerned. 
Although this is not a stringent proof, it is a first indication that the 
results published here, perhaps surprisingly, are not size dependent.
4.5. Correlation betw een endocytosis and transgene expression
Having established that p(CBA-ABOL) polyplexes are internal­
ized in ARPE-19 cells via a phagocytosis-like mechanism and Flot- 
ME, it remained to be determined whether they are equally involved 
in mediating transfection. It is important to evaluate whether 
certain endocytic pathways preferentially lead to cell transfection, 
as it would allow one to consider a strategy to target the polyplexes 
towards the most successful endocytic pathway through ligand 
coupling. Using siRNA depletion of flotillin-1 we could clearly show 
that Flot-ME is an important route for transfection. In contrast, 
despite the significant role of PAK1 in polyplex uptake, PAK1 
knockdown did not decrease GFP expression. This suggests that the 
phagocytosis-like internalization of polyplexes is not as effective for 
transfection and this could be due to the instant delivery of the 
polyplexes through phagosomes to degradative lysosomes.
In addition, we observed an intriguingly strong effect of caveolin-1 
depletion on reporter gene expression, despite the fact that polyplex 
uptake was relatively unaffected. Since this protein was not shown to 
play a major role in early intracellular trafficking of p(CBA-ABOL) 
polyplexes (Fig. 6), this suggests an indirect effect of Cavl knockdown. 
Indeed, Fig. 5C clearly shows that knockdown of caveolin-1 resulted in 
a comparable downregulation of flotillin-1 expression. Interestingly, 
a similar though opposite effect has been reported in HeLa cells [75] 
and in intestinal epithelial cells [76]. To explain the observed effects 
on uptake and transfection, we propose the following hypothesis. 
Downregulating caveolin-1 results in a decrease of Flot-ME and 
thereby decreases polyplex uptake. At the same time caveolin-1 
knockdown causes stimulation of phagocytosis (Fig. 4), resulting in 
a net unaltered uptake of polyplexes. However, because the induced 
phagocytosis-like internalization pathway of the polyplexes does not 
contribute to transfection, its overall efficiency drops.
4.6. Inhibiting endocytic pathways: chemical versus molecular 
inhibition
Chemical inhibitors are frequently used to study endocytosis 
and results generated from studies using these agents are often 
insightful. However, without adequate controls their effects are 
difficult to interpret and could give rise to erroneous conclusions. 
The experiments with genistein and resulting data highlight this 
issue. Genistein is frequently used to study Cav-ME functioning as 
a tyrosine kinase inhibitor that impairs actin recruitment and 
DNM2 recruitment to the site of endocytosis [48]; both are indis­
pensable for Cav-ME. However, genistein treatment might also 
affect other endocytosis routes as we observed here and in fact our 
studies showed that CDE was the only endocytic pathway tested 
that was insensitive to this drug. Phagocytosis has been also shown 
to be sensitive for genistein [77,78] and Flot-ME is reported to be 
tyrosine kinase dependent [79]. Therefore, if genistein inhibits 
uptake of gene complexes, one cannot necessarily draw the 
conclusion that they are taken up by Cav-ME. Indeed, while we 
found that the uptake of p(CBA-ABOL) complexes is inhibited by 
genistein, RNAi depletion revealed that it is not Cav-ME but rather 
a combination of phagocytosis and Flot-ME that regulate polyplex 
uptake. Similar issues and difficulties in interpretation were 
encountered with rottlerin, a PKC inhibitor reported to inhibit 
macropinocytosis [52]. Macropinocytosis and phagocytosis have 
been reported to be PKC dependent [52], thus questioning the 
specificity of this drug. Indeed, our own results showed rottlerin to 
inhibit uptake of 70 kDa dextran, but it also inhibited 40% of EC 
uptake and 30% of hTf and LacCer uptake (Fig. 3).
It is clear that chemical inhibitors by itself are generally not 
sufficient to fully elucidate endocytosis of gene complexes or
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nanoparticles in general. As demonstrated in this work, RNAi 
downregulation of specific, proteins can provide further comple­
mentary data. It is however, important to note that not all cells will 
be evenly affected by siRNA and thus the cell population may be 
heterogeneous with respect to their level of expression of the target 
protein. To analyze the cells which were successfully depleted, 
cotransfection experiments with reporter gene forming a selection 
marker for knockdown cells are often employed [14]. Alternatively, 
to increase the probability of downregulating a majority of cells, 
one can repeatedly transfect the cells with siRNA [14,80]. It is the 
latter strategy that was applied in this work. Furthermore, siRNA 
mediated knockdown exhibits generally high specificity. However, 
in some cases protein downregulation can affect, directly or indi­
rectly, expression of other proteins. These effects were also 
observed in our studies, where the siRNAs against caveolin-1 
seemed to knockdown flotillin-1 expression (Fig. 5C).
5. Conclusion
In this work we performed a detailed study on the attachment 
and internalization mechanisms of p(CBA-ABOL) gene complexes in 
a in vitro model of the retinal pigment epithelium. To elucidate 
endocytic mechanisms, we encourage the combination of different 
methodological approaches, like chemical and RNAi based inhibi­
tion, which can be further complemented with dual color fluores­
cence colocalization microscopy. Here, we show that the polyplexes 
are internalized via two endocytic portals to the cell, after associ­
ation with cell surface HSPGs. These portals are flotillin mediated 
endocytosis and a PAK1 dependent, phagocytosis-like mechanism. 
Interestingly we found that of both internalization routes, only Flot- 
ME leads to successful transfection. An elaborate comprehension of 
both the characteristics of the vectors as well as the mechanisms by 
which they interact with the targeted cells is required to eventually 
help us design safe and efficient non-viral gene vectors to transfect 
the RPE and, by extension, any other type of target cells. This 
knowledge may help us (1) to evaluate the effects of chemical 
modifications of the carrier polymer on cell attachment and 
endocytosis, (2) to identify new specific cell surface targets to 
improve cell attachment and (3) to aim for specific endocytic 
pathways that lead to successful transfection.
Acknowledgments
D. Vercauteren is a doctoral fellow of the Institute for the 
Promotion of Innovation through Science and Technology in Flan­
ders (IWT), Belgium. We gratefully acknowledge the European 
Commission for funding through the Integrated 6th Framework 
Programme MediTrans. Monerah al Soraj is supported by a Kuwaity 
Government sponsored PhD studentship awarded to Cardiff 
University.
Appendix. Supplementary material
Supplementary data related to this article can be found online at 
doi:10.1016/j.biomaterials.2010.12.045.
References
11 ] Varga CM, Tedford NC. Thomas M, Klibanov AM, Griffith LG, Lauffenburger DA.
Quantitative comparison of polyethylenimine formulations and adenoviral
vectors in term s of intracellular gene delivery processes. Gene Ther
2005;12:1023-32. >
[2] Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem
2009:78:31.1-31.46.
[3] Jones AT. Macropinocytosis: searching for an endocytic identity and role in the
uptake of cell penetrating peptides. J Cell Mol Med 2007;11:670-84.
[4] Kerr MC, Teasdale RD. Defining macropinocytosis and others. Traffic 
2009;10:364-71.
[5] Maxfield FR, Mcgraw TE. Endocytic recycling. Nat Rev Mol Cell Biol 
2004;5:121-32.
[6] Mayor S, Pagano RE Pathways of dathrin-independent endocytosis. Nat Rev 
Mol Cell Biol 2007;8:603-12.
[7] Pelkmans L, Helenius A. Endocytosis via caveolae. Traffic 2002;3:311-20.
[8] Glebov OO, Bright NA, Nichols BJ. Flotillin-1 defines a dathrin-independent 
endocytic pathway in mammalian cells. Nat Cell Biol 2006;8:46-U16.
[9] Doherty GJ, Lundmark R. GRAF1 -dependent endocytosis. Biochem Soc Trans 
2009;37:1061-5.
[10] Douglas KL Toward development of artificial viruses for gene therapy: 
a comparative evaluation of viral and non-viral transfection. Biotechnol Prog 
2008;24:871-83.
[11] von Gersdorff K, Sanders NN, Vandenbroucke R, De Smedt SC, W agner E, 
Ogris M. The internalization route resulting in successful gene expression 
depends on polyethylenimine both cell line and polyplex type. Mol Ther 
2006:14:745-53.
[12] Rejman J, Bragonzi A, Conese M. Role of clathrin- and caveolae-mediated 
endocytosis in gene transfer mediated by lipo- and polyplexes. Mol Ther 
2005:12:468-74.
[13] Midoux P, Breuzard G, Gomez JP, Pichon C. Polymer-based gene delivery: 
a current review on the uptake and intracellular trafficking of polyplexes. Curr 
Gene Ther 2008;8:335-52.
[14] Payne CK, Jones SA, Chen C, Zhuang XW. Internalization and trafficking of cell 
surface proteoglycans and proteoglycan-binding ligands. Traffic 2007; 
8 :389-401.
[15] Goncalves C, Mennesson E Fuchs R, Gorvel JP, Midoux P, Pichon C. Macro­
pinocytosis of polyplexes and recycling of plasmid via the dathrin-dependent 
pathway impair the transfection effidency of human hepatocardnom a cells. 
Mol Ther 2004;10:373-85.
[16] McLendon PM, Fichter KM, Reineke TM. Poly(glycoamidoamine) vehicles 
promote pDNA uptake through multiple routes and effident gene expression 
via caveolae-mediated endocytosis. Mol Pharm; 2010.
[17] Gabrielson NP, Pack DW. Efficient polyethylenimine-mediated gene delivery 
proceeds via a caveolar pathway in HeLa cells. J Control Release 2009; 
136:54-61.
[18] Diaz-Moscoso, Vercauteren D, Rejman J. Benito JM, Ortiz Mellet C, De 
Smedt SC, e t al. Insights in cellular uptake mechanisms of pDNA-polycationic 
amphiphilic cyclodextrin nanoparticles (CDplexes). J Control Release 
2010;143:318-25.
[19] Vercauteren D, Vandenbroucke rRE Jones AT, Rejman J, Demeester J, De 
Smedt SC, e t al. The use of inhibitors to study endocytic pathways of gene 
carriers: optimization and pitfalls. Mol Ther 2010;18:561-9.
[20] Ivanov Andrei 1. Pharmacological inhibition of endocytic pathways: is it 
specific enough to  be useful? Methods Mol Biol 2008;440:15-33.
[21] Strauss O. The retinal pigment epithelium in visual function. Physiol Rev 
2005;85:845-81.
[22] Murata T, Cui J, Taba KE, Oh JY, Spee C, Hinton DR, et al. The possibility of gene 
therapy for the treatm ent of choroidal neovascularization. Ophthalmology 
2000;107:1364-73.
[23] Naik R, Mukhopadhyay A, Ganguli M. Gene delivery to the retina: focus on 
non-viral approaches. Drug Discov Today 2009;14:306-15.
[24] Lin C, Zhong ZY. Lok MC Jiang XL, Hennink W E Feijen J, et al. Novel bio- 
reducible poly(amido aminejs for highly effident gene delivery. Bioconjug 
Chem 2007;18:138-45.
[25] Jere D, Arote R, Jiang HL, Kim YK, Cho MH, Cho CS. Bioreducible polymers for 
effident gene and siRNA delivery. Biomed Mater 2009;4.
[26] Christensen LV, Chang CW, Kim WJ, Kim SW, Zhong ZY. Lin C, et aL Redudble 
poly(amido ethyleniminejs designed for triggered intracellular gene delivery. 
Bioconjug Chem 2006;17:1233-40.
[27] Jeong JH, Kim SH, Christensen LV, Feijen J. Kim SW. Reducible poly(amido 
ethylenimine)-based gene delivery system for improved nucleus trafficking of 
plasmid DNA. Bioconjug Chem 2010;21:296-301.
[28] W ang R, Zhou L, Zhou Y, Li G, Zhu X. Gu H, e t al. Synthesis and gene delivery of 
poly(amido aminejs w ith different branched architecture. Biomacromolecules 
2010;11:489-95.
[29] Lin C, Engbersen JFJ. The role of the disulfide group in disulfide-based poly­
meric gene carriers. Expert Opin Drug Deliv 2009;6:421-39.
[30] Gandhi NS, Mancera RL The structure of glycosaminoglycans and their 
interactions with proteins. Chem Biol Drug Des 2008;72:455-82.
[31] Belting M. Heparan sulfate proteoglycan as a plasma membrane carrier. 
Trends Biochem Sci 2003;28:145-51.
[32] Nakase I, Tadokoro A, Kawabata N, Takeuchi T, Katoh H, Hiramoto K, e t al. 
Interaction of arginine-rich peptides w ith membrane-associated proteogly­
cans is crucial for induction of actin organization and macropinocytosis. 
Biochemistry 2007;46:492-501.
[33] Vives RR, Lortat-Jacob H. Fender P. Heparan sulphate proteoglyeans and viral 
vectors: ally or foe? Curr Gene Ther 2006;6:35-44.
[34] Mislick KA, Baldeschwieler JD. Evidence for the role of proteoglycans in cation- 
mediated gene transfer. Proc Natl Acad Sd U S A 1996;93: 
12349-54.
[35] Mounkes LC, Zhong W, Cipres-Palacin G, Heath TD, Debs RJ. Proteoglycans 
mediate cationic Liposome-DNA complex-based gene delivery in vitro and in 
vivo. J Biol Chem 1998;273:26164-70.
3084 D. Vercauteren et al. /  Biomaterials 32 (2011)3072-3084
[36] Page E, Goings GE, Upshaw-Earley J. Hanck DA. Endocytosis and uptake of 
lucifer yellow by cultured atrial myocytes and isolated intact atria from adult 
rats. Regulation and subcellulaHocalization. Circ Res 1994;75:335-46.
[37] Ernst S, Langer R, Cooney CL, Sasisekharan R. Enzymatic degradation of gly- 
cosaminoglycans. Crit Rev Biochem Mol Biol 1995;30:387-444.
[ 38] Marks DL Singh RD, Choudhury A, W heatley CL, Pagano RE. Use of fluorescent 
sphingolipid analogs to study lipid transport along thepathway endocytic 
Methods 2005;36:186-95.
[39] Mercer J, Helenius A. Virus entry by macropinocytosis. Nat Cell Biol 2009; 
11:510-20.
[40] Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B, Sandvig K. Extraction 
of cholesterol w ith methyl-beta-cydodextrin perturbs formation of dath rin - 
coated endocytic vesicles. Mol Biol Cell 1999;10:961-74.
[41] Cooper JA. Effects of cytochalasin and phalloidin on actin. J Cell Biol 
1987;105:1473-8.
[42] Sampath P, Pollard TD. Effects of cytochalasin. phalloidin, and pH on the 
elongation of actin-filaments. Biochemistry 1991:30:1973-80.
[43] Peterson JR. Mitchison TJ. Small molecules, big impact: a history of chemical 
inhibitors and the cytoskeleton. Chem Biol 2002;9:1275-85.
[44] Akinc A. Thomas M, Klibanov AM, Langer R. Exploring polyethylenimine- 
mediated DNA transfection and the proton sponge hypothesis. J Gene Med 
2005;7:657-63.
[45] Bayer N, Schober D, Prchla E, Murphy RF. Blaas D, Fuchs R. Effect of bafilo- 
mycin Al and nocodazole on endocytic transport in HeLa Cells: implications 
for viral uncoating and infection. J Virol 1998;72:9645-55.
[46] Baravalle G. Schober D, Huber M, Bayer N, Murphy RF, Fuchs R. Transferrin 
recycling and dextran transport to lysosomes is differentially affected by 
bafilomycin, nocodazole. and low temperature. Cell Tissue Res 2005; 
320:99-113.
[47] W ang LH, Rothberg KG, Anderson RG. Mis-assembly of clathrin lattices on 
endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 
1993;123:1107-17.
[48] Akiyama T, Ishida J, Nakagawa S. Ogawara H, Watanabe S, Itoh N, et al. 
Genistein, a specific inhibitor of tyrosine-specific protein-kinases. J Biol Chem 
1987;262:5592-5.
[49] Praefcke GJK, McMahon HT. The dynamin superfamily: universal membrane 
tubulation and fission molecules? Nat Rev Mol Cell Biol 2004;5:133-47.
[50] Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. Dynasore, 
a cell-permeable inhibitor of dynamin. Dev Cell 2006;10:839-50.
[51] Gschwendt M, Muller HJ, Kielbassa K, Zang R. Kittstein W, Rincke G. e t al. 
Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 
1994;199:93-8.
[52] Sarkar K, Kruhlak MJ, Erlandsen SL Shaw S. Selective inhibition by rottlerin of 
macropinocytosis in monocyte-derived dendritic cells. Immunology 
2005;116:513-24.
[53] Romer W, Berland L, Chambon V, Gaus K, Windschiegl B, Tenza D, et al. Shiga 
toxin induces tubular membrane invaginations for its uptake into cells. Nature 
2007;450:670-5.
[54] Liu YW, Surka MC, Schroeter T, Lukiyanchuk V, Schmid SL Isoform and splice- 
variant specific functions of dynamin-2 revealed by analysis of conditional 
knock-out cells. Mol Biol Cell 2008;19:5347-59.
[55] Lakhan SE, Sabharanjak S, De A. Endocytosis of glycosylphosphatidylinositol- 
anchored proteins. J Biomed Sci 2009; 16.
[56] Gong Q, Huntsman C  Ma D. Clathrin-independent internalization and recy­
cling. J Cell Mol Med 2008;12:126-44.
[57] Lundmark R, Doherty GJ, Howes MT. Cortese K, Vallis Y, Parton RG, e t al. The 
GTPase-activating protein GRAF1 regulates the CUC/GEEC endocytic pathway. 
Curr Biol 2008;18:1802-8.
[58] Dharmawardhane S, Schurmann A, Sells MA, Chemoff J, Schmid SL 
Bokoch CM. Regulation of macropinocytosis by p21-activated kinase-1. Mol 
Biol Cell 2000;11:3341-52.
]59] Liberali P, Kakkonen E, Turacchio G, Valente C. Spaar A, Perinetti G, et al. The 
closure of Pak1-dependent macropinosomes requires the phosphorylation of 
CtBPl/BARS. EMBO J 2008;27:970-81.
[60] Donaldson JG. Arfs, phosphoinositides and membrane traffic. Biochem Soc 
Trans 2005;33:1276-8.
[61] Frick M, Bright NA. Riento K, Bray A, Merrified C, Nichols BJ. Coassembly of 
flotillins induces formation of membrane microdomains, membrane curva­
ture, and vesicle budding. Curr Biol 2007;17:1151-6.
[62] Kopatz I, Remy JS, Behr JP. A model for non-viral gene delivery: through syn- 
decan adhesion molecules and powered by actin. J Gene Med 2004;6:769-76.
[63] Paris S, Burlacu A, Durocher Y. Opposing roles of syndecan-1 and syndecan-2 
in polyethylenimine-mediated gene delivery. J Biol Chem: 2008:7697-704.
[64] Fan TC, Chang HT. Chen IW. Wang HY, Chang MDT. A heparan sulfate-facili­
tated and raft-dependent macropinocytosis of eosinophil cationic protein. 
Traffic 2007;8:1778-95.
[65] W ittrup A, Sandgren S, Lilja J, Bratt C, Gustavsson N, Mdrgelin M, et al. 
Identification of proteins released by mammalian cells that mediate DNA 
internalization through proteoglycan-dependent macropinocytosis. J Biol 
Chem 2007;282:27897-904.
[66] Grosse S, Aron Y, Thevenot G, Francois D. Monsigny M, Fajac I. Potocytosis and 
cellular exit of complexes as cellular pathways for gene delivery by poly­
cations. J Gene Med 2005;7:1275-86.
[67] Khalil IA, Kogure K, Futaki S, Harashima H. High density of octaarginine 
stimulates macropinocytosis leading to efficient intracellular trafficking for 
gene expression. J Biol Chem 2006;281:3544-51.
[68] Clement C, Tiwari V. Scanlan PM. Valyi-Nagy T. Yue BYJT, Shukla D. A novel 
role for phagocytosis-like uptake in herpes simplex virus entry. J Cell Biol 
2006;174:1009-21.
[69] Bonazzi M, Spano S, Turacchio G, Cericola C, Valente C, Colanzi A, e t al. CtBP3/ 
BARS drives membrane fission in dynamin-independent transport pathways. 
Nat Cell Biol 2005;7:570-80.
[70] Castellano F, Chavrier P, Caron E  Actin dynamics during phagocytosis. Semin 
Immunol 2001;13:347-55.
[71] Zhang J, Zhu J, Bu X, Cushion M, Kinane TB, Avraham H, e t al. Cdc42 and RhoB 
activation are required for mannose receptor-mediated phagocytosis by 
human alveolar macrophages. Mol Biol Cell 2005;16:824-34.
[72] Lambaerts K, Wilcox-Adelman SA, Zimmermann P. The signaling mechanisms 
of syndecan heparan sulfate proteoglycans. CurrOpin Cell Biol 2009;21:662-9.
[73] Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J Control 
Release 2010;145:182-95.
[74] Braeckmans K. Buyens K, Bouquet W, Vervaet C, Joye P. De Vos F, e t al. Sizing 
nanomatter in biological fluids by fluorescence single particle tracking. Nano 
Lett 2010;10:4435-42.
[75] sasiik P, Padari K, Niinep A. Lorents A, Hansen M, Jokitalo E, et al. Protein 
delivery with transportans is mediated by caveolae rather than flotillin- 
dependent pathways. Bioconjug Chem 2009;20:877-87.
[76] Vassilieva EV, Ivanov Al, Nusrat A. Flotillin-1 stabilizes caveolin-1 in intestinal 
epithelial cells. Biochem Biophys Res Commun 2009;379:460-5.
[77] Finnemann SC. Focal adhesion kinase signaling promotes phagocytosis of 
integrin-bound photoreceptors. EMBO J 2003;22:4143-54.
[78] Zhao MW, Jin ML He S, Spee C, Ryan SJ, Hinton DR. A distinct integrin- 
mediated phagocytic pathway for extracellular matrix remodeling by RPE 
Cells. Invest Ophthalmol Vis Sci 1999;40:2713-23.
[79] Riento K, Frick M, Schafer I, Nichols BJ. Endocytosis of flotillin-1 and flotillin-2 
is regulated by Fyn kinase. J Cell Sci 2009;122:912-8.
[80] Hybiske K, Stephens RS. Mechanisms of Chlamydia trachomatis entry into 
nonphagocytic cells. Infect Immun 2007;75:3925-34.
[81 ] Irschick EU. Haaa G, Geiger M, Singer W, Ritsch-Marte M, Konwalinka G, et al. 
Phagocytosis of human retinal pigment epithelial cells: evidence of a diurnal 
rhythm, involvement of the cytoskeleton and interference of antiviral drugs. 
Ophthalmic Res 2006;38:164-74.
